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Abstract
In the human airways, transepithelial ion transport is facilitated by a complex arrangement
of ion channel, pump, cotransporter and tight junction proteins. The transepithelial potential
difference (Vt), which shows characteristic changes in cystic fibrosis (CF) disease, is com-
monly measured in the study of epithelial ion transport. In this thesis I develop a mathematical
model of ion transport in human nasal epithelia (HNE), in order to quantitatively investigate
the relationship between individual transport protein activities and the transepithelial potential
generated.
In the first part of this work, I investigate the biophysical basis of hyperpolarised basal Vt
and increased amiloride sensitive Vt in CF HNE cells. Using published electrophysiological
measurements from in vitro experiments, I estimate the value of apical Na+ and apical Cl−
permeability in both CF and non-CF HNE cells. I find apical Na+ permeability is increased
in CF relative to non-CF cells, and apical Cl− permeability is decreased in CF, suggesting
increased epithelial sodium channel (ENaC) activity, as well as decreased activity of anion
specific CFTR channels, is responsible for the abnormal bioelectric properties of CF HNE cells.
In the second part of this work, I focus on the nasal potential difference (NPD) test com-
monly made in patients with CF, investigating the biophysical basis of interpatient variability in
NPD measurements. I find that the variation in amiloride insensitive Vt observed in a group of
CF patients, cannot be accounted for by variation in apical Na+ and Cl− permeability alone. It
is necessary to assume incomplete block of ENaC channels by amiloride, and patient to patient
variability in other physiological parameters, in order to fully explain the observed variability
in this cohort of NPD traces.
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Chapter 1
Introduction
My research investigates the pathogenesis of cystic fibrosis (CF), a genetic disorder, by con-
sidering theoretically the biophysical basis of transepithelial ion transport in human airway ep-
ithelia. This approach is inherently interdisciplinary in nature, and lies at the interface between
physiology and applied mathematics. Hence in the following sections I will first introduce some
important concepts in epithelial physiology and ion transport, then discuss CF disease and how
it affects airway epithelial electrophysiology. I will go on to review the previous mathematical
analyses of epithelial ion transport processes, and finally outline some of the specific research
goals of my thesis, in the context of this previous work.
1.1 Physiology of epithelial ion transport in the human airways
1.1.1 Form and function of epithelial tissue
Epithelial tissue consists of planar arrangements of closely packed cells which can line internal
structures and compartments, or form thick secretory glands. In the human lungs, there is a
continuous epithelium from the nasal pharynx, through the trachea and bronchus, all the way to
the distal airways (see Figure 1.1). To a first approximation, the structure of the human airway
epithelium (HAE) is that of a single monolayer of cells, which separates the airway lumen
from the interstitial fluid (Figure 1.2). This form underlies two of the primary functions of this
epithelium; (a) to create a physical boundary layer between the airway lumen and the internal
body compartments, and (b) to regulate transport of small molecules and fluids between these
two compartments (Wills et al., 1996).
A schematic diagram of an idealised epithelial monolayer is shown in Figure 1.2. A thin
layer of liquid (the airway surface liquid or ASL) sits on top of the monolayer of epithelial
cells, protecting them from inhaled bacterial pathogens (this is discussed further in Section
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Figure 1.1: Diagram showing a cross-sectional view of the human respiratory system (Villareal,
2007a). The surface of the airways is covered by an epithelial layer that extends continuously
from the nasal cavity, through the trachea and bronchus, towards the alveoli.
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Figure 1.2: Schematic diagram of idealised human airway epithelia. The airway surface liquid
(ASL) covers a monolayer of polarised epithelial cells, which separates the lumen from the in-
terstitial fluid. Tight junction proteins bind epithelial cells together laterally, and divide the cell
membrane into apical and basolateral areas. Transepithelial transport can occur via the trans-
cellular route across apical and basolateral membrane, or via the paracellular route through the
tight junctions and lateral intracellular space.
1.2.2). Individual epithelial cells are polarised and have two distinct membrane regions, the
lumen-facing apical membrane, and the internal facing basolateral membrane. Tight junction
proteins, which bind the lateral membranes of epithelial cells together, demarcate the boundary
between these two regions and give the epithelial monolayer structural integrity. Transepithelial
transport of small molecules is possible via two routes, along the transcellular pathway via
the apical and basolateral membranes, and along the paracellular pathway through the tight
junctions.
As well as being in contact with different compartments, the apical and basolateral mem-
branes also differ intrinsically since they contain different sets of membrane proteins. Having
an asymmetric distribution of membrane proteins allows the epithelium to direct transport vec-
torially across the monolayer. Net transport of small molecules across an epithelial barrier can
thus be carried out.
1.1.2 Mechanisms of membrane transport in airway epithelia
The co-ordinated regulation of ion transport along the paracellular route, by tight junction pro-
teins, and the trans-cellular route via membrane proteins, allows an epithelium to perform its
role as a controller of ion transport. There are several modes of ion transport that are important
to consider; passive, active and secondary active.
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Figure 1.3: Small hydrophilic molecules cannot easily diffuse across lipid bilayer membranes
with hydrophobic interiors. Mammalian cells facilitate movement of small molecules via chan-
nel or carrier proteins inserted in the lipid bilayer. Channel proteins form a small hydrophilic
pore through which charged ions can diffuse, while carrier proteins bind molecules on one side
of the membrane and release them on the other side, facilitating net transmembrane movement.
Image from Villareal (2007b).
1.1.2.1 Passive transport in epithelia
Passive transport is so called, as it does not require any explicit energy input from the cell to
take place. If there is an existing chemical or electric potential gradient, free ions in solution
will diffuse down the gradient to the area of lower potential energy, providing there is no barrier
to movement. However, small hydrophilic ions like Na+ or Cl− cannot diffuse across the
hydrophobic centre of the cell’s lipid bilayer membrane. Passive ion transport across the cell
membrane must therefore be facilitated by proteins such as ion channels or transporters inserted
in the cell membrane, as highlighted schematically in Figure 1.3.
In the case of passive transport, ion channel proteins provide a hydrophilic pore through
which ions can diffuse, unimpeded by the hydrophobic interactions of the lipid bilayer. In the
presence of an electrochemical gradient, ions will diffuse passively across the cell membrane,
if there are ion channels whose pores are open - the cell is not using energy explicitly in the
movement of these ions, but rather utilizing the free energy inherent in the potential energy
gradient.
In airway epithelia, various ion channels localised in the apical and basolateral membranes
facilitate passive transport. Tight junction proteins also allow passive transport of certain ions
along the paracellular pathway of HAE.
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Figure 1.4: The Na+ −K+ −ATPase actively transports Na+ against an electrochemical gra-
dient, by coupling the reaction cycle to the hydrolysis of ATP molecules. Image from Villareal
(2007c).
1.1.2.2 Active transport in epithelia
Without the active energy input from a cell, all electro-chemical gradients would eventually
dissipate, and no further passive transport would be possible. However if there is energy input
from the cell to keep the internal ionic concentrations away from equilibrium, electro-chemical
gradients can be maintained.
Active transport of ions against an electrochemical gradient is mediated by pumps. Rather
than simply provide a pathway for movement, as in the case of channel proteins, carrier proteins
must physically translocate the molecules from one side of the cell membrane to the other.
This involves binding the transported molecule on one side of the membrane, and undergoing a
conformational change which leaves the binding site exposed on opposite side of the membrane,
from where the molecule can finally unbind from the carrier having been transported across the
membrane.
Perhaps the most important protein to carry out active transport is the Na+−K+−ATPase,
which is ubiquitous in animal cells. The Na+ − K+ − ATPase is expressed in the basolateral
membrane of HAE cells, and moves K+ ions into the cell, while pumping Na+ out, against
an electrochemical gradient (a schematic diagram of this process is shown in Figure 1.4). The
pump uses energy from the hydrolysis of an ATP molecule to drive the reaction cycle in the
direction necessary to move Na+ ions out of the cell.
1.1.2.3 Co-transport in epithelia
Co-transport proteins can also move molecules across a membrane without direct energy input.
In a similar manner to active transport, the carrier protein physically binds the molecules to be
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Figure 1.5: Diagram showing the major ion transport proteins in human nasal epithelial cells.
In the apical membrane there are channel proteins, and in the basolateral membrane there are
channel and carrier proteins (pumps and cotransporters).
transported. In contrast to active transport however, the movement of the bound molecules is not
always against an electrochemical gradient. Typically one of the bound species will be moving
in an energetically favourable direction, and the energy gained from this movement helps the
conformational change required to move a second species against a potential energy gradient.
This type of transport is referred to as secondary active, as it does not require explicit energy
input from the cell, but does require the cell to keep ion gradients away from equilibrium. It
is also referred to as cotransport or symport as typically two or more ions or molecules are
transported simultaneously.
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1.1.3 Ion transport pathways in human airway epithelia
Ion transport in the human airways is mediated by a collection of ion channels, pumps and co-
transporters. Figure 1.5 shows a schematic diagram highlighting several of the major transport
pathways in a typical human nasal epithelial (HNE) cell. The apical membrane contains Na+
and Cl− ion channels, the epithelial sodium channel (ENaC) and the cystic fibrosis transmem-
brane conductance regulator (CFTR). The basolateral membrane of these epithelial cells contain
Cl− and K+ ion channels, as well as Na+ −K+ −ATPase pumps, and Na+ −K+ − 2Cl−
cotransporters. The tight junctions of the epithelia also allow transport of ions such as Na+,
Cl− and K+, directly between the ASL and interstitial fluid.
1.1.3.1 Ion channel proteins
The epithelial Na+ channel, ENaC, is known for its high affinity for amiloride, a potassium
sparing diuretic. In concert with the Na+ −K+ −ATPase , ENaC is involved in active re-
absorption of Na+ in several epithelia - in humans it is expressed in the kidney, colon, lung and
sweat glands (Garty and Palmer, 1997). As a result ENaC activity is important in maintaining
homeostasis of Na+ and K+ in the body, and has been implicated in the pathogenesis of several
diseases. These include hypertension resulting from improper function of ENaC in the kidneys
(Bubien, 2010), and cystic fibrosis, which I will discuss further in Section 1.2.
In the human airways, ENaC channels are constitutively active, therefore play an important
role in regulating ASL composition. ENaC activity in the airways can be regulated by myriad
factors, although regulation by proteases, intracellular, extracellular and membrane bound, pre-
dominates (for a review see Gaillard et al. (2010)). There is also evidence that ENaC activity
can be regulated by CFTR channel activity, directly through physical interaction (Berdiev et al.,
2009), or indirectly via intracellular messengers such as cAMP (Stutts et al., 1995), although
this regulatory interaction remains a matter of debate.
Cystic fibrosis trans-membrane conductance regulator (CFTR) is an ATP gated, anion spe-
cific channel, which is activated by phosphorylation, primarily by protein kinase A, following
a rise in intracellular cAMP. CFTR is localised to the apical membrane of secretory epithelia,
and in humans is expressed in the respiratory and digestive systems, the pancreas and in sweat
glands (Gadsby et al., 2006). The primary role of CFTR in the airways is to facilitate secretion
of Cl− and HCO−3 by epithelial cells, regulating the ionic composition of the ASL. Mutations
in the CFTR gene are responsible for cystic fibrosis disease, but there are multiple hypotheses
1.1. Physiology of epithelial ion transport in the human airways 18
as to how the disease progresses from malfunctioning channel to persistent lung infections. The
presence of a putative regulatory interaction between CFTR and ENaC, that is lost in CF, has
been particularly controversial. In Section 1.2.2 and 1.2.5 I discuss these issues in more detail.
Other ion channels expressed in the apical membrane of airway epithelia include Calcium-
activated Cl− channels (CaCC), and K+ channels. CaCC channels are not thought to be basally
active, but are interesting in the context of CF disease, as they provide an alternate route for Cl−
transport, that could form part of a therapeutic strategy (Cuthbert, 2011). There is limited evi-
dence for voltage gated KCNQ type K+ channels expressed in the apical membrane of certain
cell types (Moser et al., 2008; Bardou et al., 2009), but they have not yet been implicated in the
pathogenesis of CF lung disease.
The basolateral membrane of airway epithelial cells expresses a number of different
types of K+ channels. Evidence of functional voltage gated (KvLQT1) and calcium activated
(KCa3.1) K+ channels has been found in human nasal epithelial cells (Bardou et al., 2009), and
they have been shown to influence Cl− secretion in studies of ion transport in epithelial cells
(Cowley and Linsdell, 2002). These channels provide a route for K+ that enters the cell via
the Na+ −K+ −ATPase to be recycled, and hence are important for cellular homeostasis. As
K+ channels can influence the basolateral membrane potential, and hence the electric potential
across the apical membrane, they can be stimulated to induce Cl− secretion from epithelial cells
(Cotton, 2000).
Basolateral Cl− channels have been reported, distinct from the CFTR and CaCC channels
that are found apically (Itani et al., 2007). Their exact physiological role in regulating transport
is not yet clear, but may involve regulating the driving force for Cl− secretion by appropri-
ately altering the basolateral membrane potential (He et al., 2011), and again similarly to the
basolateral K+ channels, provide a route for recycling the Cl− ions that enter the cell via the
Na+ −K+ − 2Cl− co-transporter.
1.1.3.2 Carrier proteins
The Na+ −K+ −ATPase pump is expressed in the basolateral membrane of all epithelial
cells in the human airways. As outlined previously (Section 1.1.2.2) the pump uses energy
from the hydrolysis of one ATP molecule to transport three Na+ ions out of the cell and two
K+ ions into the cell per cycle. The action of the ion pump ensures that sodium concentrations
within the cell are kept low, and potassium concentrations high. Maintaining these concentra-
1.1. Physiology of epithelial ion transport in the human airways 19
tion gradients is essential for other transport mechanisms, such as co-transport and diffusion
through ion channels. As well as maintaining ion concentrations away from equilibrium, the
Na+ −K+ −ATPase strongly couples the transport of Na+ and K+ ions, and is implicated in
cell volume regulation. The pump can be blocked by the cardiac glycoside ouabain, which is
used in experimental studies of epithelial transport.
The Na+ −K+ − 2Cl− cotransport protein (NKCC) is expressed in the basolateral mem-
brane of several secretory epithelia, including the intestines, airways and salivary glands. In the
airways the NKCC1 isoform of the protein is expressed, and under normal physiological con-
ditions it couples the movement of two Cl− ions into the cell (along with one Na+ and one K+
ion), which can then be secreted onto the airway lumen via apical Cl− channels. As the NKCC
co-transporter couples the transport of three osmotically important ions, its activity has been
linked to cell volume regulation. NKCC co-transport can be inhibited by loop diuretics such
as furosemide and bumetanide. Readers interested in a further details of NKCC co-transport in
secretory epithelia can consult the review of Haas and Forbush (2000).
1.1.3.3 Tight junction proteins
Ion transport directly between the luminal and serosal compartments occurs via tight junctions
and the lateral intracellular space, together referred to as the paracellular pathway. The tight
junctions are formed by claudins, a family of complex proteins that adhere to the lateral mem-
brane of epithelial cells. Claudins maintain the structural integrity of the epithelial barrier and
also determine the electrical resistance of the paracellular pathway. Depending on the claudin
proteins expressed, the conductance of the pathway and its ion selectivity can vary dramatically
(Coyne et al., 2003), and in the human airways there is limited evidence for cation selectivity
(Coakley et al., 2003).
An important characteristic of an epithelial monolayer’s electrophysiology, is how perme-
able the paracellular junctions are. Highly permeable paracellular pathways are termed leaky,
as current is shunted through the less resistant paracellular path. Epithelia which can support
a large transepithelial electric potential difference (PD) are referred to as tight, and have sig-
nificantly less paracellular permeability. As a rule of thumb, epithelia are considered tight if
their junctional resistance is greater than 500 Ω cm2 and they can generate a transepithelial PD
on the order of 10 − 100 mV (Wills et al., 1996). For comparison, the mean shunt resistance
of human nasal epithelium has been previously estimated to be 412 Ω cm2 and 623 Ω cm2 in
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non-CF and CF cultures respectively (Willumsen and Boucher, 1989).
1.1.3.4 HCO−3 and H
+ transport in airway epithelia
The focus of this thesis is understanding ion transport in human nasal epithelial cells, with par-
ticular emphasis on understanding the transepithelial potential difference (PD) that is generated
by this epithelium. As ion transport in nasal epithelial cells is expected to be dominated by
Na+, Cl− and K+ movements, I have thus far focused on outlining the major proteins involved
in the transport of these three ions. In general however, there will also be movement of other
ions into and out of nasal epithelial cells.
Bicarbonate (HCO−3 ) and proton (H
+) transport are of particular note. Although it is
not known if HCO−3 and H
+ currents significantly influence the transepithelial PD in nasal
epithelial cells, they are important in regulating cell pH and have been implicated in a number
of hypotheses regarding the pathogenesis of CF disease in the airways (discussed in detail in
Section 1.2.2). Hence I will now introduce several transport mechanisms that are involved in
the movement of these ions.
It is known that HCO−3 can permeate through CFTR ion channels, although it is less
permeable than Cl−, with the permeability ratio of Cl− : HCO−3 being estimated as ≈ 4 : 1
(Poulsen, 1994). There is also evidence that these ions are transported by several carrier proteins
located in the basolateral membrane of airway epithelial cells. Calu-3 cells, cells derived from
human bronchial submucosal glands, express sodium bicarbonate cotransporters (NBC), which
move both Na+ and HCO−3 ions into the cell. The stoichiometry of Na
+ : HCO−3 cotransport
by NBC can be either 1:2 or 1:3 depending on which protein variant is expressed, but in Calu-
3 cells the stoichiometry has yet to be determined definitively (Kreindler et al., 2006). Other
carrier proteins known to be expressed in several regions of bronchial epithelia, include cation
exchangers (NHE), which move one H+ out and one Na+ into the cell per cycle, and anion
exchangers (AE), which can exchange one Cl− for one HCO−3 ion in either direction (Dudeja
et al., 1999).
1.1.4 Investigating epithelial electrophysiology experimentally
A common experimental apparatus used in the study of epithelial electrophysiology, is the Uss-
ing chamber, named after the Danish physiologist Hans Ussing who pioneered studies of elec-
trogenic transport in frog skin epithelia. An Ussing chamber typically consists of two half
chambers separated by a semi-permeable membrane. An epithelial monolayer can be cultured
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Figure 1.6: An Ussing chamber type experimental set up, modified to allow intracellular micro-
electrode recordings. An epithelial monolayer is cultured on a permeable support, and is bathed
on either side by physiological saline solutions. The electric PD across the epithelium can be
recorded while the composition of either the lumenal or serosal compartments is altered during
an experiment.
on the permeable support and placed in the chamber, and the epithelium will be bathed on both
sides by physiological solution. Electrodes inserted into both half-chambers, on either side of
the monolayer, allow transepithelial electrical recordings to be performed. By adding pharma-
cological compounds into either of the chambers, an experimentalist can selectively inhibit or
activate transport proteins expressed in the apical or basolateral membrane of the epithelium,
and record the resulting change in the electrical properties that result. Similarly, the ionic com-
position of the bathing solutions can be manipulated to probe mechanisms of ion transport.
Two common modes of recording are the open circuit and short circuit configurations.
In an open circuit recording, the spontaneous transepithelial PD is recorded, and no external
current is driven across the monolayer. This scenario reproduces the conditions that epithelia
would operate in, in vivo, under normal physiological circumstances. In the short circuit config-
uration, an external current is injected across the epithelium to clamp the transepithelial PD (Vt)
to 0 mV. If the solutions on both sides of the monolayer are identical, then with Vt = 0 mV,
there will be no passive transport, and hence the epithelium is said to be short circuited. In this
manner an experimentalist can focus exclusively on changes in the short circuit current Isc that
arise from active transport mechanisms.
Figure 1.6 has a schematic diagram of a modified Ussing chamber, showing a cross-section
of the apparatus. This works on the same principle as a standard Ussing chamber - transep-
ithelial electrical recordings are made while the solutions bathing the monolayer are altered.
However here the luminal chamber is open, so that a microelectrode can gain direct access
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to the monolayer and make electrical recordings from inside epithelial cells. In this set up,
intracellular concentrations and individual membrane potentials can be measured, as well as
transepithelial potential and current recordings.
This is the experimental scenario I aim to model mathematically, primarily because of the
extensive data sets available in the literature for these types of experiment, which I can use for
parameter estimation purposes. In particular, there are data sets covering the electrophysiologi-
cal response of CF HNE cells and non-CF HNE cells to amiloride addition in the luminal bath,
and also removal of Cl− from the lumen perfusate (Willumsen et al., 1989b; Willumsen and
Boucher, 1989, 1991b,a). If I can simulate these experimental perturbations computationally,
then I can make predictions required to estimate parameter values from these data sets.
1.2 Cystic fibrosis disease and abnormal epithelial transport
1.2.1 Overview of CF disease
Cystic fibrosis (CF) is an autosomal, recessive genetic disorder that impairs quality of life and
reduces life expectancy (Davies et al., 2007). CF is prevalent amongst Caucasians, being the
most common lethal single gene disorder found in people of European descent, and on average
1 in 2500 children born in the UK will suffer from the disease (Dodge et al., 2007).
The disease is caused by loss of function mutations in the CFTR gene. CFTR was first
identified in 1989 (Rommens et al., 1989), and since then over 1900 different disease causing
mutations have been recorded in CF patients (see www.genet.sickkids.on.ca/cftr). Mutations are
classified according to how they manifest at the level of protein function. The most common,
the ∆F508 mutation, is present in 90% of patients (in one or two copies). ∆F508 mutations
result in incorrect protein folding and subsequent premature degradation, prior to trafficking and
membrane insertion (class II) (Rowe et al., 2005; Lukacs and Verkman, 2012). Other classes
of mutations produce proteins with reduced or absent ion channel activity (class III and IV), or
decrease the amount of transcripts of CFTR being produced (class V).
Since CFTR is expressed in several tissues in the body, CF has several different symptoms
including chronic lung infections, fibrosis of the pancreas, gastrointestinal difficulties, abnormal
function of the sweat glands and infertility in male patients (Ratjen and Do¨ring, 2003). The most
common cause of death amongst CF sufferers is lung failure resulting from persistent bacterial
infections (Kerem et al., 1992) and the median survival age is 40 years in the UK (Simmonds
et al., 2011).
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1.2.2 Pathogenesis of CF disease in the human airways
While the genetic origins of CF are known and have been extensively characterised at the molec-
ular level, how exactly the absence of functioning CFTR anion channels leads to the chronic
lung infections observed in CF, is not understood to the same degree. There is a consensus that
CFTR channels, either directly or indirectly, are involved in the failure of the lungs’ mucociliary
clearance mechanism, responsible for defence against inhaled bacterial pathogens (Boucher,
2003). In order to begin to understand the link between the two, I first must look at how the
airway surface microenvironment differs between healthy and CF patients.
1.2.2.1 Airway surface microenvironment in health and disease
Figure 1.7 shows a schematic diagram of the microenvironment present on the surface of the
human airways under normal physiological conditions. Covering a monolayer of ciliated ep-
ithelial cells lies a thin liquid layer, the airway surface liquid (ASL) layer. The ASL itself
consists of two separate phases, an upper gel like layer of mucins (mucus layer) sitting atop a
thin liquid layer bathing the cilia that protrude from the epithelial cells, known as the periciliary
liquid (PCL) layer. The mucus layer can be transported by co-ordinated beating of the cilia.
Any pathogens that enter the airways and get stuck in the mucus can be removed from the lungs
via this mucociliary clearance mechanism. Maintaining a suitable ASL volume is critical to the
proper functioning of this defence mechanism. As the airway epithelial cells are highly water
permeable, the ionic content of the ASL will largely determine its depth. It has hence been
hypothesised that disrupted ion transport can lead to abnormal ASL depth, contributing to lung
disease in CF airways.
Figure 1.8 shows a schematic diagram of the airway epithelium surface microenvironment
in tissue with a CF mutation. The mucus layer is thicker and more viscous than in healthy tissue,
and there is some evidence that the depth of the PCL is reduced. Cilia cannot beat effectively in
this environment, and this reduces efficacy of the mucociliary clearance mechanism. As a thick
mucus layer builds up, and as inhaled bacterial pathogens are not removed rapidly, bacterial
colonies can grow and take hold in the ASL. The major cause of morbidity and mortality in CF
patients arises from chronic lung infections (and resulting inflammatory responses) that begin
in this manner.
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Figure 1.7: Schematic diagram of airway surface liquid (ASL) microenvironment on the surface
of an epithelial monolayer. The volume of the periciliary liquid layer (PCL) is tightly regulated
by movement of ions and water controlled by epithelial cells. Maintaining PCL depth at the
same height as cilia, allows for efficient transport of mucus by a ciliary beating mechanism.
Figure 1.8: Schematic diagram of airway epithelial surface in the presence of a CFTR gene
defect. Lack of functioning chloride channels in the apical membrane of epithelial cells disrupts
normal electrolyte transport. As a result the mucus layer becomes dehydrated and viscous,
mucociliary clearance is reduced, and bacterial infections can take hold in thick mucus layer.
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1.2.2.2 ASL dehydration hypothesis
There are various theories as to why loss of function of CFTR channels in the airways results
in this pathogenesis, and one of these is the dehydration hypothesis. This theory claims co-
ordinated regulation of ion and water transport is crucial to maintaining adequate ASL depth
and sufficiently hydrated mucus. Under normal circumstances, Cl− transport via CFTR and
CaCC channels, along with Na+ transport through ENaC channels, is necessary to maintain
the fluid balance between ASL and cell (Tarran et al., 2006). In CF this co-ordination is lost,
and there is hyper-absorption of Na+ and an inability to adequately secrete Cl−. This leads
to excess fluid absorption and loss of volume from the ASL. Implied in these theories is mis-
regulation of ENaC as a major contributing factor to CF pathogenesis. For interesting reviews
see Boucher (2007a,b) and Gaillard et al. (2010).
1.2.2.3 Abnormal mucin hypothesis
A second hypothesis claims that CF lung disease is the result of a direct involvement of CFTR
in the production and secretion of mucins in the airways. One common line of reasoning here is
that bicarbonate rich secretions allow mucins to acquire certain physicochemical properties that
favour low viscosity and prevent adhesion of mucus plaques to the airway surface. With the loss
of HCO−3 transport through CFTR channels in CF, bicarbonate concentrations during mucin
secretion are lower, and it is theorised that mucins become quite dense as a result (Quinton,
2008, 2010). While there is limited evidence of this happening in vivo in the human airways,
there have been studies giving evidence that inhibiting Cl−/HCO−3 exchange in the submucosal
glands of porcine distal bronchi leads to mucus obstruction of these airways (Inglis et al., 1998).
Whether or not this phenomenon is critical to CF pathogenesis in the human airways is however
still an open question.
1.2.2.4 Innate immune hypothesis
There is another line of thought that considers deficiencies in the lungs’ innate immune system
to be the primary cause of bacterial infections in the airways of CF patients. Under normal
circumstances, the mucus layer of the ASL contains antimicrobial molecules which prevent in-
flammation and infection when bacterial pathogens are inhaled (Parker and Prince, 2011). In CF
the activity or expression of these antimicrobial agents in the mucus layer may be reduced - and
hence the inability to prevent persistent bacterial infections arises (Smith et al., 1996). The re-
duced effectiveness of these agents could be the result of the abnormal ASL microenvironment
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in CF - there is evidence that in the CF pig lung, airway surface pH can negatively impact on
the ability of antimicrobial molecules to kill bacterial pathogens (Pezzulo et al., 2012). There is
also evidence that reduced fluid secretion by submucosal glands in the airways results in lower
numbers of these innate immune proteins being present in the mucus layers, which would give
rise to a similar inability to defend against bacterial infection (Wine and Joo, 2004).
1.2.3 Abnormal electrophysiological properties of CF epithelia
Before the CFTR gene was isolated, it was known that cystic fibrosis disease was causing prob-
lems in the human airways related to ion permeation and transport. In a series of studies in
the early 1980’s, transepithelial potential difference (PD) was measured in the airways of CF
and non-CF patients (Knowles et al., 1981, 1983). These studies found that CF patients had
increased baseline transepithelial PD, increased amiloride sensitive transepithelial PD, and re-
duced or absent response in PD when Cl− in the lumen perfusate was removed. Initially it was
not known if excessive Na+ absorption was responsible for these abnormalities, or if it was
possible they were due to problems with a Cl− secretion pathway.
Indeed in subsequent studies, these transepithelial PD properties were measured in vitro
in studies on primary cultures of airway epithelial cells from CF patients (Stutts et al., 1985;
Boucher et al., 1986, 1988). It was shown with the use of ion replacement experiments that CF
epithelial cells did not have a Cl− conductance in their apical membrane, in contrast to non-
CF cells. CF cells also appeared to have increased apical Na+ permeability, inferred from an
increased amiloride sensitive short circuit current.
Further studies on primary cultures of CF and non CF human nasal epithelial (HNE)
characterised the electrophysiological differences quantitatively (Willumsen et al., 1989a,b;
Willumsen and Boucher, 1991a,b). Willumsen and Boucher estimated the apical Na+ perme-
ability of CF HNE cells to be approximately 2-3 fold increased relative to non-CF HNE cells,
and apical Cl− permeability was estimated to be an order of magnitude smaller in CF, however
these findings remain controversial.
1.2.4 Nasal potential difference measurements in the clinic
The transepithelial potential generated by the nasal epithelium is widely measured in patients
with CF, as it is currently the only means of measuring ion transport function in vivo in the
human airways. Information about the rate of Na+ and Cl− transport in a patient can be inferred
from the transepithelial potential recording, and thus it can be used to assess the underlying
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Figure 1.9: Standard nasal potential difference measurement protocol for studies of ion trans-
port in CF. Basal Vt is measured initially, before amiloride is added to block ENaC channels.
The change in Vt caused by amiloride addition is referred to as ∆Vt+amiloride, in this figure it
is taken as the value of Vt in the second rectangle minus the value of Vt in the first. This is fol-
lowed by manoeuvres to elicit Cl− secretion, the first removing Cl− from the lumen perfusate,
and recording the change in Vt. This is referred to as ∆Vt+0[Cl−]l and is found by taking
the value of Vt in the second rectangle from the value of Vt in the third rectangle. The sec-
ond manoeuvre is adding isoproterenol to stimulate CFTR channel activity, and finally, adding
ATP in order to stimulate and calcium activated Cl− channels present. The metrics ∆Vt+iso.
and ∆Vt+ATP can be measured from the values of Vt before and after the respective solution
exchanges. Image from Rowe et al. (2011).
CFTR and ENaC channel activity (Middleton et al., 1994; Knowles et al., 1995). Nasal potential
difference measurements are often taken as outcome measures in clinical trials of therapies
aimed at rescuing CFTR activity in CF patients (Wilschanski and Yahav, 2003; Konstan et al.,
2004), and they can also be used for diagnosis of CF in cases where the sweat test does not give
a definitive result (Goubau et al., 2009).
A typical nasal potential difference (NPD) test consists of several stages (Rowe et al.,
2011). Initially the basal level of ion transport is assessed by making a recording of the stable
potential difference generated under normal physiological circumstances (see Figure 1.9). This
recording is made with one probe placed in the airway lumen as saline solution is passaged
over the surface of the nasal epithelium, while a second electrode is placed subcutaneously in
order to measure the potential of the interstitium. The second stage involves passing a saline
solution with amiloride across the mucosal surface, and recording the depolarisation that occurs
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Figure 1.10: Comparison of a typical CF (red) and non-CF (black) NPD trace. In CF there
is a hyperpolarised basal Vt, increased amiloride sensitive Vt, and little or no Cl− secretion
responses through CFTR channels. Image from Rowe et al. (2011).
due to blocking any amiloride sensitive Na+ channels that are active under basal conditions.
Following this, a solution with a low Cl− concentration is perfused in place of the standard
saline solution, usually a Na+-gluconate− solution replaces the NaCl. If there are any basally
active Cl− channels present at this stage, a large hyperpolarisation of the transepithelial PD will
be observed, as there is now a favourable electrochemical gradient for Cl− ions to leave the cell
(which is not present under normal conditions). The magnitude of the change in Vt evoked
at this stage is usually inferred as an indicator of the level of CFTR channel activity present.
The next stage is to add a beta agonist, such as isoproterenol, or add forskolin, to the Na+-
gluconate− solution (which still contains amiloride). This acts to raise the cAMP level in the
cell, leading to further activation of CFTR channel activity, if any are present, and a consequent
further hyperpolarisation of the Vt level. Finally, in some NPD protocols, ATP is added to the
solution that has been perfusing in the lumen, in order to raise internal Ca2+ levels in the cell,
and determine if there are a significant number of calcium activated Cl− channels present, by
looking at the following change in Vt if any.
Typical NPD traces taken from a CF and non-CF patient are shown in Figure 1.10. The
characteristic features are a hyperpolarised basal Vt and increased amiloride sensitive Vt in CF,
and reduced or no response in CF to manoeuvres aimed at stimulating Cl− secretion. While the
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value of Vt or ∆Vt at any of the stages is on average different between groups of CF and non-CF
patients, the actual range of individual values recorded can overlap between the two groups. In
order to overcome this variation when diagnosing a patient, a combination of the different Vt
metrics can be used, as this gives more discriminatory power. For example, the Wilschanskii
ratio, defined as exp{((∆Vt + isoproterenol) + (∆Vt+0Cl−))/(∆Vt+amiloride)}, is one
such measure that is used for diagnosis. It remains an open question however, as to where the
variation in the individual Vt metrics arises. Is the variation in the response to low Cl− due
to variations in CFTR activity? If so, do some CF patients have residual CFTR activity while
others do not? Could this be related to disease severity or to a particular genotype? These are
some of the questions of interest that arise from the clinical nasal potential test that I will begin
to address in Chapters 5 and 6.
1.2.5 Activity of CFTR and ENaC channels in CF epithelia
While the bioelectric properties of CF epithelia as just outlined arise as result of mutations
in the CFTR gene, which encodes an anion channel, it is not clear they can all be explained
simply due to a loss of apical Cl− transport. Indeed many of the early studies into abnormal
ion transport in CF suggested issues with Na+ absorption and permeability, and the loss of Cl−
channel function does not have an explicit effect on Na+ transport.
In microelectrode studies on both non-CF and CF HNE cells, it was shown that Cl− was
at or near electrochemical equilibrium across the apical membrane. Therefore in these HNE
cells, Cl− secretion was not significant, and it was the large level of Na+ absorption that was
generating the transepithelial PD. The question then arises, can the loss of an apical Cl− channel
cause this increase in Na+ transport indirectly? Are Na+ and Cl− currents coupled electrically
by the apical membrane potential to such an extent to allow the observed phenomena to arise?
Or are there other mechanisms causing Na+ transport to be increased.
It has been suggested that CFTR also regulates the activity of other transport processes in
epithelial cells, in particular ENaC activity, although the mechanism is unclear and is the cause
of much debate (Donaldson and Boucher, 2007; Berdiev et al., 2009; Collawn et al., 2012).
Studies focusing on CFTR-ENaC interactions found that co-expressing CFTR with ENaC can
decrease the basal Na+ current (Stutts et al., 1995), and that CFTR can decrease the apical
Na+ permeability, by reducing mean open time and open probability of ENaC (Stutts, 1997).
If this regulation is also lost in CF, then airway epithelial cells will have a higher basal level
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of apical Na+ conductance, and this could explain some of the abnormal electrophysiological
measurements in CF epithelia.
More recent studies investigating these phenomena, have shed some doubt on the increased
ENaC activity hypothesis. Electrophysiological studies on in vitro differentiated primary cul-
tures of cells from CF patients failed to find evidence of increased Na+ conductance and in-
creased Na+ absorption (Itani et al., 2011). This followed on from a previous study on bronchial
and tracheal epithelial studies from a pig CF model, which also found no electrophysiological
evidence for increased ENaC activity (Chen et al., 2010). Both studies suggest that the loss
of anion conductance alone can account for hyperpolarised baseline transepithelial PD, as well
as the increased amiloride-sensitive transepithelial PD observed. The authors suggest that it is
simply the electrical coupling of the CFTR and ENaC currents which gives rise to the abnormal
electrophysiological properties.
1.3 Review of mathematical models of epithelial ion transport
1.3.1 Early models of Na+ transporting epithelia
In the late 1950’s the first model to explain active sodium transport was proposed by Koefoed-
Johnsen and Ussing, while they were working on ion transport in frog skin epithelia (Koefoed-
Johnson and Ussing, 1958). They put forward a two-membrane model which became known
as the Koefeod-Johnsen-Ussing (KJU) model, shown schematically in Figure 1.11. This model
assumed that Na+ was actively pumped out of the cell across a first, inward facing membrane,
and in order to maintain steady Na+ levels in the cell, it entered from the lumen via Na+-
specific ion channels in a second, outward facing membrane. K+ is pumped into the cell by
the same mechanism that moves Na+ out, and in order to maintain homeostasis of K+ in the
cell, there are channels in the inward facing membrane that allow K+ to move back out to
the interstitial fluid. This was called the pump-leak mechanism (Reuss, 2001). Although this
was a vastly simplified model, it captured the essential features of active Na+ transport, which
we know today to be co-ordinated by the activity of Na+ −K+ −ATPase pumps and ENaC
channels.
The first mathematical analyses of epithelial transport appeared in the late 1970’s. Schultz
et al. (1977) described a phenomenological model of a Na+ transporting epithelium, which
elaborated on the concepts introduced in the simple double-membrane hypothesis of the KJU
model. Their model proposed paracellular Na+ transport, in parallel to the transcellular active
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Figure 1.11: Original Koefoed-Johnson and Ussing model of the frog skin epithelium. Na+
is actively transported across the epithelium with a combination of pumps in the basolateral
membrane and channels in the apical membrane. A pump-leak mechanism recycles the K+
that is entering the cell across the basolateral membrane, as a result of the active Na+ transport.
Na+ transport route, as well as passive diffusional movement of a second general ion. They use
an equivalent electrical circuit description to relate the different transcellular and paracellular
currents to one another. The authors focused on deriving the analytical expressions relating
individual circuit elements (Na+ membrane conductances, electromotive driving force and in-
tracellular potential) which arise from their proposed model, and outline how these properties
could be measured quantitatively from electrophysiological experiments on amiloride sensitive
epithelia.
Lew et al. (1979) published one of the earliest numerical simulation studies of an epithelial
ion transport model. Their model cell also has two membranes, an apical membrane permeable
to Na+, Cl− and K+, and a serosal facing membrane which also contains electrogenic Na+-K+
pumps. Rather than use an equivalent electrical circuit description as Schultz et al. had, they
take a compartment based approach. The lumen, cell and serosa are considered as independent
entities, with their state changing due to mass transfer of ions between compartments. The
variables in Lew et al.’s model are the ionic concentrations of the intracellular compartment,
and the electrical potential difference between the cellular and extracellular compartments.
Their study was also the first to simulate time courses of cellular properties after the ep-
ithelial cell is perturbed. For example they simulate amiloride addition by reducing the apical
membrane permeability to Na+, and they perform ion substitution experiments by changing
external Na+ and Cl− concentrations. Their model reproduces several features of a tight, Na+-
transporting epithelium, such as abolition of the short circuit current in response to amiloride
addition and dissipation of ionic gradients after ouabain application. Interestingly, the authors
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also point out the utility of mathematical models in highlighting shortfalls in our understand-
ing when predictions diverge from experimental observations. Their original model predicted
steady state intracellular Cl− concentration which was much lower than the level observed.
However on inclusion of a basolateral Na+ − Cl− co-transport mechanism, a more realistic
concentration was achievable. This is an important observation to make in general about mod-
els of physical systems; it is often when a model makes an incorrect prediction that it is most
informative, as it points out a misunderstanding on the part of the modeller. In this case Lew et
al. discovered they could not reproduce physiological conditions with only passive and active
transport elements – co-transport of ions was necessary to create a realistic model system.
Latta et al. (1984) put forward a general framework for the formulation and solution of
epithelial transport kinetic simulations. Their method is based on the principles of conserva-
tion of mass and electro-neutrality in the cellular compartment, much like the model of Lew
et al., but generalised so that any combination of ionic species or transport mechanisms can be
taken into consideration. They also put forward numerical schemes for simulating open-circuit,
short-circuit and current clamped experimental protocols, allowing comparison between model
predictions and experimental data for those scenarios. Following on from this work, many
different mathematical models of epithelial transport have been studied which utilise the frame-
work of Latta et al., only differing in the tissue specific components and parameter values used.
These include models of proximal tubule (Weinstein, 1992, 2004), pancreatic duct (Whitcomb
and Ermentrout, 2004), corneal epithelial (Levin et al., 2006), cochlear marginal (Quraishi and
Raphael, 2007) and bronchial epithelial cells (Novotny and Jakobsson, 1996a,b). From here on
I will discuss the specific details of several of the airway epithelial models which are interesting
because of their relevance to my own modelling work.
1.3.2 Models of airway epithelial transport
The first study focusing on the relevant epithelial electro-kinetics was from Hartmann and Verk-
man (1990), focusing on the kinetics and regulation of transepithelial chloride secretion across
canine tracheal epithelial cells. The cellular transport components incorporated in their model
included apical Na+, Cl− and K+ conductance, a non-specific paracellular conductance, baso-
lateral K+ conductance, and basolateral Na+, Cl− and K+ symport. Hartmann and Verkman
also included intracellular second messengers in their model, which allowed for regulatory
mechanisms of ion channel conductance to be simulated. By choosing appropriate parame-
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ters estimated using experimental data found on canine tracheal cells, their model was able to
recreate short and open-circuit currents from these cells in response to stimulation from cAMP
and Ca2+ dependent signaling pathways. A particular feature of note, was the attempt of the
authors to determine quantitatively the effect of each individual transport protein on properties
of the whole epithelium, such as short circuit current, by altering their value independently and
observing how the model system responded to the perturbation.
The first model of human airway epithelial cells was from Duszyk and French (1991).
While they only studied steady state and not kinetic model behaviour, their analysis was inter-
esting for similar reasons to the Hartmann and Verkman model. Rather than changing transport
properties and looking at how the system evolved in time, in response to the change, Dusyk and
French determined how transport parameters changed the steady state properties of the system.
This was particularly relevant to our research, as they asked questions such as how do short cir-
cuit current and Na+ flux vary as a function of apical Na+ or Cl− permeability? Their model
predicted that Na+ flux would be much greater than Cl− flux into the cell, even when Na+
permeability was much less than Cl− permeability.
Horisberger (2003) developed a simple model of renal epithelial transport in A6 cells. Al-
though Horisberger used estimates from a non-airway epithelial cell line to parameterize his
model, as many of the transport mechanisms in his model are common to airway epithelia also,
his analysis is relevant to our research. This study is also of interest because it addresses the
question of how the relative values of apical Na+ and Cl− permeabilities influence the magni-
tude of amiloride-sensitive Vt. This question is particularly relevant to the debate over CFTR
and ENaC interactions in CF disease, and it has been suggested that the apical Cl− conductance
could be driving the increased amiloride sensitive Vt observed in CF airway epithelia. The pa-
per does indeed show how the change in short circuit current due to amiloride block could be
decreased by increasing apical Cl− conductance, highlighting how simple electrical coupling
could account for this phenomenon without the proteins needing to interact directly. The study
only looked at one particular set of parameter values, specific to A6 cells, however, and did not
speculate as to the quantitative relationship between CFTR permeability and amiloride sensitive
Isc, simply showing that qualitatively there was an inverse relationship between the two.
Another mathematical model relevant to consider here, is the recent model of Garcia et al.
(2013). The authors develop a generic model of human airway epithelia, that is similar to that
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of Hartmann and Verkman in terms of transport proteins and not in itself very novel. The nov-
elty is in their description of a methodology for making quantitative estimates of the constituent
ionic permeabilities, given electrophysiological data on cell behaviour during a number of Uss-
ing chamber experimental scenarios. While this study focused primarily on the methodological
parameter estimation aspect, rather than interpreting the physiological meaning of the estimates
they arrive at, it is relevant to my work as it validates the principle of inferring permeability
information on individual transport pathways, from measurements of whole epithelium proper-
ties, an approach I will take in analysing my model in later chapters.
1.4 Specific research aims of this thesis
Before outlining my research aims I will first summarise what I have presented so far. I have
shown that ion transport in human airway epithelia is relatively well understood, and there is
a consensus as to the main ion transport processes involved in electrolyte transport in a typical
HAE cell. A lot is also known about cystic fibrosis, and how it affects airway ion transport;
loss-of-function mutations in CFTR anion channels (expressed throughout the airways) lead to
abnormalities in epithelial Na+ and Cl− transport. However there is a controversy over the
precise link between mutations in the CFTR gene and the disrupted transport properties. Is
it simply the CFTR ion channel function that is lost? Or is there a CFTR-ENaC regulatory
interaction that is also lost in CF, meaning ENaC channels are hyperactive in the disease?
I have also seen that it is possible to develop physiologically realistic mathematical models
of airway epithelial transport processes. Given that major ion transport pathways are known,
knowledge of how channel and carrier proteins work individually can be integrated into whole-
epithelium models. Models can then be used to investigate the effect of experimental scenarios
such as ion substitution experiments and inhibition or activation of different transport proteins,
on membrane potentials and intracellular concentrations. Experimental electrophysiological
data can hence be used for model validation and parameter estimation purposes.
The goal of this thesis is to develop a biophysical model of this type, and to use it to
investigate the pathogenesis of CF in the human airways, focusing on what is underlying the
characteristic changes in CF HNE cell electrophysiology. Particularly I want to understand
quantitatively how the hyperpolarised basal transepithelial PD and increased amiloride sensitive
PD arise in CF, in terms of changes to cell membrane ion permeabilities. With this in mind, the
specific aims of my research project are:
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• Develop a physiologically realistic model of ion transport processes in human nasal ep-
ithelial (HNE) cells. The model will describe the biophysical details of passive, active and
secondary active transport via channels, pumps and co-transporters. It will describe the
electrophysiology of HNE cells (ion concentrations, membrane potentials) as a function
of the activity of its constituent ion transport proteins.
• Simulate common Ussing chamber experiments using mathematical model. Perform
model simulations that can be compared with experimental electrophysiological record-
ings, particularly interventions where the lumen perfusate is altered, either by adding
pharmacological compounds or changing its ionic composition.
• Estimate transport parameters from electrophysiological data. Given a biophysical
model capable of simulating Ussing chamber experiments, along with appropriate elec-
trophysiological data, perform parameter estimation in order to determine membrane per-
meabilities of HNE cells.
• Determine activity of transport proteins in both CF and non-CF HNE cells. Investigate
the quantitative evidence for differences in apical Cl− and Na+ permeability between
non-CF and CF HNE cells.
• Investigate quantitatively the relative influence of model parameters on electrophysio-
logical properties. Determine quantitatively which transport proteins are important in
determining properties such as transepithelial PD and amiloride sensitive PD.
• Simulate clinical nasal PD recordings. In a similar manner to the Ussing chamber exper-
iments, attempt to reproduce clinical nasal PD measurements by altering the composition
of lumenal perfusate. Relate model predictions to clinical data.
• Investigate viability of parameter estimation from clinical nasal PD traces. Determine
if it is possible to uniquely estimate transport parameter values from clinical nasal PD
traces. Discuss the consequences of interpreting this data incorrectly in clinical trials.
Chapter 2
Ion transport model development and analysis
methods
2.1 Physical models of ion transport across cell membranes and
epithelia
One of the aims of this thesis is to develop a mathematical model of ion transport by the air-
way epithelial system. As we have seen in Section 1.1.3, this transport system co-ordinates a
complex set of different channel and carrier mediated processes. In order to develop an inte-
grated mathematical description of this system, it is first necessary to have models of how the
individual transport processes work. Consequently, in this section I will outline the quantitative
models of active, passive and secondary active ion transport processes, that I will use in my
mathematical description of epithelial transport. In particular I will describe how the rate of ion
transport by the different transport processes is functionally related to the cell’s physiological
state, in terms of its intracellular ion concentrations and transmembrane electrical potentials.
2.1.1 Passive transport - Goldman-Hodgkin-Katz flux equation
In the previous chapter (Section 1.1.2) I described how, in the case of channel mediated trans-
port, ion flux is simply the result of diffusion down an electrochemical gradient. Here I will
give a brief overview of the mathematical description of this physical process, and how it can
be applied to the specific case of ion transport across a cell membrane. Readers interested in
a full theoretical treatment of this topic can refer to excellent discussions in Hille (2001) and
Weiss (1996).
The Nernst-Planck equation describes the general theory of electrodiffusion, it is given
here for the one dimensional case, where concentration c and electric potential Ψ are both
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functions of distance x
In = −znFDn
(
dc
dx
+
znFc
RT
dΨ
dx
)
(2.1)
For a given ion n with a valence of zn, the current density In due to electrodiffusion is linearly
related to both the concentration gradient (dc/dx) and the electric potential gradient (dΨ/dx),
and is also directly proportional to its diffusion coefficient in the relevant medium Dn. Note
here F is the Faraday constant, R is universal gas constant, and T is temperature.
A commonly used form of equation 2.1, the Goldman-Hodgkin-Katz (GHK) flux equation,
is applicable to channel mediated electrodiffusion across a cell membrane.
In = Pnz
2
n
VmF
2
RT
ai − aoexp (−znFVm/RT )
1− exp (−znFVm/RT ) (2.2)
In this special case of equation 2.1, the electric field across the membrane is assumed to be
constant, hence the electrical potential changes linearly within the membrane. This is known
as the constant field approximation and a full derivation of equation 2.2 in given in Appendix
A.2. The membrane potential, Vm, is defined as the difference between the electric potential
inside the cell and outside the cell, ψi − ψo. In 2.1 the current is expressed in terms of Dn
whereas in the new expression it is in terms of Pn, the permeability of the membrane to ion n.
Membrane permeability is related to the diffusion coefficient of the ion within the membrane,
via the expression Pn = Dnkn/L, where L is the width of the membrane and kn is the partition
coefficient. The partition coefficient is defined as the ratio of ionic concentrations on either side
of the membrane interface at equilibrium, and is discussed in more detail in Appendix A.2.
Note also that the GHK flux equation 2.2 is expressed in terms of the thermodynamic
activity of the transported ion (ai and ao). This is necessary as the intracellular and extracellular
solutions will not necessarily behave as ideal electrolyte solutions governed solely by their
chemical concentration (ci and co). Activity and concentration are related via a = γc where γ
is the activity coefficient of the ion in question. The activity coefficient of an electrolyte solution
is dependent on various factors such as its concentration, its composition and the temperature.
Hille gives the activity coefficient of a 100 mM NaCl solution to be γ = 0.77 (Hille, 2001).
This is sufficiently close to the composition of the physiological solutions I will consider in my
work, and so I use this activity coefficient throughout for converting concentrations of Na+,
K+ and Cl− to their respective activities.
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Figure 2.1: Current In of a univalent positive ion (zn = +1) across a membrane with per-
meability Pn = 0.01 µm/s predicted by the GHK flux equation. The internal ion concen-
tration ci is fixed at 20 mM, while I-V curves are plotted for different external activities;
co = {10, 20, 40, 60, 80, 100} mM. (Note this is for an ideal electrolyte, such that the activity
coefficient γ = 1.)
In the constant field GHK model, the ionic current In is simply proportional to the mem-
brane permeability, Pn, modulated by a non-linear function of the membrane potential and ionic
concentration gradient, In = Pnf (Vm, ci, co). We can gain intuition for the functional relation-
ship between these physiological variables and the predicted current by looking at a number of
features of the GHK flux equation:
• When there is no difference in the electric potential on either side of the membrane, the
current is directly proportional to the transmembrane concentration gradient, ∆cm =
ci − co. This is intuitively what one would expect from Fick’s law of diffusion.
lim
Vm→0
In =
PnznF
γ
(ci − co) (2.3)
• The membrane potential at which no current will flow, called the reversal potential (Vrev),
can be found by setting In = 0 and solving for Vm. The expression for Vrev reduces to
that of the well known Nernst potential
Vrev =
RT
znF
ln
co
ci
(2.4)
2.1. Physical models of ion transport across cell membranes and epithelia 39
• The GHK flux equation predicts that the membrane is rectifying. That is, the effective
conductance of the membrane changes with voltage, and rectification is characterised by
non-linear I − V relationships. Figure 2.1 shows the predicted current In for a given
Vm, at different concentration gradients. At negative membrane potentials (favourable
for positive ions to enter the cell), the greater the external - internal concentration gra-
dient, the greater the magnitude of the inward current. However at positive membrane
potentials, the concentration gradient has little effect on current.
At this point it is important to note that in using the GHK flux equation and the constant
field approximation, we are not utilising any information about the physical structure of the
channels through which the ions are moving, their gating properties or how they are regulated.
The GHK flux model simply characterises the ease through which ions can traverse the cell
membrane for a given electrochemical driving force.
For example, consider the case of modelling transmembrane transport by CFTR channels.
If I assume that the apical membrane has a certain permeability to Cl− ions, P ap
Cl− , I can de-
termine the transmembrane Cl− current Iap
Cl− , provided I know the apical membrane potential
V apm , and lumen and cell Cl− concentrations. I do not use information on how many channels
are present in the membrane, how many are open, or information about the single channel con-
ductance of CFTR. Similarly, if I want to model Na+ transport in epithelial cells via ENaC
channels, then given the membrane potential and sodium concentration gradient, I can compute
the current Iap
Na+
if I know P ap
Na+
.
Finally, the GHK flux equation can also be used to model paracellular current flows. As
in the case of ion channels, I can use permeability as the transport parameter that characterises
the ease with which current flows through tight junctions. I can then compute the paracellular
current for a given ion, say K+, if I assume a certain permeability P pa
K+
, and if I know transep-
ithelial PD and lumen / serosal K+ concentration. When simulating the paracellular flux of
several ions, I can assume they will all flow with the same ease characterised by one common
paracellular permeability (i.e. P pa
Na+
≡ P pa
Cl− ≡ P paK+), or I can investigate selectivity in this
pathway by allocating different permeabilities to anions and cations.
2.1.2 Active ion transport models - Na+ −K+ − ATPase pump
Carrier mediated transport is a more complex process to model in general than channel medi-
ated transport. This is because carrier mediated transport necessarily involves several distinct
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Figure 2.2: Post-Albers model of the Na+ −K+ −ATPase reaction cycle, highlighting the
sequence of binding and unbinding of Na+ and K+ ions, conformational changes and the hy-
drolysis of MgATP. P1-P15 represent the 15 intermediate states in the reaction cycle. Image
from Smith and Crampin (2004)
processes, such as the binding and unbinding of ions to the carrier protein, or conformational
changes in the protein in order to translocate bound ions across the membrane. In general there
may be several ions that bind the carrier protein during each translocation cycle, and there may
also be a strict sequence in which they must associate with the carrier protein. In order to quan-
titatively model this process I need to know several pieces of information; the order in which
ions bind, the rate of binding and unbinding of each ion to the carrier, the rate at which the con-
formational change occurs, and whether or not any of these stages are voltage or concentration
dependent. In comparison, for electrodiffusion I only needed one parameter to characterize the
transport process - the permeability of the membrane to the ion of interest. However, as in the
case of channel mediated transport, there are theoretical models in the literature than I can use
to compute the rate of active transport, given knowledge of the physiological state of the cell.
I focus my attention on models of active transport by Na+ −K+ −ATPase pumps, as
these are expressed in human airway epithelial cells. As outlined in the previous chapter (Sec-
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tion 1.1.3.2) one of the primary functions of Na+ −K+ −ATPase pumps is to keep cell Na+
concentration low, and cell K+ concentration high. This movement requires work to be done by
the pump, as it is moving both Na+ and K+ against their respective electro-chemical gradients.
In order to perform this work the pump couples the translocation of these ions to the hydrolysis
of ATP, and the net outcome of a single reaction cycle can be summarised as follows:
3Na+i + 2K
+
s +ATP 
 3Na+s + 2K+i +ADP + Pio (2.5)
For every cycle of a pump, 3 Na+ ions are moved from the intracellular compartment (subscript
i) to the serosal compartment (subscript s). In the same process, 2 K+ are moved from the
serosal compartment into the cell, and one molecule of ATP is hydrolysed to give a molecule
of ADP and an inorganic phosphate Pio. There is a net movement of one positive ion per cycle
moved out of the cell by the activity of Na+ −K+ −ATPase pumps, therefore it contributes
an electric current across the basolateral membrane of epithelial cells.
The binding of Na+ and K+ ions, as well as MgATP molecules, occurs in a strict se-
quence. The model of Albers and Post outlines the various binding and unbinding stages, as
well as the translocation stages of the Na+ −K+ −ATPase reaction cycle (Post et al., 1972;
Albers, 1967). Their model contains 15 distinct stages, and is shown schematically in Figure
2.2. A reduced, 4 stage cycle was derived from the Post-Albers scheme by Smith and Crampin
(2004), for use in whole cell modelling. To achieve this reduction in complexity the authors
make the assumption that association and dissociation reactions are in a rapid equilibrium with
each other, as they happen on a much faster time scale than the rates that the enzyme undergoes
translocation (see Figure 2.3).
In the Smith and Crampin model, it is assumed that the pump reaction cycle itself is in a
quasi-steady state. The turnover rate of a single pump νNaK can be determined based on the
difference between the rate of movement around the cycle in the clockwise direction (α+1→4)
relative to the anti-clockwise (α−1→4) directions.
νNaK(t) =
α+1 α
+
2 α
+
3 α
+
4 − α−1 α−2 α−3 α−4
Σ
(2.6)
Here Σ is a combinatorial function of these rates, which can be found using the Hill diagram-
matic method . α+/−1→4 contain information regarding the separate association and dissociation
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Figure 2.3: Reduced 4 stage kinetic model of active transport by Na+ −K+ −ATPase pumps.
Ion binding and dissociation events are lumped together, as they are assumed to be in rapid
equilibrium, relative to the rate of translocation of the substrate. Image from Smith and Crampin
(2004).
reactions that are assumed to be in rapid equilibrium in the Smith and Crampin model. These
rates are functionally dependent on internal and external Na+ and K+ concentrations amongst
other factors (a full derivation of the Smith and Crampin model is outlined in Appendix A.3).
For my purposes here, it suffices to comment that if I know the concentrations of Na+ and K+
inside and outside of the cell, as well as basolateral membrane potential V bam , I can compute the
individual rates α+/−1→4 , and hence the net turnover rate of a pump, νNaK .
Knowing the turnover rate of an individual pump allows us to compute the total transmem-
brane pump current as
INaK(t) = ρNaKνNaK(t)zNa+F (2.7)
Here the parameter ρNaK is the number of moles of Na+ −K+ −ATPase per unit area of the
cell membrane. Now I have reduced my model to a form similar to the GHK equation in 2.1.
The current is directly proportional to a transport parameter modulated by a non-linear function
of concentrations and membrane potentials. Here the transport parameter is the number of pump
proteins, ρNaK , previously it was the membrane permeability, Pn, and both of these parameters
will be proportional to the expression level of the relevant protein in the cell membrane. The
expression level of the transport protein is an intrinsic property of the cell in this model, whereas
the information about the local electrochemical environment is the variable quantity which may
change over time.
Figures 2.4 and 2.5 show how the ion translocation rate changes as a function of intracel-
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Figure 2.4: Plot of νNaK as a function of intracellular Na+ concentration at three different
membrane potentials, Vm = (−100,−75,−50) mV, as predicted by the Smith and Crampin
model. Intracellular [K+] is fixed at 120 mM, and extracellular concentrations are assumed to
be that of physiological saline, [Na+]s = 140 mM and [K+]s = 5 mM. The translocation
rate increases approximately linearly in the range 10 mM ≤ [Na+]i ≤ 50 mM, concentrations
likely to be found in vivo in human airway epithelial cells. νNaK is relatively insensitive to
membrane potential in the range of [Na+]i values that are physiologically realistic (20 mM ≤
[Na+]i ≤ 35 mM).
Figure 2.5: Translocation rate of Na+ −K+ −ATPase, νNaK , as a function of intracel-
lular K+ concentration, at various membrane potential values. Intracellular Na+ is fixed
at 30 mM, and extracellular concentrations are assumed to be that of physiological saline,
[Na+]s = 140 mM and [K+]s = 5 mM. Here the translocation rate decreases in an approx-
imately linear manner, as K+ increases, although the rate of change is not as large as that in
Figure 2.4.
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Figure 2.6: 10 stage model of the Na+ −K+ − 2Cl− co-transporter ion translocation activity,
proposed by Lyttle and McManus. Image taken from Benjamin and Johnson (1997).
lular Na+ and K+ concentrations, and the basolateral membrane potential. Over the ranges of
these variables which are physiologically realistic in airway epithelial cells, we see that pump
activity increases with intracellular Na+ and decreases with intracellular K+, and is relatively
insensitive to basolateral membrane potential by comparison. This is how we would expect the
pump to work intuitively, given its function is to keep cell Na+ low and cell K+ high. If Na+
builds up in the cell, it will begin to work harder to pump it out, and similarly, if K+ begins to
lower, it will increase activity to bring more K+ into the cell raising its concentration level.
2.1.3 Secondary active transport - Na+ −K+ − 2Cl− model
In contrast to the Na+ −K+ −ATPase which requires active energy input to function, the
Na+ −K+ − 2Cl− transports Na+, Cl− and K+ in to the cell passively. It couples the transport
of K+ and Cl− ions, to that of Na+, as Na+ is moving in an energetically favourable direction
down an electrochemical gradient.
The NKCC co-transporter binds Na+, K+ and 2 Cl− ions on one side of the membrane,
in the sequence Na+, Cl−, K+, Cl−, before translocating the ions to the opposing side and
unbinding in the same sequence, in a first on - first off manner.
Benjamin and Johnson (1997) wrote down relevant differential equations which quantify
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Figure 2.7: The rate at which ions are translocated into the cytoplasm by the NKCC co-
transporter, is plotted here as a function of intracellular Na+ and Cl− concentrations. Intra-
cellular K+ concentration is fixed at 120 mM, and extracellular concentrations of [Na+]s =
140 mM, [Cl−]s = 120 mM and [K+]s = 5 mM. Under physiological conditions in HNE
cells, intracellular Na+ will typically be less than 40 mM and Cl− less than 75 mM. With both
concentrations below these bounds, νNKCC is positive, and ions will be moved into the cell by
this cotransport mechanism.
these rates, giving quasi-steady state turnover rate of an individual NKCC co-transporter of
νNKCC(t) =
kfullf k
empty
f [Na
+]s [K
+]s [Cl
−]2s − kfullb kemptyb [Na+]i [K+]i [Cl−]2i∑16
n=1 Z
n
nkcc
(2.8)
Here Znnkcc are associated with rates of moving between states of the 10 stage reaction cycle
(see Figure 2.6), similar to the rates α+/−1→4 in the case of the Na
+ − K+ pump, and Benjamin
and Johnson provide estimates of these rate constants. Therefore given the relevant intracellular
and extracellular Na+, Cl− and K+ concentrations, I can compute νNKCC .
In contrast to the Na+ −K+ −ATPase which is electrogenic, a turnover of the NKCC
protein does not produce net movement of charge, as 2 cations (Na+ + K+) move in the same
direction as 2 anions (2 Cl−). Transport due to NKCC activity is then said to be electrically
silent, or electroneutral. While this means there is no net current, INKCC = 0, it is still
necessary to model net ion flux due to cotransport. If I assume, as in the case of the pumps, that
I know the surface density of NKCC protein, ρNKCC , then I can compute the relevant ion flux
into the cell, as ρNKCCνNKCC for Na+ and K+, and 2ρNKCCνNKCC in the case of Cl− (due
to the 1 : 1 : 2 stoichiometry of the reaction cycle). Figure 2.7 shows the relationship between
intracellular Na+ and Cl− concentrations, and the cycling rate of the NKCC co-transporter.
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Figure 2.8: Equivalent electrical circuit description of a cell membrane. The plasma membrane
acts as a capacitor separating the internal and external ionic solutions, in parallel with a resistor,
which represents the fact that the membrane can conduct current to a certain extent. If there are
no external current sources flowing into the system, then the the sum of the ionic and capacitive
currents must equal zero (Iion + Icap = 0).
The NKCC co-transporter tends to move Na+ and Cl− towards an equilibrium concentration
level. For the example of Cl−, below a certain concentration threshold (dependent on [Na+]i)
Cl− will be moved into the cell, i.e. νNKCC > 0. This will tend to increase [Cl−]i, and the
value of νNKCC will decrease and move towards 0. Similarly above a certain [Cl−]i level,
νNKCC will become negative, the co-transport process will work in reverse, moving Cl−ions
out of the cell, and their concentrations may decrease, moving νNKCC in a positive direction
back towards its own equilibrium value of 0.
2.1.4 Equivalent electrical circuit description of epithelial ion transport
Figure 2.8 shows the equivalent electrical circuit commonly used to describe a single cell mem-
brane. The circuit assumes that a cell membrane acts like a parallel plate capacitor in parallel
with a resistor. The capacitor element takes into account the fact that the plasma membrane cre-
ates a separation of electric charge between the cell cytoplasm and the external physiological
fluid. The membrane can also conduct electric current via ion channels (or via other routes) and
this is represented by a resistive element in parallel with the capacitor.
The relationship between transmembrane ion current Iion and electric potential difference
Vm across the membrane can be determined by comparing the capacitive current Icap to Iion.
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The charge q on a parallel plate capacitor is given by the formula
q = CmVm (2.9)
where Cm is the capacitance of the parallel plates (assumed not to vary in time), and Vm is the
electric potential difference, or voltage, across the plates. The rate of change of that charge q,
or the capacitive current, is then given by
Icap =
dq
dt
= Cm
dVm
dt
(2.10)
Assuming there are no additional current sources into this circuit, then it follows from Kir-
choff’s Laws that the net currents in the circuit must add to zero.
Icap + Iion = 0 (2.11)
Replacing the expression for Icap derived in 2.10 into 2.11 and re-arranging, one can write
dVm
dt
= − 1
Cm
Iion (2.12)
The rate of change of membrane potential Vm is directly proportional to the transmembrane
current Iion.
The electrical state of an epithelium can also be described by an equivalent electrical cir-
cuit. The equivalent circuit is more complex than the single membrane system, as an epithelium
effectively consists of two separate membranes (apical and basolateral) in series, in parallel with
the current flowing through the paracellular pathway. This is shown schematically in Figure 2.9.
In order to understand how the transepithelial potential difference, Vt, changes as a function of
the currents across the apical membrane Iap, basolateral membrane Iba and paracellular current
Ipa, one must first understand how the individual currents change the apical and basolateral
membrane potentials.
Using the same logic as with the simpler circuit, one can determine expressions for the
capacitive current across the apical membrane, CmdV
ap
m /dt, and across the basolateral mem-
brane, CmdV bam /dt. However in this situation the paracellular current Ipa must be accounted
for, and the sum of the capacitive and transmembrane currents in each of the individual paral-
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Figure 2.9: Equivalent electrical circuit description of an epithelium. The apical and basolat-
eral membranes are represented as two resistor-capacitor circuits in series, and the paracellular
transport route is represented by a resistive circuit element in parallel with the trans-cellular
route. Assuming no external current flows into the system, and using Kirchoff’s current law,
we can relate the paracellular current Ipa to the ionic and capacitive current at each membrane,
where Ipa is by convention positive for the flow of positive ions in the serosal to luminal direc-
tion. At point 1, the current leaving the RC circuit must equal the current entering it, therefore
Iap + CmdV
ap
m /dt = −Ipa, and similarly at point 2, Iba + CmdV bam /dt = Ipa.
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lel resistor-capacitor circuits (RC) is no longer simply equal to zero. In the case of the apical
current, if we apply Kirchoff’s junction rule at point 1 (in Figure 2.9), one finds
Iap + Cm
dV apm
dt
= −Ipa (2.13)
Similarly, looking at the basolateral RC circuit and applying Kirchoff’s junction rule at point 2,
one finds
Iba + Cm
dV bam
dt
= +Ipa (2.14)
These equations can then be re-arranged to give expressions for the rate of change of each
membrane potential with respect to time
dV apm
dt
= − 1
Cm
(Iap + Ipa) (2.15)
dV bam
dt
= − 1
Cm
(Iba − Ipa) (2.16)
It is clear from this equivalent electrical circuit description how the coupling of the apical and
basolateral membrane potentials arises - as the paracellular or shunt current Ipa influences the
rate of change of both V apm and V bam .
Note in both the apical and basolateral membrane cases, the same convention regarding
current has been used as in the single membrane case, namely the movement of positive charge
out of the cell constitutes a positive current. For the paracellular current, I use the convention
that the movement of positive charge in the serosal to luminal direction constitutes a positive
current. Membrane potentials are commonly expressed as the electric potential inside of the
cell minus the electric potential outside the cell. For an epithelium there are three different
electric potentials to consider, the potential of the lumen Vl, the potential inside the cell Vi,
and the serosal potential Vs. The apical and basolateral membrane potential differences can
then be written as V apm = Vi − Vl and V bam = Vi − Vs respectively. In the study of epithelial
electrophysiology, the transepithelial potential difference is commonly recorded with respect
to the potential of the serosal or interstitial compartment, that is Vt = Vl - Vs. This can be
expressed in terms of the membrane potential differences in place of the electric potential of the
compartments themselves
Vt = Vl − Vs = (Vi − V apm )− (Vi − V bam ) = V bam − V apm (2.17)
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2.1.5 Transmembrane water transport
Transmembrane water flux ensures the intracellular compartment is always iso-osmolar with
the extracellular fluid. The osmolarity of a solution is defined as
∑
h
φhnh[C]h (2.18)
where the [C]h is the molar concentration of the h-th solute in the solution, nh is number
of particles that this solute dissociates into, and φh is its osmotic coefficient. The osmotic
coefficient accounts for certain factors, such as interactions between charged particles, which
may cause an ionic solution to deviate from ideal behaviour. Solutions of NaCl and KCl at
physiological concentrations do not deviate from ideality by more than 10% (Weiss, 1996),
hence I assume in all my calculations that φ = 1.
With this assumption, in my model the osmolarity [S] of any of the compartments is the
sum of the concentrations of all ions present in that compartment. If I consider a compartment
which consists primarily of Na+, K+, and Cl− ions in solution, then the osmolarity of the
compartment would be as follows
[S] = [Na+] + [Cl−] + [K+] + [ψ] (2.19)
Here [ψ] accounts for the presence of all other impermeable anions. In the model the values of
[ψ] used for each compartment are chosen so that the compartment is initially electroneutral,
and iso-osmolar with all other compartments to begin with. For example, in the extracellular
compartments if I assume concentrations in mM of [Na+] = 140, [K+] = 5, and [Cl−] = 120,
(and these are the only ions modelled) then I would set [ψ] = 25 mM in both the lumen and
serosa. This means the total osmolarity is 290 mOsm and there are equal amounts of cations
and anions present.
The water flux across the apical (Japw ) or basolateral (Jbaw ) membrane is assumed to be
linearly related to the difference in osmolarity across that membrane, and assumed to be positive
in the serosal to luminal direction,
Japw = Lwνw ([S]l − [S]i) (2.20)
Jbaw = Lwνw ([S]i − [S]s) (2.21)
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Here Lw is the hydraulic conductivity of the cell membrane, and νw is the partial molar volume
of water. Available literature values were used for these parameters (see Appendix A.1, Table
A.1).
2.2 Whole cell model of ion transport in human nasal epithelial
cells
Figure 1.2 shows the basis for the model epithelial system which I analyse. The mathematical
model represents a mono-layer of HNE cells placed between two well perfused compartments
containing physiological saline solution. This scenario approximates the environment experi-
enced by HNE cells in vitro during an Ussing chamber experiment, where the two compartments
represent the half chambers on the mucosal and serosal sides of the epithelium. Equally it ap-
proximates the situation in vivo during measurement of the nasal transepithelial potential when
the airway surface is flooded, where the compartments are representative of the airway lumen
on the apical side, and interstitial fluid on the basolateral side. The transport processes I include
are those which are most significant in contributing to the generation of the transepithelial po-
tential difference in the airways. In particular in this model I consider the movement of Na+,
Cl−, K+ and H2O directly between interstitial fluid and airway lumen (paracellular route) and
between the cell and external solutions via transport processes in the apical and basolateral
plasma membranes (transcellular route). Focusing on this system allows us to use experimental
Ussing chamber data for model validation and parameter estimation purposes, and also allows
us to simulate ion transport kinetics during a clinical nasal potential difference measurement -
both of which are amongst the aims outlined at the start of this thesis.
2.2.1 Modelling framework: state variables, parameters and fluxes
The framework I use for modelling ion transport in HNE cells is motivated by the general
methodology proposed by Latta et al. (1984) for developing and simulating models of epithelial
transport. In this approach, the behaviour of a single representative epithelial cell is assumed to
be a good description of the entire epithelial layer. The epithelial cell is modelled as a single
compartment described by several state variables. These variables are related to the physio-
logical quantities I am interested in modelling, such as the intracellular ionic concentrations
and transmembrane potentials. In this approach, the flux due to each type of transport pro-
tein expressed in the cell is modelled individually, and by summing the contribution from all
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transport proteins present, the net movement of each ion type into or out of the cell can be deter-
mined. By enforcing conservation of mass in the intracellular compartment, I can write down
state equations, which describe the time evolution of the physiological state variables. Hence
in this framework, given the initial state of the cell and its surroundings, one can compute the
flux along each transport pathway, update the state of the cell, and continue in this fashion to
numerically simulate the epithelial ion transport kinetics.
In the case of a HNE cell model which I develop, its state at any time is described by six
variables, cell volume,Wi(t), moles of Na+, Cl−, and K+, (Na+i (t),Cl
−
i (t),K
+
i (t)), and api-
cal and basolateral membrane potentials, (V apm (t) and V bam (t) respectively) (subscript i denotes
intracellular quantities). Therefore cell volume and ionic composition vary in time, as well as
its electrical state. The transport pathways considered include CFTR and ENaC channels in the
apical membrane, characterized by apical Cl− permeability (P ap
Cl−) and apical Na
+ permeabil-
ity (P ap
Na+
) respectively; K+ and Cl− channels in the basolateral membrane are characterized by
the basolateral K+ (P baK+) and Cl
− (P baCl−) permeabilities. Transport via Na
+ −K+ −ATPase
pump proteins and NKCC cotransport proteins in the basolateral membrane, are also consid-
ered, and they are characterized by their densities per unit area of the membrane, ρNaK and
ρNKCC respectively. Paracellular transport modelled includes movement of Na+, K+ and Cl−
through the tight junctions, as well as gluconate− transport along the paracellular pathway
in some simulations. Finally, water transport across the apical and basolateral membranes is
incorporated into the model HNE cell.
Note that all ion channel currents are modelled using the GHK flux equation, as described
in 2.1.1, and all paracellular currents are also modelled in this manner. The Na+ −K+ pump
flux is determined using the Smith and Crampin model, as outlined in Section 2.1.2, and the
NKCC co-transport flux is determined using the Benjamin and Johnson model as described in
Section 2.1.3.
With this framework how the relative expression levels of different transport proteins influ-
ence the physiological state of the cells can be determined by varying the appropriate transport
parameters. Similarly, one can simulate inhibition or activation of different proteins, by appro-
priate manipulation of the transport parameter characterising their expression level, and how
this would be expected to perturb the model cell can be observed.
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2.2.2 Kinetics of cellular variables
Each cellular variable xh has a state equation associated with it. The state equations are derived
from the principle of conservation of mass in the case of ions and water, and the conservation
of current (Kirchoff’s laws) in the case of membrane potentials. Since creation or destruction
of ions or small molecules in the epithelial cell is not considered (i.e. no chemical reactions are
modelled), the number of ions of a particular species (or the number of water molecules) can
only change if there is a net influx or efflux of that particular particle into the cell. Specifically,
this can be formulated in terms of the rate of change of species number, dxh/dt, and the rate at
which that species enters or leaves the cell, via different transport pathways
dxh
dt
=
∑(
J inh − Jouth
)
(2.22)
The fluxes from all relevant pathways are included. This can be explicitly written in the case of
each cellular variable that is to be included in the proposed HNE cell model. Starting with cell
volume, Wi (note subscript i refers to an intracellular quantity), which will change if there is a
net flow of water into or out of the cell
dWi
dt
= Jbaw − Japw (2.23)
Here Japw is the H2O flux across the apical membrane, and Jbaw is the corresponding flux across
the basolateral membrane, computed as described in Section 2.1.5. I use the convention that
water flux in the serosal to luminal direction is positive. Next, considering the number of Na+
ions in the cell, I write down the appropriate state equation.
dNa+i
dt
= ρNKCCνNKCC − 3 ρNaKνNaK −
Iap
Na+
FzNa+
(2.24)
In the model system there are three routes by which Na+ can enter the cell. ENaC channels ex-
pressed in the apical membrane facilitate an apical current, Iap
Na+
. In the basolateral membrane,
pump and co-transporter proteins create two separate pathways for Na+ movement, charac-
terised by the flux terms ρNaKνNaK and ρNKCCνNKCC . Note the stoichiometry of the pump
means that 3 Na+ ions are extruded on every cycle, and Iap
Na+
has been normalised by the Fara-
day constant F in order to convert a current, expressed in terms of electric charge movement,
as a flux in terms of movements of moles of Na+.
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Using an analogous approach, I can write down the state equation for the number of moles
of Cl− in the cell. This will change due to the apical CFTR current, Iap
Cl− , the basolateral Cl
−
channel current, IbaCl− , and the activity of the NKCC cotransporter, ρNKCCνNKCC , (note 2 Cl
−
ions transported per cycle)
dCl−i
dt
= 2 ρNKCCνNKCC −
Iap
Cl−
FzCl−
− I
ba
Cl−
FzCl−
(2.25)
Cell potassium levels will change due to the basolateral K+ channels, IbaK+ , and as in the case of
Na+, due the presence of Na+ −K+ −ATPase and NKCC proteins in the basolateral mem-
brane (note two K+ ions enter the cell per pump cycle)
dK+i
dt
= ρNKCCνNKCC + 2 ρNaKνNaK −
IbaK+
FzK+
(2.26)
In the case of the apical and basolateral membrane potentials, I use the conservation of cur-
rent along with the equivalent electrical circuit description of the plasma membrane / epithelium
(described in Section 2.1.4) to write down the following state equations
dV apm
dt
= − 1
Cm
(+Iap
Na+
+ Iap
Cl− + I
pa
Na+
+ Ipa
Cl− + I
pa
K+
+ Ipa
gluc−) (2.27)
dV bam
dt
= − 1
Cm
(IbaCl− + I
ba
K+ + INaK − IpaNa+ − IpaCl− − IpaK+ − Ipagluc−) (2.28)
The net apical current is the sum of the CFTR and ENaC currents, Iapnet = I
ap
Na+
+ Iap
Cl− , using
the convention that apical current is positive in the cell to lumen direction. The net basolateral
current is Ibanet = I
ba
Cl− + I
ba
K+ + INaK , noting that INKCC = 0 since an equal number of
cations and anions are transported at the same time by the Na+ −K+ − 2Cl− cotransporter.
For paracellular currents I use the convention that the flow of cations in the serosal to mucosal
direction defines a positive paracellular current (Ipa > 0). The net paracellular current is the
sum of sodium, chloride and potassium currents along this pathway, Ipanet = I
pa
Na+
+ Ipa
Cl− +
Ipa
K+
. In some cases, if additional ions are being simulated in the lumen these may also be
transported along the paracellular pathway. For example, when NaCl is replaced in the lumen
with Na+gluconate−, gluconate ions will permeate through the tight junction proteins and
contribute a term Ipa
gluc− to net paracellular current I
pa
net.
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2.2.3 Mathematical form of model system
I can formalise the description of my model HNE cell as follows. The state of a dynamical
system at time t is defined by a state vector
x(t) = (x1(t), x2(t), . . . , xnx(t)) (2.29)
where xh are the nx state variables. The system is characterised by a parameter vector
θ = (θ1, θ2, . . . , θnθ) (2.30)
where θj are the nθ model parameters. The time evolution of state variables is a function of
both the current state of the system, x(t), and the parameter vector θ
dx(t)
dt
= f(x(t), θ) (2.31)
This defines a system of first order, ordinary differential equations (ODEs). Given the initial
state of the system x(0) = x0 one can attempt to determine the system dynamics, x(t), by
numerically integrating (2.31) over a time period of interest.
In the case of my model HNE cell, the state vector is given by
x(t) =
(
Wi(t), Na
+
i (t), Cl
−
i (t),K
+
i (t), V
ap
m (t), V
ba
m (t)
)
(2.32)
and the parameter vector for my model system contains amongst others:
• Transport pathway information, such as membrane permeabilities and protein densities
P ap
Na+
, P ap
Cl− , P
ba
K+ , P
ba
Cl− , ρNaK , ρNKCC , P
pa
Na+
, P pa
K+
, P pa
Cl− .
• Ionic composition of bathing solutions [Na+]l, [Cl−]l, [K+]l, [ψ]l, [Na+]s, [Cl−]s, [K+]s,
and [ψ]s.
• Physical constants, such as the Faraday constant F , universal gas constant R and temper-
ature T
The right hand side of equations 2.23-2.28 are dependent on both the current state of the
cell x(t) and the model parameters θ, and hence are of the form f (x(t), θ). The particular
form of the functions used in my HNE cell model will in general be non-linear. For example
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Model element Notation Index Quantity
Variables x h nx
Parameters θ j nθ
Observation times t k nt
Observables y l ny
Outputs Y m nY
Table 2.1: Overview of nomenclature and notation used for different quantities in analysis of
mathematical model.
we saw in Section 2.1.1 that the transmembrane current Im predicted by the GHK equation has
a non-linear dependence on the transmembrane potential Vm. We also saw how the cycle rate
of NKCC cotransporters νNKCC is non-linearly dependent on the internal Cl− concentration
(Section 2.1.3).
Another feature of the model ODE system is that the rates of change of the state vari-
ables are strongly coupled. That is, elements of fh (x(t), θ)) involved in determining the rate
of change of a particular variable xh, are dependent on other state variables in x. One such
example is the particle flux due to the Na+ −K+ −ATPase pump ρNaKνNaK , which is func-
tionally related to Na+i and V
ba
m and also appears in the rate equation for intracellular K
+
i .
2.2.4 Assumptions implicit in model
While the approach described above can give us powerful insights into the kinetics of epithelial
transport in the human airways, it is only an approximate description of the true physiology of
complex, living HNE cells. There are several simplifications and assumptions implicit in the
model formalism which we need to remain conscious of:
• It is assumed that the behaviour of the whole epithelial monolayer can be understood by
investigating ion transport in a single idealised, ciliated epithelial cell. Using parameter
values (such as membrane permeabilities) that are normalised to the surface area of the
epithelium, allows one to scale up appropriately. Also, airway epithelia will consist of a
mixture of ciliated, secretory, undifferentiated and basal cells (Crystal et al., 2008), but
for my model I assume as a first approximation a monolayer consisting only of ciliated
epithelial cells.
• Only transport between lumen and cell, cell and serosa, and lumen and serosa are con-
sidered in the model. Lateral transport or communication between cells is not modelled
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and it is assumed that these processes are not necessary to describe the transepithelial
electrical properties of the airway epithelium.
• It is assumed that the electrical properties of an airway epithelium are accurately de-
scribed by the equivalent electrical circuit shown in 2.9.
• There is no description of the cell’s pH, metabolic state, Ca2+ concentration or cAMP
levels. These properties of the HNE cell are assumed to be constant throughout any
simulations that are implemented, and are assumed not to be responsible for any observed
changes in state variables.
• There are no channel gating variables in the model. Transmembrane ion currents are as-
sumed to be adequately described by the GHK flux equation 2.2. The underlying channel
activity facilitating these currents is characterised solely by the ionic permeability per
unit surface area.
• Solutions in all compartments are assumed to be well stirred. There is no description of
cell geometry or spatial variation in variables, so it is implicitly assumed that concentra-
tions in the cell are homogeneous throughout.
• The ionic composition of the extracellular compartments do not change due to transmem-
brane or transepithelial fluxes. This assumes that they are effectively infinite in extent
when compared with the cell volume, and act as reservoirs for ions and water.
• Cell volume changes due to transmembrane water fluxes only. It is assumed that the
volume of transmembrane ion fluxes are negligible in comparison and do not contribute
to changes in volume.
2.3 Methods of analysis of mathematical model
In this section I will outline the various mathematical analysis methods I use to study the bio-
physical ion transport model defined by equations 2.23-2.28. This includes methods to de-
termine model steady states, as well as the methods used to simulate ion transport kinetics.
Methods of estimating model parameter values from experimental observations are also dis-
cussed.
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2.3.1 Determining steady states and numerically integrating model ODEs
2.3.1.1 Determining steady states of model system
The system of ODEs 2.23-2.28 define the kinetics of ion transport processes of interest in a typ-
ical HNE cell. However as these cells are not excitable, under normal physiological conditions
we would not expect the physiological variables that I consider, concentrations and membrane
potentials, to be varying in time. We would expect that HNE cells are capable of maintaining a
stable, constant volume, and capable of balancing the movement of ions into and out of the cell,
in such a way that no concentration grows indefinitely or collapses to zero. Therefore, when
I am studying these cells I am quite often interested in the conditions necessary for constant
volume and ionic concentrations to be maintained. To posit this question in the framework
of the mathematical model, I am interested in determining the set of conditions which allow
f(x∗, θ) = 0. Here I use x∗ to refer to a specific set of variable values which give a steady state
of the model system. In full, for a steady state of the model system, the following conditions
must be true
0 = Jbaw − Japw (2.33)
0 = JNKCC − 3JNaK −
Iap
Na+
FzNa+
(2.34)
0 = 2JNKCC −
Iap
Cl−
FzCl−
− I
ba
Cl−
FzCl−
(2.35)
0 = JNKCC + 2JNaK −
IbaK+
FzK+
(2.36)
0 = Iap
Na+
+ Iap
Cl− + I
pa
Na+
+ Ipa
Cl− + I
pa
K+
(2.37)
0 = IbaCl− + I
ba
K+ + INaK − IpaNa+ − IpaCl− − IpaK+ (2.38)
Equations 2.33 to 2.38 comprise a set of non-linear equations of the form f(x, θ) = 0. Assum-
ing I know the parameter values θ, I can find the steady state variable values x∗ which solve
f(x, θ) = 0 using the fsolve function in MATLAB Optimisation Toolbox (MATLAB, 2010).
2.3.1.2 Numerically integrating model ODEs
The system of ordinary differential equations that describe the model are first order ODEs as
only the first derivative of the dependent variable x, with respect to the independent variable
time t, is present. The specific problem I need to solve is an initial value problem, as I want to
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know how the system evolves in time from an initial starting point x0. This is summarised as
dx
dt
= f(x, θ)
x(t = 0) = x0
(2.39)
Initial value problems can be solved in MATLAB using a number of different numerical inte-
gration algorithms. In my work I used the function ode15s, as this is specifically designed for
solving systems of stiff ODEs. A set of ODEs is said to be stiff if the variables in the system
are changing on very different timescales. In the case of the model HNE system, membrane
potentials tend to equilibrate on the time scale of milliseconds, where as cell volume and con-
centrations tend to equilibrate on the timescale of seconds to minutes. Hence I have a stiff ODE
system and must use appropriate algorithms, such as ode15s, when numerically integrating
them.
2.3.2 Estimating model parameters via error minimisation
In the previous section I described how, given a set of parameter values θ, one could determine
model variables at steady state, x∗, or given parameter values and initial variables values, x0,
solve for the state variable values as a function of time, x(t). Now I describe the inverse
problem, that is, how to find the values of parameters, θˆ, given a set of experimental data
yˆ(t) which is functionally related to the time evolution of model variables x(t). In this case I
estimate model parameter values by minimising the error between what my model predicts for
certain observables, and the experimental values that have been measured for them.
I construct the parameter estimation problem by first considering a model ODE system
which describes the dynamics of state variables x(t, θ), given parameters θ, as before in 2.39.
I then expand this framework, to consider a set of observables y(t) which are functionally
related to the dynamics of my variables by some function g (x(t, θ), θ). My model system and
experimental measurements are defined by
dx
dt
= f(x, θ)
x(t = 0, θ) = x0 (θ)
y(t, θ) = g (x(t, θ), θ) + (t)
(2.40)
The observables y will typically only be measured at discrete time points tk, k = 1, . . . , nt, and
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there will also generally be measurement noise (tk) associated with each of these data points.
If I perform a forward simulation of the model ODE system, by solving 2.39 for a given θ,
I can then determine the values of y that my system would predict. If I compare my predictions
at the time points tk, y(tk, θ), with the observations at the nt different measurement times,
yˆ(tk), I can compute the weighted sum of squared errors, or sum of squared residuals, using
χ2 (θ) =
ny∑
l=1
nt∑
k=1
(
yˆl(tk)− yl(tk, θ)
σˆ2lk
)2
(2.41)
Here the summation is over the ny different observables in the vector y, and over each of the
nt measurement time points, weighted by the measurement errors σˆlk at each yˆl(tk).
As before, I can use an algorithm to minimize the objective function χ2(θ). I define the
best fit or optimal parameter set θˆ, as that which minimizes the objective function.
θˆ = arg min
θ
{
χ2 (θ)
}
(2.42)
If I assume the measurement noise is normally distributed, such that  ∼ N (0, σ2), then χ2(θ)
is related to the statistical likelihood L(θ) as follows (Raue et al., 2009)
χ2(θ) = constant− 2 logL(θ) (2.43)
Since the sum of the weighted square residuals and the likelihood only differ by a constant,
minimising χ2(θ) will maximise L(θ). Hence I can find the maximum likelihood estimate
(MLE) of θˆ via 2.42.
In order to determine how tightly constrained my estimates of a particular parameter θˆj
are, I can compute confidence intervals of the form [θ−j , θ
+
j ] for the estimate. A Monte Carlo
approach is possible here. I can randomly generate a large number (Nsim) of synthetic noisy
data sets of the form
y˜ = yˆ
(
1 +N(0, σˆ2)
)
(2.44)
Minimising 2.41 for each synthetic data set y˜ independently, will leave us with a distribution
of Nsim estimates for each particular parameter,
{
(θj)
1, (θj)
2, . . . , (θj)
Nsim
}
. Looking at the
median of one of these distributions allows one to make an estimate of the true value of the pa-
rameter in question, and by computing the interquartile (IQR) range one determine the relative
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uncertainty in that estimate.
2.3.3 Monte Carlo parameter sampling and filtering
In my analysis of ion transport in HNE cells, I am interested in understanding what is causing
the differences in physiological properties observed between cells with a CF mutation, and
those without a mutated CFTR gene. The differences observed in physiology manifest in the
cell’s steady state properties, such as baseline transepithelial PD, and also manifest in the cell’s
response to experimental interventions, such as increased sensitivity of transepithelial PD to
amiloride addition, or lack of response to removal of Cl− from the lumen perfusate.
In terms of analysing my mathematical model, the physiological properties just de-
scribed can be thought of as a set of nY model outputs Y = (Y1, Y2, . . . , YnY ) which are
a functionally related to model inputs, the transport parameters θ = (θ1, θ2, . . . , θnθ). If
I can determine the mapping from transport parameter values to each of the model outputs,
Ym = f (θ1, θ2, . . . , θnθ), then I can hope to understand how the differences in Y correspond
to differences in θ.
To investigate the differences in transport physiology between non-CF and CF cells, I can
first quantify these differences by defining the different ranges each Ym takes in CF and non-CF
states. For example, in the case of transepithelial PD, in non-CF HNE cells in vitro one might
expect to observe −15 mV ≤ Vt ≤ −5 mV, but in a CF HNE cell one might expect it to
be in the range −45 mV ≤ Vt ≤ −20 mV. Repeating this for a group of several different
model outputs Y, I can describe bounds on allowed outputs in non-CF cell, Bnon−CF , and a
separate set of bounds BCF for CF cells. If these bounds on allowed outputs can be mapped to
constraints on allowed inputs, I can gain insight into what parameters are critical to the observed
physiological changes and which are not.
In general the mappings Ym = f (θ1, θ2, . . . , θnθ) will have to be found numerically. This
is because the outputs will require solving both (a) the set of non-linear equations, 2.33 - 2.38,
for steady state properties like basal transepithelial PD, and (b) the set of non-linear ODEs 2.23
- 2.28, for metrics like the change in Vt due to amiloride addition. One approach to determine
the mapping numerically, is to perform a Monte Carlo sampling on the input parameter space,
generating many sample parameter vectors θ, and compute the corresponding outputs Y(θ) at
each point of parameter space sampled. The set of individual Y = f (θ) that are computed,
are then used to filter the sampled parameter vectors into separate distributions, depending on
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whether Y falls within the constraints Bnon−CF or BCF .
This is an approach referred to as Monte Carlo Filtering (MCF) (Saltelli, 2004), and an
algorithm for performing it is as follows:
• Define a set of model outputs Y to use as a basis of the MCF analysis. These could be
steady state properties, based on x∗, or functions of the model’s kinetic behaviour, x(t).
• Define two distinct sets of bounds for the values of Y being considered (here I define
Bnon−CF and BCF ).
• Randomly generate a large number of parameter sets, covering the input parameter space
of interest. Compute Y for each sample θ.
• Filter model inputs θ based on whether the computed Y = f(θ) falls within Bnon−CF
or BCF . This will leave you with two sets of parameter values that come from unknown
distributions, f1 (θ|Bnon−CF ) and f2 (θ|BCF ).
• Differences between the distribution of each parameter value (θ1, θ2, . . . , θnθ) can be
observed to find what is responsible for differences in Y .
2.3.4 Variance based parameter sensitivity analysis
As well as determining how individual transport parameters θj will differ between CF and non-
CF epithelia, which I can address with an MCF analysis, I would also like to know the relative
influence of each individual transport parameter θj on each output Ym. This can help us gain
a quantitative insight into which changes in transport physiology are most likely responsible
for the changes in electrophysiology observed in CF. This requires us to perform a sensitivity
analysis on my model system, in order to be able to rank the parameters θj in order of influence
on a given output Ym.
As discussed in the previous section, the relationship between model inputs and outputs
Y = f (θ1, θ2, . . . , θnθ) will not be known in the general case. I can investigate it numerically
by generating Monte Carlo realisations of θ andY. If I assume I know the form of the mapping
f(.) relating the inputs and outputs, I can then quantitatively relate the variance in inputs to the
variance in outputs.
One approach to performing a variance based sensitivity analysis, is to assume the rela-
tionship between model inputs and outputs can be captured satisfactorily with a multiple linear
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regression model. A linear regression model relates some response or output y to a linear com-
bination of predictor terms f(x) which are functions of model inputs x. If there are several
input variables x this is referred to as a multiple linear regression. An example, linking input
parameters x = (x1, x2), to an output y, is as follows:
y = b0 + b1x1 + b2x2 + b11x
2
1 + b22x
2
2 + b12x1x2 (2.45)
y = Bx (2.46)
Here the model has predictor terms that are both linear and quadratic in the input variables, for
example terms b1x1 and b11(x1)2 respectively, as well as predictor terms based on interactions
between model inputs, here b12x1x2. It is important to note however that the regression itself is
linear combination of predictor functions f(x).
Taking this approach, I can use the following regression model to map model parameters
θj to a given model output Ym:
Ym = b0 +
nθ∑
j=1
(
bjθj + bjjθ
2
j
)
+
nθ∑
j=1
nθ∑
j′=j+1
bjj′θjθj′ (2.47)
In this model, regression co-efficients bj determine the strength of linear correlation between a
single parameter θj and the output Ym. By comparing the magnitude of the linear regression
co-efficients I have a means of determining the relative influence a given transport parameter
has on a model output (physiological observable) of interest.
2.3.5 Practical identifiability of model parameters via profile likelihood
The mathematical model I use to describe ion transport kinetics in HNE cells, has more param-
eters θ than variables x (i.e. nθ ≥ nx). In practice, it may be technically difficult to measure
all of these variables simultaneously, so the amount of measured observable data available for
parameter estimation (ny observables ×nt measurement time points) may also be similar in
quantity to or less than nθ. It is important therefore that I understand the relationship between
the goodness of fit function χ2(θ), and the amount of data I am using for parameter estimation.
Given a model system and experimental data set, I would like to be able to answer questions
such as, is it possible to make unique estimates of parameter values of interest, or is there insuf-
ficient information in the observed data to identify constraints on estimated parameter values?
Here I will outline how one can systematically investigate these issues of parameter identifia-
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bility using the profile likelihood.
2.3.5.1 Likelihood based confidence intervals
Before introducing the profile likelihood I will outline how one can compute likelihood based
confidence intervals. Assuming I know the maximum likelihood estimate θˆ, I can compute a
confidence interval for finding the true value θ†, based on thresholds in the value of the likeli-
hood. Since χ2(θ) and L(θ) differ only by a constant (as defined by 2.43), I can equally define
the threshold in terms of χ2(θ).
{
θ|
(
χ2(θ)− χ2(θˆ)
)
< ∆α
}
with ∆α = χ
2(α, df) (2.48)
The true value θ† will be in the region where χ2(θ) is less than the minimum value χ2(θˆ) plus
some threshold value ∆α. The threshold will depend on the significance level I want to assign to
the confidence interval. For a confidence level α, the threshold is found from the α-th quantile
of the relevant χ2 distribution, χ2(α, df), where df is the degrees of freedom. Using df = 1
gives a pointwise interval for the estimate of θ.
2.3.5.2 Structural and practical identifiability
In a model system of the form described in 2.40, it may not be possible to uniquely estimate
model parameters, depending on the mapping between model variables x and observable data
y = g (x(t, θ), θ). If there is a subset of model parameter values θsub which can always be
combined in such a way that χ2(θ) remains constant, then the system is said to be structurally
unidentifiable. This can be stated formally as
χ2(θ) = χ2(θˆ)⇔ h (θsub) = 0 (2.49)
There is some function h(.) that defines a relationship between parameters in θsub, such that
χ2(θ) will always remain constant regardless of individual parameter values, so long as the
condition h (θsub) = 0 is met. The corresponding confidence intervals for θj may then be
infinite. Hence I cannot assign confidence intervals and the system is said to be structurally
unidentifiable. An illustration of this can be seen in Figure 2.10(a), where χ2(θ1, θ2) does not
change along the manifold h(θ1, θ2) = θ1θ2 − 10.
If a parameter is structurally identifiable, it still may be impossible to determine finite
confidence intervals for that value to an arbitrary confidence α. In this case the parameter in
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Figure 2.10: Diagram showing profile likelihood (dashed line) of a given parameter θ1 overlaid
on a contour plot of the sum of squared residuals, χ2(θ1, θ2). In panel (a) there is a functional
relationship between θ1 and θ2, along which the value of χ2 remains the same. This means the
profile likelihood for θ1 is flat (b) and signifies a structural identifiability issue. The case in (c)
highlights a practical identifiability issue. There is a minimum in χ2(θ), but the landscape is
not convex. In (d) I see that χ2PL(θ1) does not breach the ∆α threshold as θ1 → ∞, hence I
cannot define an upper bound for θ1 to a confidence level α. Finally, in (e), there is a global
minimum in the optimisation landscape, and confidence limits can be found for θ1 since its
profile likelihood is convex (f). Image from Raue et al. (2011).
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question is said to be practically unidentifiable. This usually arises due to insufficiencies with
observed data, due to measurement noise or a small number of data points. An illustration of
this phenomenon this can be seen in 2.10(c), here the MLE of θ1 is about 4, but as θ1 → ∞, it
is always possible to find the same minimum value of χ2(θ), given the appropriate value of θ2.
2.3.5.3 Profile likelihood
One approach to assessing issues of identifiability in ODE based models, involving analysing
the profile likelihood function, was put forward by Raue and co-workers (Raue et al., 2009,
2011). The profile likelihood function is defined from the weighted sum of square residuals
function 2.42 as follows
χ2PL(θj) = minimise
θp 6=j
[
χ2(θ)
]
(2.50)
The objective function χ2(θ) is minimised by varying the parameters θp6=j , while one parameter
θj is fixed at a particular value. By fixing θj at a range of different values, and re-optimising
χ2(θ) as a function of θp 6=j each time, I can compute χ2PL(θj) for a region of interest.
The identifiability of the parameter in question θj can then be assessed from its profile
likelihood. If χ2PL never changes as θj is changed then it is structurally unidentifiable. If
χ2PL has a minimum, but the profile does not rise above a certain threshold, then the parameter
may be practically unidentifiable. Finally, if χ2PL is a convex function of θj it is possible to
define appropriate confidence intervals and that parameter is identifiable. These concepts are
illustrated schematically in Figure 2.10(b,d,f).
To compute the profile likelihood one requires an appropriate algorithm. It should (1) in-
crement the parameter θj from its maximum likelihood value, (2) minimise the objective func-
tion 2.50 as a function of θp6=j , and (3) repeat steps (1) and (2) until the profile likelihood has
passed a specified threshold value (∆α). To this end I used the PLdriver algorithm developed us-
ing MATLAB by Joep Vanlier and coworkers (http://bmi.bmt.tue.nl/sysbio/software/pua.html)
which allows a profile likelihood to be computed for a user supplied objective function (Vanlier
et al., 2012).
2.4 Model validation
Before carrying out analysis of the mathematical ion transport model, I first needed to validate
its basic properties and behaviour. By validate here I mean a couple of things. One, I needed
to ensure that the model would reproduce known properties of a HNE cell, given appropriate
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Table 2.2: Initial baseline values used for transport parameter values.
Parameter Value Units Reference
P ap
Na+
0.028 µm/s (Willumsen and Boucher, 1991b)
P ap
Cl+
0.072 µm/s (Willumsen and Boucher, 1991b)
P baK+ 0.080 µm/s (Falkenberg and Jakobsson, 2010)
P baCl+ 0.100 µm/s (Falkenberg and Jakobsson, 2010)
ρNaK 0.400 10−10mol/cm2 author estimate
ρNKCC 0.400 10−10mol/cm2 author estimate
P pa
Na+
, P pa
Cl− , P
pa
K+
0.035 µm/s (Willumsen and Boucher, 1989)
estimates for model parameter values found in the literature. For example, under physiologi-
cal conditions these cells should be primarily Na+ absorbing, and produce a lumen-negative
transepithelial potential. Secondly, I needed to ensure that the model is capable of maintaining
stable kinetics in response to small perturbations in physiological variables.
2.4.1 Baseline transport parameter values
The overarching theme of my PhD research is to understand how the activity of different
transport proteins influences the electrophysiology of airway epithelial cells. To this end,
the model parameters that I focus on are those that are proportional to the expression level
of ion channels, pumps and co-transporters in human nasal epithelial cells. Specifically they
are
(
P ap
Na+
, P ap
Cl− , P
ba
K+ , P
ba
Cl− , ρNaK , ρNKCC , P
pa
Na+
, P pa
Cl− , P
pa
K+
)
, and I refer to these as trans-
port parameters. Throughout the work that follows, all other parameter values will be assumed
fixed at a certain value unless otherwise stated. The values I use for these fixed parameters are
taken from the scientific literature and recorded in the Appendix A.1, see Table A.1.
I will now describe the source of the baseline estimates of the transport parameters of inter-
est that I initially use, which are listed in Table 2.2. Willumsen and Boucher published estimates
of apical Na+ (P ap
Na+
) and apical Cl− (P ap
Cl−) permeabilities in HNE cells with non-CF CFTR
(Willumsen et al., 1989b; Willumsen and Boucher, 1991a). They also estimated the resistance
of the paracellular pathway in these cell types, and an estimate of the corresponding paracellu-
lar permeability can be made from this data (Willumsen and Boucher, 1989). Falkenberg and
Jakobsson published estimates of the expected basolateral K+ (P baK+) and Cl
− (P baCl−) perme-
abilities in Calu-3 and human bronchial epithelial (HBE) cells, based on data in the studies of
Cowley and Linsdell (2002), Fischer et al. (2007) and Itani et al. (2007). Estimates of Na+-K+
pump (ρNaK) and NKCC (ρNKCC) co-transporter membrane densities were not available in
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Table 2.3: Selected steady state properties of model HNE cell, given literature estimates of
transport parameters.
Property Value Units
[Na+]i 16.7 mM
[Cl−]i 69.3 mM
[K+]i 114.0 mM
V apm -12.3 mV
V bam -23.7 mV
Vt -11.4 mV
DF ap
Na+
-69.2 mV
DF ap
Cl− +2.3 mV
Iap
Na+
-33.6 µA/cm2
Iap
Cl− +4.2 µA/cm
2
the literature, so I chose values which allowed a realistic steady state of the ODE system when
the other baseline parameter values were used.
2.4.2 Baseline model properties
Using these initial literature parameter estimates, one can assess whether or not my model is
giving realistic predictions for physiological variables associated with HNE cells. Table 2.3
lists the values of several physiological variables predicted by my model, found by solving the
set of non-linear equations 2.33-2.38 given parameter values in tables 2.2 and A.1.
Even though my transport parameter estimates are taken from disparate sources, I predict
a realistic picture of a HNE cell. Internal Na+ is low, and internal K+ is high, as one would ex-
pect, and I also find that the transepithelial potential difference is lumen-negative. Interestingly,
there is a large driving force for Na+ absorption across the apical membrane (DF ap
Na+
in Table
2.3), and the corresponding driving force for Cl− (DF ap
Cl−) is very low in comparison. This is
reproducing the fact that these HNE cells will actively absorb Na+ under normal conditions,
but Cl− will be near to equilibrium across the apical membrane. Here I see that I predict a
larger apical Na+ current than apical Cl−, despite P ap
Cl− being greater than P
ap
Na+
, due to the
aforementioned differences in driving forces.
2.4.3 Model stability analysis
I carried out model validation to assess the stability of the model dynamical system to small
perturbations to model variables. The perturbations were introduced for numerical validation
only, to determine if the system remained stable and behaved in a physiologically realistic
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Figure 2.11: Between times T1 = 300 s and T2 = 2100 s the ODE for the rate of change of
Wi is perturbed by a sinusoidally varying forcing term of the form u(t) = u0sin(ωt), where
ω = pi/75 s−1 and u0 = 0.18 µm3/s. All other model variables are perturbed because of the
coupled nature of the system, which nonetheless remains stable throughout.
Figure 2.12: Between times T1 = 300 s and T2 = 2100 s the ODE for the rate of change of
V bam is perturbed by a sinusoidally varying forcing term of the form u(t) = u0sin(ωt), where
ω = pi/75 s−1 and u0 = 1.00×106 mV/s. The system remains stable despite the perturbation.
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manner given baseline parameter estimates. The perturbations introduced were not intended to
simulate a particular physiological phenomenon.
Model validation was implemented by adding a sinusoidally varying forcing term u(t)
to the right hand side of the model ODEs 2.23-2.28, one ODE at a time. The term is of the
form u(t) = u0sin(ωt) with frequency ω = pi/75 s−1 and the forcing term was only switched
on for a fixed time interval T1 → T2, after which the system was allowed to return to its
original state. For each cellular quantity of interest (volume, ionic concentrations, membrane
potentials), I recorded the magnitude of the maximum displacement caused by the perturbation,
as a percentage of the initial steady state value of that property. For each ODE, I chose a
different value for the amplitude of the forcing term uo. I chose the values manually such that
the magnitude of the resulting maximum displacement in that particular cellular variable would
be approximately 10% of its steady state value.
Examples of this type of simulation can be seen in Figures 2.11 and 2.12. Here the vari-
ables being perturbed are cell volume, Wi, and basolateral membrane potential, V
ap
m , respec-
tively. I found that with the baseline estimates of transport parameter values, the system re-
mains stable during and after these sinusoidal perturbations of model variables, regardless of
the particular variable (ODE) being perturbed. The magnitude of the maximum displacement
of variable values not being forced directly, was never greater than 20% of the original steady
state level, and on average these displacements were smaller in magnitude than that the change
observed in the quantity that was being perturbed directly. This suggests that this model is rel-
atively robust to small changes in variable values. The results of this model validation exercise
can be seen in Table 2.4.
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Table 2.4: Amplitude of oscillations in cellular properties (as % of steady state value) caused
by adding a forcing term to a single model ODE, of the form u0sin(pit/75s).
Perturbed variable
Cell property u0 Wi Na+i Cl
−
i K
+
i V
ap
m V bam
Volume 0.18 µm3/s 10.0% 1.2% 3.0% 6.6% 0.2% 0.4%
[Na+]i 2.43×10−17 mol/s 4.5% 10.0% 7.7% 5.9% 0.8% 1.3%
[Cl−]i 6.05×10−17 mol/s 6.9% 3.4% 10.0% 6.3% 0.7% 1.5%
[K+]i 10.60×10−17 mol/s 7.3% 1.7% 4.3% 10.0% 0.3% 0.8%
V apm 4.48×105 mV/s 9.7% 9.5% 19.1% 13.1% 10.0% 10.5%
V bam 1.00×106 mV/s 4.9% 6.9% 12.0% 8.3% 2.6% 10.0%
Vt 1.2% 4.2% 4.3% 3.2% 5.7% 9.5%
Chapter 3
Estimating transport parameters from in vitro
electrophysiological recordings
3.1 Introduction
In the first chapter of this thesis I described the fundamental concepts behind epithelial transport
mechanisms, and highlighted the major ion transport proteins that are expressed in the human
airway epithelium. In the second chapter I described how one could model transport by each
of these proteins, and integrate these descriptions into a whole cell model of epithelial ion
transport. I also described several methods that could be used to investigate the properties of
the whole cell model, and how one could use the model to infer quantitative information about
the activity of different proteins from observed experimental data.
In this chapter I will now describe how I used the mathematical model to simulate Ussing
chamber experiments, common in the study of epithelial electrophysiology, in order to estimate
transport parameters from electrophysiological data. In particular, I make estimates of mem-
brane permeabilities to Na+ and Cl− ions, in both CF and non-CF primary cultures of HNE
cells, in order to understand how they differ in cystic fibrosis.
3.2 Methods
3.2.1 Simulating Ussing chamber experiments
In order to perform parameter estimation using the approach outlined in Section 2.3.2, it is
necessary to have a set of experimental observations {yˆ(tk), σ(tk)|k = 1, . . . , nt}, and a model
that can make predictions as to what values the observables should take as a function of model
parameters, y(tk, θ). I have previously described the mathematical model in detail (see Section
2.2), now I will describe the type of experiment and type of data I will use for parameter
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estimation.
The two types of simulated or in silico experiment that I implement are (i) pharmaco-
logical block of ENaC channels with amiloride, and (ii) removing Cl− from the solution in
luminal compartment of the Ussing chamber. Addition of amiloride and reduction of [Cl−] in
the luminal perfusing solution are also used when obtaining patient nasal potential difference
measurements, and therefore are of considerable clinical interest. The effect of (i) is to block
all apical Na+ channels, thus reducing the current Iap
Na+
to zero. The loss of this apical Na+
current will cause the apical membrane potential to change, as per equation 2.27, and hence
the transepithelial PD will change as well. The change in Vt due to this manoeuvre is usually
referred to as amiloride-sensitive Vt, or ∆Vt + amiloride. This metric (and the corresponding
amiloride-dependent change in nasal PD) is of interest as it tends to be increased on average
in CF HNE cells, as discussed in Section 1.2.3. As the magnitude of ∆Vt + amiloride will
be influenced by the permeability of the apical membrane to Na+, this is regularly used as a
surrogate measure of ENaC channel activity in epithelial cells.
The effect of (ii) is to increase the driving force for Cl− secretion across the apical mem-
brane. Typically Cl− will be at or close to thermodynamic equilibrium across the apical mem-
brane when lumen [Cl−] is approximately 120 mM (see Figure 4 in (Willumsen et al., 1989b)).
If then the external concentration is lowered significantly, there will be a favourable driving
force for Cl− to exit the cell, Iap
Cl− will change as a result, leading to a corresponding change in
the transepithelial Vt. By recording the change in Vt, commonly referred to as ∆Vt + 0[Cl−]l,
one can make inferences about the level of CFTR channel activity that is facilitating the Cl−
current.
These perturbations can be modelled with the ODE system described in Section 2.2, by
choosing an appropriate initial condition x0 and making the necessary changes to the param-
eter vector θ, in order to represent the different bath solutions perfused on the luminal side of
the nasal epithelial cells. Table 3.1 lists the relevant parameter values used to model the dif-
ferent lumen solutions. A physiological saline solution (NaCl) is used to determine the initial
model steady state, then the system of ODEs is integrated with either a NaCl + amiloride or
Na+ − gluconate− solution.
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Table 3.1: Ionic composition of lumen bath solutions used during Ussing Chamber experiments.
Lumen bath solutions (concentrations in mM)
NaCl NaCl + Amiloride Na+ − gluconate−
[Na+]l 140 140 140
[Cl−]l 120 120 3
[K+]l 5 5 5
[gluconate−]l 0 0 117
[ψ]l 25 25 25
P ap
Na+
P ap
Na+
> 0 P ap
Na+
= 0 P ap
Na+
> 0
3.2.2 Amiloride block of ENaC channels
The effect of blocking ENaC channels in a HNE cell with amiloride, can be implemented in
the following manner. Given a certain set of parameter values θ, which includes a non-zero
apical Na+ permeability (P ap
Na+
), I determine the steady state variables values x∗ by solving
f(x, θ) = 0 by the method described in Section 2.3.1.1. This steady state x∗ is then used as the
initial condition x0 for an initial value problem (IVP) of the form 2.39. When solving this IVP,
a different parameter vector θ′ is used, which is the same as θ except the value of P ap
Na+
is equal
to zero. The system then evolves in time in a state which has no apical Na+ permeability.
This approach assumes that the system is initially in a steady state configuration, then at
a certain point all ENaC channels are blocked simultaneously, at which point the system must
relax to a new steady state. The assumption that amiloride only inhibits ENaC, and no other
transport protein, is commonly made in experimental as well as modelling studies (Horisberger,
2003; Falkenberg and Jakobsson, 2010; Garcia et al., 2013) and is also the basis for interpre-
tation of amiloride sensitive Vt measurements in the standard nasal PD test (Knowles et al.,
1995).
A representative example of this type of in silico experiment, using baseline parameter
values, can be seen in Figures 3.1 (traces of model variables) and 3.2 (traces of individual cur-
rents and fluxes). One can see a significant depolarisation in Vt on blocking ENaC channels
(resulting from a large hyperpolarisation of the apical membrane and a smaller hyperpolariza-
tion of the basolateral one), which is a characteristic of airway epithelia. One can also observe
how the internal Na+ concentration decreases, as the flux across the basolateral membrane does
eventually reach zero after the loss of the ENaC current, but is rate limited by the slow kinetics
of the pump and cotransport pathways.
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Figure 3.1: Simulation to investigate the effect of blocking apical ENaC channels in a HNE
cell. At t = 600s the apical Na+ permeability is changed to 0, and the cellular variables such
as membrane potentials and concentrations must relax to a new steady state after the loss of the
apical Na+ current.
Figure 3.2: Various ionic currents and fluxes in the HNE cell model, during an in silico
amiloride addition experiment. Iap
Na+
→ 0 at t = 600s and the resulting changes in driving
force cause all other currents and fluxes to change correspondingly. Note all currents displayed
are in units of µA/cm2.
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Figure 3.3: Simulation to investigate the effect of removing Cl− from the lumen perfusate.
At t = 600s, [Cl−]l goes from 120 mM → 3 mM. As there is a significant apical Cl−
permeability, this maneouveur causes an increase in Cl− secretion, and hyperpolarisation of Vt.
3.2.3 Removing Cl− from the luminal compartment
In analogy to how I implement the amiloride addition simulation, I simulate removal of Cl−
from the luminal compartment, by making an appropriate choice of steady state conditions
x∗ and also making necessary changes to the model parameter vector θ. Initial conditions
are chosen which give a steady state when the lumen solution has [Cl−]l = 120 mM. The
ODE system is then numerically integrated from this initial condition, but with external Cl−
concentration changed to 3 mM. NaCl is typically replaced with Na+ − gluconate− in these
experiments, so this also needs to be modelled. I assume initially that there are no gluconate−
ions in the system, before the Cl− solution exchange is made, therefore when solving for the
initial steady state I set [gluconate−]l = 0 mM. Before numerically integrating the ODEs
however, I change this parameter such that [gluconate−]l = 117 mM, as gluconate− is used
as an osmotic substitute for luminal Cl−. I assume gluconate− cannot permeate through the
cell membrane, but will diffuse along the paracellular pathway, adding a term Ipa
gluc− to the total
paracellular current.
Figures 3.3 and 3.4 show the impact of this perturbation on the variables and individual
currents respectively, when I use the baseline transport parameter values. The model reproduces
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Figure 3.4: Various ionic currents and fluxes in the HNE cell model, during an in silico ex-
periment to simulate removal of Cl− from the solution in the luminal compartment. Note all
currents displayed are in units of µA/cm2.
the gross behaviour one would expect to see in airway epithelia with normal levels of CFTR ac-
tivity. On removal of Cl− from the lumen, a large driving force for Cl− secretion is introduced,
Iap
Cl− is increased, V
ap
m depolarizes more than V bam , and consequently Vt is hyperpolarised.
3.2.4 In vitro data used to constrain transport parameter values
One of the primary motivations for specifically modelling human nasal epithelial (HNE) cells
over other airway epithelial cells, is that the biophysical properties of both normal and CF
HNE cells have been characterised in detail by Willumsen and Boucher in a series of studies,
providing a large body of useful electrophysiological data that I can use for model validation
and parameter estimation purposes (Willumsen et al., 1989a,b; Willumsen and Boucher, 1989,
1991a,b).
I used a combination of data from Willumsen and Boucher’s amiloride addition experi-
ments, where intracellular [Na+] and [Cl−] as well as potentials V apm and Vt were recorded,
along with data from their Cl− removal experiment, where they recorded the individual mem-
brane potentials with simultaneous intracellular [Cl−] measurements. The data used for pa-
rameter estimation can be inspected in Tables 3.2 and 3.3. Note for the amiloride addition
experiments, two separate sets of data were available, as only one intracellular concentration
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Table 3.2: Experimental data used for estimation of non-CF transport parameters. Concentra-
tions are given in mM, membrane potentials in mV, and time in seconds (s). Data is presented
as mean ± standard error.
Experiment k Time (tk) Observed data
ˆ[Na+]i(tk) ˆ[Cl−]i(tk) Vˆm
ap
(tk) Vˆt(tk)
+amiloride 1 0 27.2±3.3 — -19.0±1.5 -12.6±3.1
2 1050 24.2±4.4 — -27.4±3.1 -5.0±1.1
3 0 — 57.0±3.5 -25.9±2.5 -11.8±1.5
4 1050 — 52.2±4.7 -36.6±2.2 -5.0±0.6
+zero Cl- 5 0 — 55.5±5.2 -22.5±1.4 -12.4±2.4
6 1050 — 35.1±4.5 -10.4±2.5 -21.8±2.2
Table 3.3: Experimental data recorded in CF HNE cells in vitro. Concentrations are given
in mM, membrane potentials in mV, and time in seconds (s). Data is presented as mean ±
standard error.
Experiment k Time (tk) Observed data
ˆ[Na+]i(tk) ˆ[Cl−]i(tk) Vˆm
ap
(tk) Vˆt(tk)
+amiloride 1 0 25.9±3.5 — -7.5±4.8 -42.3±6.1
2 1050 — — -49.5±3.5 -2.0±1.5
3 0 — 67.7±5.6 -8.2±5.0 -37.4±8.4
4 1050 — 66.6±6.8 -43.6±4.0 -1.2±1.1
+zero Cl- 5 0 — 62.7±6.2 -20.0±6.1 -27.7±9.2
6 1050 — 65.1±6.4 -17.1±5.5 -31.0±9.5
was measured at a time. Therefore when there are two data points for a membrane potential at
a given time point, I weight the error by 1/2 to compensate.
3.2.5 Implementing numerical parameter estimation
The task of estimating the subset of model parameter values θsub = (P
ap
Na+
, P ap
Cl− , P
ba
K+ ,
P baCl− , ρNaK , ρNKCC) from experimental observations of the physiological quantities yˆ =
([Na+]i, [Cl
−]i, V
ap
m , Vt) was carried out by minimising the sum of squared errors between val-
ues predicted for these quantities by the model and their observed values. This is formally stated
as minimising the following objective function:
minimize
θsub
q∑
k=1
ˆ[Na+](tk)−Na+i (tk)/Wi(tk)
σˆ[Na+]ik
+
ˆ[Cl−](tk)− Cl−i (tk)/Wi(tk)
σˆ[Cl−]ik
. . .
+
ˆV apm (tk)− V apm (tk)
σˆV apm k
+
Vˆt(tk)− Vt(tk)
σˆVtk
(3.1)
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The first parameter estimation problem I solved was to find θnon−CF which minimised the
residuals between observed data from non-CF HNE cells (Table 3.2) and model output, for
a combined data set from two experiments, +amiloride and +0[Cl−]l. Model simulations are
performed as outlined in Section 3.2.1. The second, separate parameter estimation problem was
to find θCF which would minimise residuals between observed data from CF HNE cells (Table
3.3) and model predicted variable values, again for data from a combination of +amiloride and
+0[Cl−]l experiments.
The minimisation problem 3.1 was solved repeatedly for Nsim = 200 different noisy
realisations (see Section 2.3.2) of the non-CF HNE cell data (Table 3.2), and separately, for
200 noisy realisations of the CF HNE cell data (Table 3.3). I implemented each individual
minimisation using the lsqnonlin function in MATLAB Optimisation Toolbox. Repeating the
minimisation for each of the Nsim noisy data sets, I built up a distribution of parameter values,
in both the CF and non-CF cases, from which the median and interquartile ranges could be
determined.
3.2.5.1 Note on implementation of parameter estimation
The experimental data set I used to estimate transport parameter values in CF HNE cells does
not include the value of intracellular Na+ concentration after amiloride addition (Table 3.3),
whereas I have used this information for estimating transport parameter values in non-CF HNE
cells (Table 3.2). Willumsen and Boucher (1991b) reported that on average Na+ concentration
increased in CF HNE cells after the addition of amiloride, from an initial value of 25.9±3.5 mM
to a new steady state value of 40.1 ± 5.7 mM. This behaviour is qualitatively different from
what is observed in non-CF cells, where the internal Na+ concentration intuitively decreases
after the inward apical Na+ flux is completely blocked by application of amiloride. My ion
transport model can qualitatively reproduce the reported [Na+]i decrease in the non-CF case,
but the model is incapable of reproducing an increase in [Na+]i after P
ap
Na+
→ 0, for any values
of the other transport parameters.
For this reason I decided to exclude the post-amiloride addition [Na+]i value from the CF
parameter estimation exercise. I did not want to cause parameters to take on unrealistic values
by forcing the model to attempt to reproduce a behaviour it was not capable of. In the appendix
(see Section A.6) I show the different parameter estimates and model kinetics predicted if one
does indeed include this additional [Na+]i observation in the fitting process. The estimated
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values of P ap
Na+
and P ap
Cl− are not changed significantly relative to their estimated values shown
in Table 3.4 (given the uncertainty in each estimate).
It is worth noting that several similar models of epithelial ion transport display comparable
Na+ kinetics in this situation. The models of Garcia et al. (2013), Falkenberg and Jakobsson
(2010) and Levin et al. (2006) all predict a decrease in internal sodium on amiloride addition,
and to the best of my knowledge there is no biophysical model of this kind that reports an
increase in internal sodium induced by amiloride addition. It may be that this behaviour can only
be explained if one takes into account the activity of cation exchangers and sodium bicarbonate
transporters present in these epithelial cells.
3.3 Results
3.3.1 Estimates of transport parameter values in CF and non-CF HNE cells
The results of this parameter estimation work are summarised in Table 3.4. There the median
and interquartile range found from the distribution of Nsim = 200 estimates of each parameter
are shown. It is clear that some parameters are tightly constrained by the data used for estima-
tion, while others are not. For example the IQR in the non-CF case for P ap
Na+
is 16% of the
median value, and 20% of the estimated value in the CF case. Compare this with P baCl− in the
non-CF case, where the ratio of the IQR to the median is 120%, and for ρNKCC in the non-CF
case, where it is over 800%.
Table 3.4: Estimated values of transport parameters in CF and non-CF HNE cells. Parameter
estimates are displayed as (median ± IQR) of each θj’s distribution.
Parameter Units non-CF CF
P ap
Na+
µm/s 0.024±0.004 0.070±0.014
P ap
Cl− µm/s 0.066±0.017 0.005±0.004
P baK+ µm/s 0.101±0.073 1.540±6.835
P baCl− µm/s 0.096±0.115 0.568±2.414
ρNaK 10
−10mol/cm2 0.133±0.091 1.250±4.239
ρNKCC 10
−10mol/cm2 0.199±0.408 1990 ±16267
3.4 Discussion
3.4.1 Significance of CF / non-CF transport parameter differences
By examining the scatter plots of estimated parameter values we can see where some of the
large uncertainties arise from. Figures 3.5 and 3.6 show the distributions of P ap
Na+
and P ap
Cl−
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Figure 3.5: Estimates of P ap
Na+
and P ap
Cl+
made from noisy realisations of non-CF HNE cell
data in Table 3.2. Note that both parameters are approximately normally distributed and there
is no significant correlation between these two parameters.
Figure 3.6: Estimates of P ap
Na+
and P ap
Cl+
made from noisy realisations of CF HNE cell data in
Table 3.3. As in the non-CF case these estimates are approximately normally distributed, and
there is no significant correlation between the estimates.
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Figure 3.7: Estimates of P baK+ and P
ba
Cl− made from noisy realisations of non-CF HNE cell
data in Table 3.2. Estimates are not constrained very well, and there is a significant correlation
between the two distributions.
in non-CF and CF cases respectively. The distributions of each parameter are approximately
Gaussian, and there is no significant correlations between the parameter values. Outside of
these narrow ranges of parameter values there is essentially zero probability that you could
accurately reproduce the HNE cell data in either CF or non-CF cases. Contrast this on the other
hand, with the scatter plot of P baK+ and P
ba
Cl− , shown in Figure 3.7 for the non-CF case. Here
the parameter estimates are plotted on a log log scale as they are not normally distributed, and
in fact the estimated parameter values span several orders of magnitude. This suggests that the
value of these parameters is not tightly constrained by the goodness of fit function χ2(θ). There
is also a clear correlation between the two parameters which suggests an identifiability issue.
One can get an equally good fit to data with any value of P baCl− , so long as an appropriate value
of P baK+ is chosen.
These observations have consequences when we assess the statistical significance of dif-
ferences between CF and non-CF parameter estimates. Our estimate of P ap
Na+
is increased in
CF, and we can say with high confidence that it is a statistically significant increase, as in both
cases it is tightly constrained by the data, and the interquartile ranges do not overlap. Similarly,
we estimate a statistically significant decrease in P ap
Cl− in CF HNE cells, as one might expect.
On the other hand the differences between CF and non-CF estimates of P baK+ , P
ba
Cl− , ρNaK and
ρNKCC are not significant given the uncertainty in the estimated CF values.
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Figure 3.8: Model dynamics produced by Nsim = 200 different sets of non-CF parameter
estimates for θsub (gray lines) along with the model dynamics predicted by the median estimated
non-CF parameter values (blue line) shown in Table 3.4. Simulation shown is for an amiloride
addition experiment on non-CF HNE cells, with observed data in red.
3.4.2 Physiologically realistic simulations
Figures 3.8 and 3.9 show the different solutions corresponding to the Nsim = 200 different
estimated sets of parameter values θsub in the non-CF case. The solution predicted by the
parameter values shown in Table 3.4 is also shown overlayed as a blue trace, and the data
used for parameter estimation is shown in red. Qualitatively the agreement between model
simulations and observed data is in general good, and quantitatively it is also quite good for
most variables, especially the apical membrane potential and the transepithelial PD. One aspect
that is not quite captured satisfactorily is the change in internal Cl− concentration in the external
Cl− removal experiment, where all simulations predict changes lower than the 20 mM drop
observed.
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Figure 3.9: Simulations of removing Cl− from the lumen perfusate in non-CF HNE cells,
observed data are in red. Gray lines are traces given by the different parameter sets found by
fitting to 200 different noisy data sets. The blue line is the trace predicted by the median of
these parameter estimate distributions, displayed in Table 3.4.
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Figure 3.10: Simulation of amiloride addition in CF HNE cells. Best fit solution is shown in
blue, with measured data in red. The distribution of different traces fitted to noisy data sets are
shown as gray lines.
Figures 3.10 and 3.11 show the traces predicted by the optimal CF parameter values. The
qualitative and quantitative agreement with the membrane potentials is again quite good. How-
ever, as discussed earlier, the model fails to predict an increase in internal Na+ on addition of
amiloride, which was observed in in vitro experiments in CF HNE cells, and this is the only
major qualitative difference between prediction and observed data.
The model predictions with the optimal parameter estimates listed in Table 3.4 accurately
reproduce the initial and final steady state values cellular variables take during these experi-
ments. Hence one can be confident the parameter estimates I have made here give a realistic
picture of the transport protein activity in the HNE cells in question. Interestingly our estimates
here suggest that apical Cl− and Na+ permeability do vary significantly in CF, and of particular
note it suggests ENaC activity must be increased markedly in CF relative to non-CF HNE cells.
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Figure 3.11: Simulation of reducing external Cl− concentration in CF HNE cells. Best fit
solution is shown in blue, with measured data in red. The distribution of different traces fitted
to noisy data sets are shown as gray lines.
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Case P pa
Na+
P pa
Na+
/P pa
Cl− P
pa
Cl−/P
pa
gluc−
non-CF CF
A 0.0350 0.0350 1.0 1.0
B 0.0350 0.0350 1.3 1.4
C 0.0329 0.0218 1.0 1.0
D 0.0367 0.0243 1.3 1.4
Table 3.5: List of different configurations parameter estimation was implemented under. The
effect of paracellular selectivity, and differences in non-CF / CF paracellular permeability, were
both investigated.
3.4.3 Influence of paracellular permeability and selectivity on estimates
In order to determine if the conclusion of increased P ap
Na+
in CF relative to non-CF epithelia was
dependent on assumptions I had made regarding the permeability of the paracellular pathway,
I performed a number of additional parameter estimation analyses. There is some limited evi-
dence that the paracellular pathway may be less permeable in CF HNE cells than non-CF HNE
cells (Willumsen and Boucher, 1989), and that the tight junctions may confer a cation selec-
tive conductance (Flynn et al., 2009; Levin et al., 2006). Hence I repeated the same parameter
estimation analysis described in Section 3.2.5 in a number of different scenarios in order to in-
vestigate how strongly the apical Na+ and Cl− permeability estimates would be influenced by
paracellular permeability and selectivity. The different paracellular permeability configurations
considered are shown in Table 3.5, and I discuss in more details in the appendix (Section A.5)
how I arrived at the specific values for P pa
Na+
and for the ratio P pa
Na+
/P pa
Cl− .
The first analysis (Case A) is that which has already been outlined and discussed in pre-
ceding sections. It assumes paracellular permeability is the same in CF and non-CF cells, at
the baseline value of 0.035 µm/s in both cases, and it assumes a non-selective paracellular
permeability (P pa
Na+
≡ P pa
Cl− ≡ P paK+ ≡ P pagluc−). In the next scenario considered (case B),
paracellular characteristics of CF and non-CF cells are again the same, but I assume there
is selectivity in the tight junctions, such that there is greater cation than anion permeability
(P pa
Na+
/P pa
Cl− = 1.3), and greater Cl
− than gluconate− permeability (P pa
Cl−/P
pa
gluc− = 1.4).
The third case (case C) again assumes there is non-selective paracellular transport, but this time
with a higher paracellular permeability in non-CF HNE cells (P pa
Na+
= 0.0329 µm/s) than CF
HNE cells (P pa
Na+
= 0.0218 µm/s). The fourth and final situation (case D) assumes selectivity
in the paracellular permeability (same values as case B), as well as higher paracellular perme-
ability in non-CF cells P pa
Na+
= 0.0367 µm/s versus that in CF cells P pa
Na+
= 0.0243 µm/s.
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Figure 3.12: Estimates of apical Cl− permeability inferred from CF (red) and non-CF (blue)
HNE cell data. Each of the four CF / non-CF estimate pairs are under different assumptions
regarding the paracellular permeability of the system. (A) baseline paracellular permeability
and no selectivity, (B) baseline paracellular permeability and cation selectivity, (C) no selectiv-
ity and greater paracellular permeability in non-CF than CF case, and (D) cation-selectivity and
greater paracellular permeability in non-CF cells than CF cells.
Figure 3.12 shows the resulting apical Cl− permeability estimates in the four cases. In
each case the median estimate of P ap
Cl− is plotted along with a symmetrical error bar whose
length is equal to the interquartile range of the distribution of estimated P ap
Cl− values. One can
clearly see that apical Cl− permeability is significantly lower in the CF case regardless of our
assumptions about selectivity and permeability of the paracellular pathway. Interestingly, the
non-CF estimates of P ap
Cl− in case B and D are both more than 25% smaller in magnitude than
in the cases with a non-selective paracellular permeability.
Figure 3.13 highlights the estimates of apical Na+ permeability in each of the different
scenarios considered. The median P ap
Na+
value is plotted in each case along with an error
bar whose length is given by the IQR of the distribution of estimated P ap
Na+
values. Again
the conclusion that P ap
Na+
is increased in CF relative to non-CF HNE cells is robust to the
different paracellular permeability configurations. However, it is also clear that the magnitude
of paracellular Na+ transport influences the value of ENaC permeability I estimate. When
paracellular permeability is the same in both CF and non-CF epithelia, the CF estimate of
P ap
Na+
is approximately 2.9 times greater than the non-CF estimate, but when I assume P pa
Na+
is
66% greater in non-CF cells, the difference in P ap
Na+
estimates is only 1.9 fold. The full list of
transport parameter estimates can be seen in the appendix, Section A.7.
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Figure 3.13: Estimates of apical Na+ permeability inferred from CF (red) and non-CF (blue)
HNE cell data. Each of the four CF / non-CF estimate pairs are under different assumptions
regarding the paracellular permeability of the system. (A) baseline paracellular permeability
and no selectivity, (B) baseline paracellular permeability and cation selectivity, (C) no selectiv-
ity and greater paracellular permeability in non-CF than CF case, and (D) cation-selectivity and
greater paracellular permeability in non-CF cells than CF cells.
3.4.4 Summary
In this chapter I set out to determine, then to compare, the values of airway ion transport param-
eters, in both CF and non-CF human nasal epithelial cells. To constrain the model parameter
values I used data available in the scientific literature, obtained from cultured HNE cells. This
included time course data covering the addition of amiloride or reduction of [Cl−]l at the apical
membrane (Willumsen et al., 1989b; Willumsen and Boucher, 1989, 1991b,a). I thus formulated
an optimisation problem to minimise the residual errors between the mathematical model’s pre-
dictions for physiological properties, and those observed experimentally, by varying transport
parameters of interest.
Using simulations made with parameter values optimised for non-CF epithelia, the model
accurately fits the observed initial and final steady-state values for membrane and transepithelial
potentials (V apm , V bam , and Vt) and ion concentrations ([Na
+]i, [Cl−]i) both in amiloride addition
and low Cl− experiments. A similar analysis was carried out to identify parameter values best
describing corresponding experimental data obtained on CF epithelia. The optimised parameter
values for non-CF and CF epithelia are shown in Table 3.4.
The optimal parameter values obtained for ENaC and CFTR permeability are similar to
those estimated experimentally (listed in Table 2.2). Examining the difference between opti-
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mal CF and non-CF parameter values, I found not only that in CF P ap
Cl− must be reduced (as
expected) but also that the value of P ap
Na+
must be significantly increased.
Very little experimental data are available on the magnitude and characteristics of paracel-
lular permeability. In order to determine if increased P ap
Na+
in CF epithelia was dependent on
assumptions I had made regarding paracellular ion transport, I repeated the parameter estima-
tion analysis assuming a lower Ppa in CF and/or a cation-selective paracellular transport (Levin
et al., 2006; Flynn et al., 2009). I found that while these differences in paracellular transport do
have an influence over the exact value of P ap
Na+
or P ap
Cl− estimated, they do not alter how each
of these parameters changes in CF relative to non-CF epithelia.
Chapter 4
Quantifying influence of transport parameters
on epithelial electrophysiology
4.1 Introduction
In the preceding chapter, I estimated model parameters from time series data representing the
mean behaviour of a number of HNE cell cultures, and found that there were some statistically
significant differences between the transport parameter values estimated in CF and non-CF
HNE cells. In this chapter, I will describe how I went on to determine whether or not these
differences would be present, if I took into consideration the large culture to culture variation
in properties such as membrane potentials and intracellular concentrations. I also address in a
quantitative manner, the question of why these differences in parameter values should arise.
4.2 Methods
4.2.1 Monte Carlo filtering analysis
Although my initial parameter estimation results provide good evidence for a significant in-
crease in P ap
Na+
in CF relative to non-CF HNE cells, I was conscious that the experimental
data which I used for fitting my model output to, may not realistically capture the variability
observed in cellular variable values. The data used recorded the mean behaviour of several dif-
ferent primary cultures of HNE cells. Variations in the experimental results obtained from these
cells show that a large range of values of, for example, intracellular [Na+], were observed in
practice, rather than a single concentration being measured consistently. I wanted to make sure
that by estimating parameter values from averaged data sets I did not exclude parameter sets
that could account for both CF and non-CF data given the full range of possible variation (e.g.
Willumsen and Boucher (1991b)). To achieve this, I carried out a Monte Carlo filtering analy-
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sis, of the type outlined in Chapter 2, Section 2.3.3. I will describe the procedure briefly here
again, in the context of the ion transport model (the filtering analysis is illustrated schematically
in Figure 4.1).
First I used Monte Carlo sampling to randomly generate 106 parameter sets, sampling val-
ues for each transport parameter in θsub = (P
ap
Na+
, P ap
Cl− , P
ba
K+ , P
ba
Cl− , ρNaK , ρNKCC) from a
uniform distribution on a bounded region (from zero to ten times) around the relevant baseline
parameter value (Fig 4.1(a)). Then for each of these parameter sets, I determined the steady
state values predicted for cellular variables, such as concentrations and membrane potentials,
and also ran +amiloride and +0[Cl−]l in silico experiments (Fig 4.1(b)). I then filtered the
model outputs into different categories based on the observed constraints on certain electro-
physiological properties of CF and non-CF HNE cells (see Table 4.2) (Fig 4.1(c)). This left
me with a distribution of 415 parameter sets which reproduce observed non-CF HNE cell be-
haviour, and a separate distribution of 5373 parameter sets which reproduced the observed
steady-state and kinetic behaviour of CF HNE cells (Fig 4.1(d)). Other parameter sets which
produced physiologically unrealistic behaviour, or unstable kinetics, were discarded. Finally,
the differences between non-CF and CF distributions could be assessed for each transport pa-
rameter in turn. Note the difference in the number of parameter sets remaining between normal
and disease states arises due to the fact that certain constraints were less strict in the CF relative
to the non-CF case, notably the bounds on values of ∆Vt + 0 [Cl−]l.
4.2.2 In vitro data used to constrain allowed model outputs
The bounds on physiologically feasible CF and non-CF variable values can be seen in Table
4.2. I chose the lower and upper bounds on allowed cellular variables to be the 10th and 90th
percentile respectively, of the distribution measured for each variable, wherever an appropri-
ate distribution had been published. A distribution of steady state cellular variables has been
published for [Na+], [Cl−], V apm , V bam and Vt in normal and CF HNE cells (Willumsen et al.,
1989a,b; Willumsen and Boucher, 1991a,b). The upper and lower bounds on the allowed change
in cellular variables due to a +amiloride or +0[Cl−]l experiment were determined differently,
as distributions of these quantities were not presented. Here data for initial and final variable
values (say Vt before and after amiloride addition) was published as the mean value of the quan-
tity in question, µ, plus or minus the standard error of the mean, SE. The mean change in the
quantity in question is then given by µdiff = µfinal − µinitial, and the standard error of the
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Figure 4.1: Schematic illustration of Monte Carlo filtering analysis. (a) A large number of
parameter sets are randomly generated, and (b) the steady state and kinetic model properties
predicted by these particular parameterisations are computed. (c) Parameter sets are filtered
based on whether or not the properties they predicted lie within the range of values likely to
be found in CF or non-CF HNE cells, and (d) the feasible parameter sets in each case, CF and
non-CF, can then be assessed for differences.
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Table 4.1: Region of parameter space used for Monte Carlo sampling. 106 parameter vectors
were randomly chosen from the region between 0 and 10 × Pb, where Pb are the baseline
literature estimates for each parameter value.
Parameter Lower Bound Upper Bound Units
P ap
Na+
0.00 0.28 µm/s
P ap
Cl− 0.00 0.72 µm/s
P baK+ 0.00 0.80 µm/s
P baCl− 0.00 1.00 µm/s
ρNaK 0.00 4.00 10−10mol/cm2
ρNKCC 0.00 4.00 10−10mol/cm2
mean difference can be found via SE2diff = SE
2
initial + SE
2
final. Then finally the allowed
upper and lower bounds on the quantity in question are determined with µdiff ± SEdiff .
Table 4.2: Constraints on allowed variable values in CF and non-CF cells, based on data from
primary cultures of HNE cells. Data used is from the HNE cell studies of Willumsen and
Boucher (Willumsen et al. (1989a,b); Willumsen and Boucher (1991a,b))
Non-CF CF
Property Units Lower Upper Lower Upper
[Na+]i mM 18.0 43.2 21.0 51.3
[Cl−]i mM 32.5 84.4 32.5 84.4
V apm mV -38.6 -14.6 -37.7 6.7
V bam mV -45.1 -24.2 -59.3 -33.6
Vt mV -15.5 -2.7 -59.2 -8.2
∆V apm +amiloride mV -14.0 -5.0 -50.3 -29.0
∆Vt+amiloride mV 4.3 10.9 27.7 46.6
∆V apm +0[Cl−]l mV 9.2 15.0 -5.3 11.1
∆Vt+0[Cl
−]l mV -13.0 -5.8 -16.5 9.9
4.2.3 Parameter sensitivity analysis
The data remaining from the Monte Carlo filtering analysis consists of a sample of physiolog-
ically feasible parameter sets along with the predicted steady state and kinetic model outputs
( ({(θsub)j , Yj} |j = 1, . . . , 415) in the non-CF case). In order to quantitatively investigate
the functional relationship between each individual transport parameter and the epithelial bio-
electric properties in question, I carried out a variance-based sensitivity analysis using the 415
parameter sets in the non-CF distribution, along with their model outputs. I used a multiple
linear regression model to implement the sensitivity analysis, outlined in Section 2.3.4.
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Before performing the sensitivity analysis, parameter values are z-scored. That is, the
mean and standard deviation of the remaining sample of values of an individual transport pa-
rameter, say P ap
Cl− , is calculated. Then each value in the remaining population of P
ap
Cl− is
reduced by the mean value, and then normalised by the standard deviation. Doing this ensures
that the range of values remaining for each parameter are on a similar scale. Once the popula-
tion of parameter sets is z-scored, I fit a multiple regression model between input parameter sets
(θsub)i and their set of predicted values for that a given output quantity Yi, which is of the form
of equation 2.47. Regression was performed using the function regstats in MATLAB Statistics
Toolbox. The regression coefficients bj determine the strength of the linear correlation between
parameter θj and output Ym. By comparing the magnitude of the linear regression coefficients
I have a way of objectively determining the relative influence that transport parameters have on
the physiological variable of interest.
This analysis is in the same spirit as the approaches outlined by Taylor et al. (2009),
for determining how different conductances affect electrophysiological properties of a multi-
compartmental cellular model of a neuron, and Sobie (2009), who performed parameter sensi-
tivity analysis studies on computational models of cardiac myocytes.
4.3 Results
4.3.1 Feasible parameter distributions in CF and non-CF HNE cells
Table 4.1 lists the region of parameter space model behaviour was investigated in, and Figure
4.2 illustrates the distributions of transport parameter values which remain after applying the
non-CF (blue) and CF (red) filters. The CF and non-CF distributions of remaining P ap
Na+
values
are significantly different (the range [q1−1.5 IQR, q3+1.5 IQR] in each case does not overlap),
with apical Na+ permeability being greater in the disease state (Figure 4.2(a)).
P ap
Cl− is also constrained by the experimental data, see Figure 4.2(b). There is a trend for
the apical Cl− permeability to be lower in the CF case, the median CF value is lower than the
median non-CF value, however there is significant overlap between the two distributions. As I
have used relatively conservative constraints on the allowed values of ∆Vt+0[Cl−]l in the CF
case ([−16.5, 9.9] mV), and since P ap
Cl− is quite sensitive to the magnitude of ∆Vt+0[Cl
−]l (the
results of the sensitivity analysis are displayed in Table 4.3), the range of allowed apical Cl−
permeability values has hence not been as tightly constrained as in the non-CF case.
The remaining distributions of the other parameters are not as well constrained by the
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Figure 4.2: Boxplots showing distributions of each transport parameter found by constraining
allowed model behaviour in non-CF (blue) and CF (red) states. Parameters varied were (a)
P ap
Na+
, (b) P ap
Cl− , (c) P
ba
K+ , (d) P
ba
Cl− , (e) ρNaK and (f) ρNKCC . Each boxplot highlights the
median (central line), lower quartile q1 and upper quartile q3 (lower / upper bounds of box).
Whiskers on the boxplot highlight the range [q1 − 1.5 IQR, q3 + 1.5 IQR] and red crosses
indicate outliers which lie outside this range.
experimental data, and acceptable values tend to be limited only by the region of parameter
space searched. Basolateral K+ permeability is not constrained in the non-CF case, but does
appear to have a strict lower bound in the CF case (Figure 4.2(c)). BasolateralCl− permeability
does not differ significantly between the CF and non-CF cases, and is poorly constrained by
the data in this region of parameter space, with only a lower bound evident in the non-CF
distribution. Figure 4.2(e) highlights the remaining non-CF and CF distributions of ρNaK .
There is a strict upper bound present in each distribution, but they do not differ significantly
between the CF and non-CF states. Finally, Figure 4.2(f) shows the remaining CF and non-CF
ρNKCC distributions. This parameter is not constrained by the data in either of the disease or
normal states.
Thus, extending my analysis to take into account the full distribution of allowed cellular
variable values, rather than focusing on mean behaviour, confirms that ENaC permeability must
be increased in CF relative to non-CF cells, in order to explain the observed quantitative differ-
ences in electrophysiological properties. It also re-capitulates several of the other findings of
Chapter 3, showing that apical Cl− permeability is estimated to be lower in the CF case, and
that the basolateral transport parameters P baK+ , P
ba
Cl− , ρNaK and ρNKCC are poorly constrained
by the electrophysiological data available from +amiloride and +0[Cl−] experiments on HNE
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Figure 4.3: Feasible distributions of apical Cl− permeability found via MC filtering analysis.
Distributions shown were found using non-CF (blue) and CF (red) HNE cell data, and the data
displayed are the median with error bars with length equal to the interquartile range of the
distribution. Each of the four CF / non-CF distribution pairs are under different assumptions
regarding the paracellular permeability of the system. (A) baseline paracellular permeability
and no selectivity, (B) baseline paracellular permeability and cation selectivity, (C) no selectiv-
ity and greater paracellular permeability in non-CF than CF case, and (D) cation-selectivity and
greater paracellular permeability in non-CF cells than CF cells.
cells.
4.3.2 Influence of paracellular permeability on feasible parameter distributions
As well as performing the MC filtering analysis with the baseline paracellular permeability
(case A), I also repeated the analysis to assess whether increased shunt resistance in CF or
selective paracellular permeability would significantly alter the outcomes. In line with my
previous parameter estimation work, I separately investigated the effect of differential ionic
selectivity along the paracellular pathway (case B), of reduced paracellular permeability in CF
HNE cells (case C), and finally both reduced paracellular permeability in CF combined with
selective paracellular transport (case D).
Again I found that neither a higher shunt resistance in CF, nor a cation-selective paracellu-
lar pathway, affected the conclusion that permeability distributions were shifted in CF epithelia.
In particular median apical Cl− permeability is decreased in each case relative to the median
non-CF value found for P ap
Cl− (Figure 4.3), and median apical Na
+ permeability is increased
relative to median non-CF P ap
Na+
in each case (see Figure 4.4).
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Figure 4.4: Feasible distributions of apical Na+ permeability found via MC filtering analy-
sis. Distributions shown were found using non-CF (blue) and CF (red) HNE cell data, and the
data displayed are the median with error bars with length equal to the interquartile range of the
distribution. Each of the four CF / non-CF distribution pairs are under different assumptions
regarding the paracellular permeability of the system. (A) baseline paracellular permeability
and no selectivity, (B) baseline paracellular permeability and cation selectivity, (C) no selectiv-
ity and greater paracellular permeability in non-CF than CF case, and (D) cation-selectivity and
greater paracellular permeability in non-CF cells than CF cells.
4.3.3 Insights from parameter sensitivity analysis
The results of the sensitivity analysis are given in Table 4.3. For each of the three trans-epithelial
PD measurements of interest, basal Vt, ∆Vt+amiloride and ∆Vt+0[Cl−]l, the strength of in-
fluence of each transport parameter is quantified by the regression co-efficients bj .
4.3.3.1 Hyperpolarised Vt in CF HNE cells is explained by increased P
ap
Na+
Figure 4.5 (a) and (b) shows scatter plots of P ap
Na+
and P ap
Cl− , respectively (from the non-CF
parameter value distributions), against basal (steady state) Vt predicted by each. Figure 4.5
(c) summarises the results of the sensitivity analysis. There is a negative correlation between
P ap
Na+
and Vt apparent in panel (a), and confirmed by the large negative regression coefficient
b1 (−1.77 mV) in panel (c).
A significant correlation between P ap
Cl− and Vt is not clear in panel (b). The sensitivity
analysis confirms that while P ap
Cl− does influence Vt to an extent, on average over this region of
parameter space it has a much smaller effect than P ap
Na+
, P baK+ or P
ba
Cl− (regression coefficient
b2 = −0.03 mV < 2% b1). Therefore an increase in P apNa+ is necessary to hyperpolarise basal
Vt to the values seen in CF epithelia, while changes in P
ap
Cl− do not influence Vt to the same
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Parameter Coefficient Basal Vt ∆Vt+amiloride ∆Vt+0[Cl−]l
P ap
Na+
b1 -1.77 1.76 -0.01
P ap
Cl− b2 -0.03 -0.55 -1.60
P baK+ b3 -2.11 0.67 0.87
P baCl− b4 1.35 -0.04 -0.45
ρNaK b5 0.04 -0.37 -0.55
ρNKCC b6 0.35 -0.48 -0.44
Table 4.3: Linear regression coefficients bj (units: mV) found by fitting multiple regres-
sion between z-scored transport parameters θj and model outputs Y = (Vt, ∆Vt+amiloride,
∆Vt+0[Cl
−]l) for use in sensitivity analysis.
Figure 4.5: Basal Vt is plotted as a function of (a) P
ap
Na+
and (b) P ap
Cl− , for the 415 parameter sets
belonging to the non-CF distribution. (c), strength of linear interaction (bj) between transport
parameters (θsub)j=1→6 = (P
ap
Na+
, P ap
Cl− , P
ba
K+ , P
ba
Cl− , ρNaK , ρNKCC) found via sensitivity
analysis. P ap
Na+
hyperpolarises Vt (b1 = −1.77 mV), but changing P apCl− has little influence
(b2 = −0.03 mV).
4.3. Results 100
Figure 4.6: Amiloride-sensitive Vt is plotted as a function of (a) P
ap
Na+
and (b) P ap
Cl− , for their
non-CF distributions. (c) sensitivity analysis results plotting strength of interaction (bj) between
∆Vt+amiloride and transport parameters (θsub)j=1→6 = (P
ap
Na+
, P ap
Cl− , P
ba
K+ , P
ba
Cl− , ρNaK ,
ρNKCC), found via sensitivity analysis. Apical Cl− permeability tends to decrease amiloride
sensitive Vt despite its limited influence on basal Vt.
degree.
4.3.3.2 Magnitude of amiloride-sensitive Vt can be increased by reducing P
ap
Cl−
Figure 4.6 (a) and (b) illustrates the relationship between P ap
Na+
and P ap
Cl− parameter values, re-
spectively, from the non-CF distributions, and the corresponding predicted ∆Vt+amiloride.
Not surprisingly, given ENaC channels are being blocked in these simulations, there is a
positive correlation between P ap
Na+
and ∆Vt+amiloride. However, the relationship between
∆Vt+amiloride and P
ap
Cl− is less intuitively understood. The results of the sensitivity anal-
ysis in Figure 4.6(c) show that P ap
Cl− has the third greatest influence on ∆Vt+amiloride (af-
ter P ap
Na+
and P baK+). While increasing P
ap
Na+
and P baK+ tends to increase the magnitude of
∆Vt+amiloride, increasing P
ap
Cl− tends to decrease its magnitude.
4.3.3.3 Decreasing P apCl− cannot hyperpolarise basal Vt to the extent seen in CF
It is clear that P ap
Cl− can influence basal Vt, even if it does not do so to the same extent as
P ap
Na+
. I wanted to determine, quantitatively, what magnitude of a change in basal Vt the model
would predict upon loss of P ap
Cl− alone, and compare this to the hyperpolarisation of Vt ob-
served in CF. Therefore, for each parameter set producing plausible physiological values in
the non-CF distribution, I set P ap
Cl− = 0 and found the new steady state of the system. I de-
fine ∆Vt(CFTR block) as the difference between this new Vt, and the initial basal Vt when
P ap
Cl− 6= 0.
I can analyse the magnitude of ∆Vt(CFTR block) and its relationship to ∆Vt+0[Cl−]l
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Figure 4.7: ∆Vt+0[Cl−]l is commonly used as a proxy measure for P
ap
Cl− in airway epithelial
cells. Here it is plotted against Vt induced by blocking CFTR (i.e. P
ap
Cl− → 0), for the distribu-
tion of non-CF values found. For a given low Cl− response, hyperpolarisation or depolarisation
of basal Vt can occur, but there appears to be a limit on the hyperpolarisation possible (none
greater than −4 mV), which is significantly less than the magnitude observed in CF.
(change in Vt induced by reducing [Cl−]l which is commonly used as a surrogate measure of
the underlying Cl− conductance, see Figure 4.7). For a given ∆Vt+0[Cl−]l, CFTR loss can
depolarise or hyperpolarise Vt, depending on the magnitudes of the other transport parame-
ter values. The average ∆Vt+0[Cl−]l observed experimentally in non-CF HNE cells was not
greater than -15 mV (Willumsen et al., 1989b), a value close to that reported in vivo, in nasal
PD measurements. However, the maximum hyperpolarisation achieved by blocking P ap
Cl− was
around −4 mV. This is much smaller in magnitude than the average hyperpolarisation seen
in CF patients (and in primary cultures of CF HNE cells; (Willumsen and Boucher, 1991b)),
which is around −20 mV (Knowles et al., 1995).
4.4 Discussion
4.4.1 CF / non-CF differences in P apNa+ and P
ap
Cl− are robust
In Chapter 3, after fitting my ion transport model to the mean behaviour of HNE cells, I found
not only that P ap
Cl− must be reduced, but also that P
ap
Na+
had to increase to account for the
bioelectric properties observed in the CF cells (Table 3.4). In this chapter I found that this
prediction also holds, if I take into account cell to cell variation in cellular properties such
as membrane potentials and intracellular concentrations. Specifically, parameter sets resulting
in steady-state and kinetic characteristics typical of CF cells again included increased P ap
Na+
and reduced P ap
Cl− . The fact that this analysis did not make any initial judgements regarding
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how parameters should vary in the disease state, and hence did not bias the analysis towards
computing these results, gives me confidence in their validity and further demonstrates that the
findings regarding ENaC and CFTR activities in CF HNE cells are robust.
4.4.2 Quantifying the influence of CFTR and ENaC currents on Vt
Previously published modelling work investigating the electrical coupling of CFTR and ENaC
fluxes (Horisberger, 2003) showed that increasing apical Cl− conductance could decrease
amiloride-sensitive short-circuit current (Isc) in a kidney epithelial cell model, and Falken-
berg and Jakobsson note that Isc is most sensitive to basal apical anion permeability, after the
addition of amiloride (Falkenberg and Jakobsson, 2010). More recently, evidence from pig
and human airway epithelial cell lines showed that experimentally decreasing apical Cl− con-
ductance can increase ∆Vt+amiloride (Chen et al., 2010; Itani et al., 2011). The analysis in
this chapter confirms that this relationship exists, qualitatively. However, this modelling ap-
proach enabled me to quantitatively determine the influence each transport parameter has on
the electrical properties of the epithelium (see Table 4.3, and Figures 4.5 and 4.6). Thus, I can
show that the magnitude of changes in going from non-CF to CF levels of anion permeability
is not sufficient to explain the experimentally observed hyperpolarised basal Vt, the increased
amiloride-sensitive Vt component, and the decreased ∆Vt+0[Cl−]l. In contrast, sensitivity
analysis shows that P ap
Na+
significantly hyperpolarises basal Vt, and is the most important factor
in determining the magnitude of ∆Vt+amiloride. Without altering P
ap
Na+
from non-CF levels,
the magnitude of the hyperpolarisation of basal Vt and of increased amiloride-sensitive Vt could
not be explained.
4.4.3 How does apical Cl− permeability influence amiloride sensitive Vt?
One can intuitively understand how the relative influences of ENaC and CFTR permeability on
basal and amiloride-sensitive Vt arise, by examining the driving force for movement of Na+
and Cl− ions across the apical membrane. Basal Vt depends implicitly on apical Na+ and
Cl− currents, and the changes in these currents with respect to permeability are proportional
to driving force. Hence the relative driving force for movement of different ions explains the
relative sensitivity of Vt to different permeabilities.
In the representative example of best-fit non-CF parameter values (Table 3.4), the driving
force for Na+ absorption across the apical membrane at steady state is −66.3 mV, as opposed
to +1.2 mV for Cl− transport. At these physiological potentials, the Cl− driving force is
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thus < 2 % of that for Na+, consistent with the results of our sensitivity analysis: P ap
Na+
has
a much greater influence on Vt than P
ap
Cl− . How then, can we explain the influence of P
ap
Cl−
on amiloride-sensitive Vt? After amiloride is added I
ap
Na+
is dramatically reduced and V apm
changes, altering the apical Cl− driving force and consequently Iap
Cl− . Again taking these best-
fit parameters, this driving force goes from +1.1 mV to −10.1 mV for Cl−, while Iap
Na+
= 0.
Therefore P ap
Cl− now has a greater relative influence on V
ap
m and Vt, while P
ap
Na+
can have no
further effect.
4.4.4 Agreement with observed epithelial electrophysiological properties
The results of our sensitivity analysis are in agreement with a range of additional experimental
data not used to constrain the model. For example, we observed basal Vt to be strongly de-
pendent on P baK+ (hyperpolarising). This was found experimentally by Mall et al. (2000) who
blocked basolateral K+ channels in human bronchial epithelial (HBE) cells. Modelling studies
have also shown that Isc can be increased by stimulating basolateral K+ currents (Falkenberg
and Jakobsson, 2010), supporting the hypothesis that increased basolateral K+ conductance is
necessary to hyperpolarise the basolateral (and consequently, apical) membrane, providing an
increased driving force for Cl− secretion (Cotton, 2000). Further, Vt tends to be depolarised by
P baCl− in our model, which agrees with the observations of Fischer and colleagues in human and
bovine tracheal primary cultures (Fischer et al., 2007) who also found Vt to be dependent on
P baCl− .
Chapter 5
Quantitative analysis of nasal transepithelial
potential recordings
5.1 Introduction
5.1.1 Nasal potential difference as a biomarker of CF disease
We saw in Section 1.2.4 that the measurement of nasal transepithelial potentials is widely used
as an aid to CF diagnosis and as a biomarker in clinical trials. Hyperpolarised basal Vt and
larger amiloride-sensitive Vt changes are hallmarks of CF disease that have become central
to the debate on the role of sodium hyper-absorption in CF pathology. These same altered
bioelectric properties are the foundation of therapeutic approaches aimed at reducing ENaC
activity (Hofmann et al., 1998; Coote et al., 2009). Also, the response in Vt induced by a
combination of a Cl− free solution and isoproterenol addition was used as a biomarker during
the clinical trials to assess the efficacy of the VX770 potentiator (Accurso et al., 2010).
The correct interpretation of transepithelial potentials therefore carries important implica-
tions for both understanding CF and assessing potential therapies. For example it is regularly
assumed that there is a one to one correspondence between ENaC activity and the magnitude of
∆Vt+amiloride, and a linear relationship between CFTR activity and ∆Vt+0[Cl−]l. However,
to my knowledge, this assertion has not been assessed in a quantitative manner before. In this
chapter I will address this question, as well as a number of other issues, using my mathematical
modelling approach to analysing airway epithelial transport.
5.1.2 What issues with nasal PD measurements can modelling address?
In this chapter I will simulate standard nasal PD recordings using my mathematical model in
order to address some of the questions surrounding the use of NPD tests as a biomarker of CF
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disease. Initially I will address the question - how do the major transport pathways influence
the nasal PD metrics commonly recorded? By simulating a nasal PD recording repeatedly, each
time changing a single model parameter value, I can gain a better quantitative understanding of
these relationships. While we know how ENaC and CFTR are expected to alter the recorded
∆Vt+amiloride and ∆Vt+0[Cl−]l metrics, it is not clear that the influence on these metrics that
other parameters can have, such as the basolateral K+ and Cl− permeabilities, has fully been
appreciated. This exercise will highlight the other possible sources of variability in observed
nasal PD traces.
5.2 Methods
5.2.1 Simulating nasal PD tests
It is possible to simulate the first three stages of a standard clinical nasal PD test using our
mathematical model, in the same manner that I simulated in vitro Ussing chamber experiments.
Appropriate changes to the model parameters are implemented to reflect the altered composition
of the perfusing solution. As before, to model amiloride addition the parameter P ap
Na+
is set to
zero, and to model the effect of a low Cl− lumen solution, the external concentration [Cl−]l is
reduced and the lumen [gluconate−]l is increased in its place. The main difference with the
simulations in Chapter 3 and 4 is that in a nasal PD test these perturbations are carried out in
sequence, whereas previously I had carried them out in separate simulations. During the nasal
PD test once amiloride is applied it remains in the perfusing solution for the rest of the test, so
that P ap
Na+
will remain zero when the Cl− concentration in the external solution is reduced.
One other minor difference with the work outlined in Chapter 3 and 4, is in the ionic
composition of the lumen solution in these simulations. Since I intended to compare my sim-
ulations to data from nasal PD recordings made in the clinic, I wanted to follow closely the
solution exchange protocol that are actually used in these studies. In particular, for this work
I used the perfusing solutions of Simmonds et al. (2011), as I would look to analyse their data
using my model at a later stage (see Chapter 6). Simmonds et al. used a HEPES solution
with a higher Cl− concentration ([Cl−]l = 151.7 mM) than that used in the Ussing Cham-
ber experiments of Willumsen and Boucher ([Cl−]l = 120 mM). In order to take this into
account, I use the following fixed external concentrations to simulate the HEPES buffer, and
HEPES buffer containing amiloride solutions perfusing the lumen; (in mM) [Na+]l = 140,
[Cl−]l = 145, and [K+]l = 5. The low chloride HEPES solution contained a small change in
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potassium concentration (5.7→ 11.7 mM), as well as changes in chloride (151.7→ 11.7 mM)
and gluconate (0 → 145.4 mM) concentrations. To take this into account the fixed concentra-
tion values I used to simulate the low chloride HEPES solution are (in mM): [Na+]l = 140,
[Cl−]l = 5, [gluc−]l = 140, and [K+]l = 5. These values were chosen such that the total os-
molarity remains at 290 mOsm/L in order to be iso-osmolar with the previous lumen solution,
and with the solution in the serosal compartment. In order to achieve this condition of iso-
osmolarity, and in order to introduce changes in Cl− and gluconate− (∆[Cl−]l = −140 mM,
∆[gluc−]l = +140 mM) that were similar in magnitude to those introduced in the Simmonds
et al. work, I have not been able to incorporate the small change in potassium concentration
present in their work. However as I do not consider apical K+ channels, and potassium con-
centration is not considered to influence nasal PD significantly (Knowles et al., 1983), I assume
this is a reasonable approximation to make.
In the analysis that follows I will focus on simulating the initial steady state configuration,
followed by the system response to +amiloride and +0[Cl−]l solution exchange. The other
common solution exchanges, adding isoproterenol and ATP to the lumen perfusate, are not
modelled as they would require additional assumptions to implement, and hence would increase
the complexity of the model further. For example, in order to implement the +isoproterenol
solution exchange, I would have to include parameters to quantify what percentage increase in
existing CFTR activity would arise due to raising intracellular cAMP levels, and I would have
to include a further parameter (possibly more) to characterise the kinetics of this process, as it
tends to occur over a timescale of minutes.
5.2.1.1 Representative CF and non-CF nasal PD simulations
In order to validate this approach to modelling nasal PD tests, I will use the parameter estimates
I found in Chapter 3 (Table 3.4) to simulate two representative traces. Figure 5.1 highlights
these exemplary simulations, the blue trace results from the non-CF parameter set, and the
red trace from the CF parameter values. Relative to patients with normally functioning CFTR
channels, patients with a CF mutation generally exhibit a hyperpolarised basal Vt, increased
amiloride-sensitive Vt and little or no change in Vt when the lumen Cl− concentration is re-
duced. This is unsurprisingly what is observed in the example here, and the differences in
each of the three nasal PD metrics is summarised in Figure 5.1(b). Using these simulations we
can relate physiologically meaningful parameters, such as apical Cl− and Na+ permeability, to
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Figure 5.1: The left hand panel shows a simulation of the first two stages of a clinical nasal
PD test. Vt is recorded at steady state, and after amiloride addition and removal of Cl− from
the lumen perfusate. The two simulations shown make use of the optimal non-CF (blue trace)
and CF (red trace) parameter sets taken from Table 3.4. The values that are usually reported
from a clinical nasal PD test are highlighted for the non-CF trace, and these are (1) basal Vt,
(2) ∆Vt+amiloride and (3) ∆Vt+0[Cl−]l. The right hand panel compares the value of these
metrics in the CF and non-CF cases. Basal Vt is more hyperpolarised in CF, ∆Vt+amiloride is
increased in CF, and ∆Vt+0[Cl−]l is reduced in CF.
relevant metrics like ∆Vt+amiloride or ∆Vt+0[Cl−]l which are routinely made in the clinic.
5.2.2 Parameter sensitivity analysis
As mentioned previously, when interpreting nasal PD measurements, it is common to assume
that ∆Vt+amiloride is determined solely by ENaC activity, and ∆Vt+0[Cl−]l is similarly only
determined by CFTR activity. To investigate to what extent this is a reasonable assumption, I
wanted to determine quantitatively how these measurements were influenced by changes in the
major ion transport pathways in HNE cells.
To this end, I performed a parameter sensitivity analysis, in the same spirit of that outlined
in Section 4.2.3. For each model parameter of interest I initially simulated a standard nasal
PD test using (a) the optimal non-CF transport parameters and (b) the optimal CF transport
parameters, and repeated the simulations for different values of this parameter. In each case,
the parameter was varied in steps of 10% between the limits of ±50% of its CF or non-CF
estimated value.
Figure 5.2 shows the results of making these parameter changes on predicted nasal PD
traces, for a selection of the parameters investigated. In each simulation, transport parameters
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Figure 5.2: The panels on the left hand side show non-CF nasal PD simulations (amiloride and
Cl− free perfusion stages). A single parameter is varied in each, between ±50% of its optimal
non CF value - (a) P ap
Na+
, (c) P ap
Cl− , (e) P
ba
K+ , (g) Ppa and (i) η. Right hand panels show the
corresponding variation in basal Vt (blue line), amiloride-sensitive Vt (green line with circles)
and ∆Vt+0[Cl−]l (red line) caused by varying these parameter values.
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that are not being varied are set to their estimated non-CF values. In panels (a),(c),(e) and (g)
it is assumed that P ap
Na+
→ 0 when amiloride is added, whereas in simulations plotted in (i)
I investigate the effect of only a fraction η of ENaC channels being blocked (i.e. P ap
Na+
→
(1− η)P ap
Na+
; 0 ≤ η ≤ 1). The reason for considering this phenomenon (allowing a partial
apical Na+ permeability to remain after amiloride addition) will become clearer in Chapter 6,
when I look at factors influencing amiloride insensitive Vt levels in the nasal PD traces of CF
patients.
Beginning with apical Na+ permeability, panel (a) shows the simulated nasal PD traces
for various values of P ap
Na+
, going from −50% of its optimum value (light gray line) to +50%
of this value (black line). Panel (b) explicitly plots the nasal PD metrics basal Vt (blue line),
amiloride sensitive Vt (green line with circles) and ∆Vt+0[Cl−]l (red line) as function of P
ap
Na+
.
The subsequent panels show the result of varying P ap
Cl− ((c) and (d)), P
ba
K+ ((e) and (f)), Ppa ((g)
and (h)) and finally η ((i) and (j)).
Table 5.1 summarises the results of this analysis for all model parameters investigated. The
total change caused in a Vt metric by the±50% parameter change is recorded in each entry. For
example we can see from Figure 5.2(a), that changing P ap
Na+
from 0.0121 → 0.0362 µm/s
results in ∆Vt+amiloride going from 3.9 mV → 9.5 mV, hence in Table 5.1 a value of
+5.60 mV is recorded for this particular entry. The table then allows us to compare quantita-
tively the influence each transport parameter has on the measured nasal PD values.
As the membrane potentials and permeabilities in a CF HNE cell are different to those
present in non-CF cells, the driving forces for each ion are also different and one would expect
that consequently the influence of each transport pathway on the measured Vt metrics may also
diverge. Figure 5.3 shows the result of a parameter sensitivity analysis to investigate if this is the
case. The analysis performed is analogous to that shown previously, except now the transport
parameters are fixed to their estimated CF values. Visual inspection of these simulations alone
can confirm that the sensitivity of the nasal PD metrics to membrane permeabilities is vastly
different in this CF case, than in the non-CF case plotted in Figure 5.2. Table 5.2 gives the
quantitative data for changes in Vt metrics found given ±50% changes in the model parameters
of interest, and by comparing the values here with those in Table 5.1 we can confirm that the
parameter - metric sensitivities are indeed quantitatively different as well.
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Figure 5.3: The panels on the left hand side show simulations of the first two stages of an nasal
PD test (amiloride and Cl− free perfusion) in a CF HNE cell. The following transport parameter
is being varied in each panel - (a) P ap
Na+
, (c) P ap
Cl− , (e) P
ba
K+ , (g) Ppa and (i) η. Right hand panels
show the corresponding variation in basal Vt (blue line), amiloride-sensitive Vt (green line with
circles) and ∆Vt+0[Cl−]l (red line) caused by varying these parameter values.
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Non-CF
baseline Vt ∆Vt+amil. ∆Vt+0[Cl−]l Vt after amil.
Parameter mV mV mV mV
P ap
Na+
-5.58 5.60 -0.07 0.03
P ap
Cl− 0.68 -3.11 -6.32 -2.43
P baK+ -5.35 2.03 2.23 -3.32
P baCl− 2.29 0.59 -1.74 2.89
ρNaK -0.19 -0.21 -0.52 -0.41
ρNKCC 0.33 -0.68 -0.87 -0.35
Ppa 8.65 -4.75 8.99 3.90
η 0.00 3.89 0.15 3.89
Table 5.1: Table summarising the result of changing model transport parameters on measure-
ments of nasal potential difference. Model transport parameters were set at their estimated
non-CF values, then one at a time were varied from −50% → +50% of this value. The re-
sulting changes in basal Vt, ∆Vt+amiloride and ∆Vt+0[Cl−]l caused by this single parameter
change are listed here, as well as the change in value of amiloride insensitive Vt.
5.3 Results
5.3.1 Non-CF sensitivity analysis
The analysis performed here to assess the influence of changing transport parameters on mea-
sured basal Vt, amiloride sensitive Vt and ∆Vt+0[Cl−]l in non-CF HNE cells, recapitulates
many of the insights from Chapter 4. I saw that P ap
Na+
is influential - the greater this per-
meability the more hyperpolarised Vt is and the greater ∆Vt+amiloride becomes. Similarly,
basolateral K+ permeability influences the baseline Vt value, tending to hyperpolarise it as
the permeability increases, and P baK+ will also influence amiloride sensitive Vt, but not to the
same extent to as P ap
Na+
. It was also noted in Chapter 4 that increasing P ap
Cl− tends to increase
∆Vt+0[Cl
−]l and decrease the measured amiloride sensitive Vt. The simulations displayed in
Figure 5.2 and the quantitative data in Table 5.1 highlight these relationships again.
In the sensitivity analysis of Chapter 4 however, I did not vary paracellular permeability,
whereas I do here and it has a significant effect on Vt (see panel (g) and (h) in Figure 5.2).
In fact a ±50% change in Ppa results in a change in basal Vt (+8.65 mV) that is greater in
magnitude than the equivalent change arising from a ±50% change in P ap
Na+
(−5.58 mV), and
a greater change in ∆Vt+0[Cl−]l (+8.99 mV) than the equivalent relative change induced by
increasing P ap
Cl− (−6.32 mV). The paracellular permeability does not have as great an influence
on ∆Vt+amiloride (−4.75 mV) as P apNa+ (+5.60 mV) however. In general increasing Ppa
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CF
baseline Vt ∆Vt+amil. ∆Vt+0[Cl−]l Vt after amil
Parameter mV mV mV mV
P ap
Na+
-19.37 19.37 0.01 0.00
P ap
Cl− 0.16 -1.37 -0.64 -1.21
P baK+ -7.37 6.78 0.30 -0.58
P baCl− 5.29 -4.53 -0.20 0.76
ρNaK 1.22 -1.40 -0.08 -0.17
ρNKCC 0.00 -0.00 0.00 -0.00
Ppa 21.30 -19.72 0.86 1.58
η 0.00 19.70 0.10 19.70
Table 5.2: Table summarising the result of changing model transport parameters from their
estimated CF values, on measurements of nasal potential difference. Parameters were varied
from −50% → +50% of their estimated CF value, and the amiloride and Cl− free solution
stages of an nasal PD test were simulated. The resulting changes in basal Vt, ∆Vt+amiloride
and ∆Vt+0[Cl−]l caused by this single parameter change are listed here, as well as the change
in value of amiloride insensitive Vt.
shorts the epithelium by reducing the resistance to direct lumen to serosal ion flow, and tends to
dampen the changes in Vt that occur due to any changes to other permeabilities or external ion
concentrations.
5.3.2 CF sensitivity analysis
When we assess the sensitivity of the baseline Vt in a CF HNE cell to changes in transport
parameters, we see that the same factors are influential, paracellular permeability, apical Na+
permeability and basolateral K+ permeability. The effect of varying these parameters ±50%
induces a greater magnitude of change in Vt than in the non-CF case (21.3,−19.4 and−7.4 mV
respectively), but the order of their relative influence is unchanged.
The interesting observation from Figure 5.3(a)-(h) is how little influence any of the mem-
brane or paracellular permeabilities have on the magnitude of Vt the system relaxes to after
amiloride is added. This only appears to be significantly influenced by η, which governs the
fraction of apical Na+ permeability blocked on amiloride addition. Looking at the data in Table
5.2 we can also see that changes to the value of ∆Vt+0[Cl−]l are less than 1 mV in case of
±50% changes in all transport parameters. This is in contrast to the non-CF case where changes
in P ap
Cl− and Ppa cause changes of −6.32 mV and 8.99 mV respectively.
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CF cells with incomplete amiloride block
baseline Vt ∆Vt+amil. ∆Vt+0[Cl−]l Vt after amil
Parameter mV mV mV mV
P ap
Na+
-19.37 14.62 -0.02 -4.76
P ap
Cl− 0.16 -1.06 -0.66 -0.90
P baK+ -7.37 5.51 0.28 -1.86
P baCl− 5.29 -3.61 -0.19 1.68
ρNaK 1.22 -1.03 -0.08 0.19
ρNKCC 0.00 -0.00 0.00 0.00
Ppa 21.30 -14.27 0.95 7.03
η - - - -
Table 5.3: Table summarising the result of changing model transport parameters on measure-
ments of nasal potential difference, assuming only 90% of apical Na+ permeability is blocked
by amiloride. As in Table 5.1 and 5.2, the change in the values of basal Vt, ∆Vt+amiloride and
∆Vt+0[Cl
−]l caused by varying a single model parameter, are listed in mV.
5.3.3 Investigating partial block of ENaC channels
To investigate the effect of only partially blocking ENaC channels, I introduced the parameter
η, such that the permeability changes from P ap
Na+
→ (1− η)P ap
Na+
when amiloride is added,
where in all previous simulations it would have changed to zero, i.e. η = 1 and hence P ap
Na+
→
0. I then varied the fraction of ENaC channels blocked from between 50% and 100%, and
looked at the resulting nasal PD traces. Figure 5.2(i) and (j) show the results when all transport
parameters are set to their estimated non-CF values, and Figure 5.3(i) and (j) the equivalent
simulations with transport parameters at CF estimated values.
In the non-CF simulations, varying η by 50% leads to changes in amiloride insensitive
Vt of 3.89 mV, which is the same order of magnitude as the change induced by other transport
parameters (see Table 5.1). However, in the case of CF simulations, a 50% variation in η induces
a 19.7 mV increase in the amiloride insensitive Vt value, an order of magnitude greater than the
next greatest change of 1.58 mV caused by changing Ppa.
Given this knowledge, I performed a third sensitivity analysis, now assuming that each
patient had P ap
Na+
reduced by 90% on addition of amiloride, instead of a complete reduction
(The value of η = 0.9 was chosen arbitrarily). I kept all model parameters apart from η at their
estimated CF value, and then performed nasal PD simulations while changing one parameter
at a time ±50% of the aformentioned CF estimated value. The results of this analysis are
presented in Table 5.3. If a fraction of P ap
Na+
remains after the amiloride solution perfusion,
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then the value of Vt that the system relaxes to can be influenced by both Ppa (+7.03 mV) and
P ap
Na+
(−4.76 mV), to a greater extent than if amiloride completely blocked all apical Na+
transport.
5.4 Discussion
5.4.1 How do the major transport proteins alter nasal PD metrics?
I showed that it was possible to simulate the first two solutions exchanges of a standard nasal
PD measurement, in the same manner as I had previously simulated Ussing Chamber experi-
ments in Chapter 3 and 4. I then went on to investigate the sensitivity of standard nasal PD
measurements to changes in individual transport parameters. As well as varying the membrane
permeability and pump / co-transporter density parameters as before (in Chapter 4), in this set
of analyses I also varied paracellular permeability. On this occasion I performed three separate
analyses, assuming transport parameters were fixed at previously estimated (1) non-CF and (2)
CF values, as well as (3) investigating the effect of incomplete amiloride block of P ap
Na+
, on the
results of the sensitivity analysis in the CF case.
The sensitivity analysis provided the following insights:
• Non-CF: The influence of transport parameters is generally the same as observed pre-
viously (see Table 4.3), however I also took into account variation in Ppa on this oc-
casion. Basal Vt is sensitive to (in order of influence) Ppa, P
ap
Na+
, P baK+ and P
ba
Cl− .
∆Vt+amiloride is sensitive to P
ap
Na+
, Ppa, P
ap
Cl− and P
ba
K+ , while ∆Vt+0[Cl
−]l is sensi-
tive to Ppa, P
ap
Cl− , P
ba
K+ and P
ba
Cl− .
• Non-CF: Increasing Ppa tends to decrease the magnitude of all three nasal PD metrics,
that is, decreasing the paracellular resistance tends to dampen the magnitude of ∆Vt
caused by the solution exchanges.
• CF: Baseline Vt and ∆Vt+amiloride are strongly influenced by Ppa, P apNa+ , P baK+ and
P baCl− . The other transport parameters have very little influence on these aspects of simu-
lated CF nasal PD traces.
• CF: If it is assumed that amiloride completely blocks all apical Na+ transport (i.e.
P ap
Na+
→ 0), ±50% changes in transport parameter values only induce subsequent
changes in Vt of the order of ±1 − 2 mV. Large variations in amiloride insensitive
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Vt (of the order of 10 mV) therefore cannot be explained by variations in membrane or
paracellular permeabilities in this situation.
• CF: Allowing for partial block of ENaC channels on amiloride addition (P ap
Na+
→
(1− η)P ap
Na+
; 0 ≤ η ≤ 1) increases the sensitivity of Vt to transport parameters after
amiloride addition. For example, when I assume only 90% of apical Na+ permeability is
blocked on amiloride addition, changes in amiloride insensitive Vt of the order of 10 mV
can be explained by ±50% changes in Ppa and P apNa+ .
5.4.2 Summary
At the beginning of this chapter I stated that it was commonly assumed that ∆Vt+amiloride
could be used as a biomarker of ENaC activity, and similarly ∆Vt+0[Cl−]l could be used as
a biomarker of CFTR activity. I have shown via the sensitivity analysis in this chapter that
P ap
Na+
and P ap
Cl− are indeed capable of increasing the magnitude of these two nasal PD metrics,
and the relationship in both cases is approximately linear over the region of parameter space
searched. Given this fact, one could be forgiven to think about equating a fixed percentage
change in say, ∆Vt+amiloride, with a certain percentage change in P
ap
Na+
. However, I also
saw that amiloride sensitive Vt can be significantly influenced by changes in other parameters,
particularly Ppa and P baK+ . Attributing a change in ∆Vt+amiloride to one of these parameters,
without justifying why it could not have been caused by a change in the other two, could hence
be misleading. This highlights one of the problems with attempting to reverse engineer transport
parameter estimates from nasal PD measurements. In the next chapter I will address this issue
in more detail, investigating the problem of estimating transport parameter values directly from
a patient’s nasal PD trace.
Chapter 6
Estimating parameters from individual
transepithelial potential recordings
6.1 Introduction
In the previous chapter I investigated quantitatively how measurements of airway ion transport
commonly made in the clinic, were influenced by membrane transport parameters, using esti-
mates of parameter values in non-CF and CF HNE cells (Table 3.4) as reference points. I now
want to investigate the feasibility of inferring these parameter values directly from nasal PD
measurements, in a manner analogous to that outlined previously which utilised in vitro mea-
surements (see Section 3.2.5). I was fortunate to be given access to a substantial set of nasal
PD recordings made by physicians at the Royal Brompton Hospital, and I will make use of this
data throughout. I will now outline a number of the specific questions I hope to address in this
chapter.
6.1.1 Can variations in CFTR and ENaC activity explain variable nasal PD
data?
Given a cohort of nasal PD traces, I will use my modelling framework to estimate the values of
P ap
Na+
and P ap
Cl− from each individual set of Vt measurements (basal Vt, ∆Vt+amiloride, and
∆Vt+0[Cl
−]l). I will then investigate if allowing these two parameters to vary (i.e. P
ap
Na+
, P ap
Cl−
free to vary) is sufficient to reasonably explain the variability that exists in the group of patient
nasal PD traces. If this is not sufficient to accurately reproduce all traces, I will endeavour to
understand what aspects of the nasal PD recordings they fail to explain. I can combine this
knowledge along with the insights from the sensitivity analysis in Chapter 5, to assess what
factors are likely to account for any additional variability. Consequently I will investigate if
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estimating three, and finally four, transport parameters from each nasal PD trace improves the
ability to reproduce all nasal PD traces in the data set.
6.1.2 Can all parameters be identified from nasal PD traces?
Given that nasal PD traces are recorded non-invasively in vivo, we do not typically have any
information on intracellular concentrations or on individual membrane potential values. This
lack of information limits the ability of a single Vt trace to constrain the values of all transport
parameters. Here I will address the question of when degenerate parameter estimates might
arise, and what implications this would have for our ability to uniquely identify physiological
parameters.
6.1.3 Are permeability estimates more informative than nasal PD metrics?
Finally, given the results of previous analyses, I will investigate whether or not there are any
significant correlations between the estimated values of model parameters and the measures of
disease severity, such as FEV1, in this particular data set. This will go some way in determining
the value of using transport parameter estimates, over raw nasal PD measurements, in assessing
a person’s underlying physiology.
6.2 Methods
6.2.1 Patient data from clinical study of CF severity
As mentioned in the introduction to this chapter, I have kindly been given access to a data set
of nasal PD recordings made by clinicians at the Royal Brompton Hospital. In their study, the
researchers were investigating potential links between measures of airway ion transport and
disease severity, as well as correlations between CFTR function and extended disease survival.
The data set consists of 92 different nasal PD traces recorded from 74 different patients (18
patients with 2 recordings, 54 with a single recording). Patients recruited to the study had a
confirmed diagnosis of CF (with pancreatic insufficiency) and class I-III disease causing muta-
tions on both alleles. Each patient’s age and sex, as well as information on their lung function
is contained in the data set. Patients’ lung function is assessed by common spirometry mea-
sures, the forced expiratory volume in 1 second (FEV1) and the forced vital capacity (FV C).
Patients were recruited for the study based on their age, being in one of two groups: young (age
18-23 years) or Old (age ≥ 40 years). Patients in the younger group were also further classi-
fied by disease severity as either “Young/Mild” or “Young/Severe”, based on how their lung
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capacity compared to the expected value for their age, height and BMI (% of predicted FEV1
value). In their analysis of this data set Simmonds et al. found that there was a statistically
significant correlation between ∆Vt+amiloride and FEV1, suggesting an association between
ENaC activity and disease severity. However there was no significant link between length of
survival and ∆Vt+0[Cl−]l, which was assumed to be an indicator of residual CFTR function
(Simmonds et al., 2011).
Each trace was recorded using the following protocol and a representative example can be
seen in Figure 6.1 (Note description of solutions used was previously given in Section 5.2.1).
Initially a HEPES buffer solution (high Na+,Cl−, low K+) is perfused across the lumen surface
and the maximum (most negative) stable potential achieved is recorded as the baseline Vt. The
red dashed line (marked 1 in Figure 6.1) highlights the baseline Vt value in this case. After
recording basal Vt, a HEPES buffer solution containing amiloride (100 µM) is passed across
the epithelial surface for five minutes. The amiloride sensitive Vt (labelled 2) can then be
determined by the difference between the initial baseline Vt, and the new value of Vt the trace
stabilises at . The HEPES + amiloride solution is followed by a low chloride HEPES + amiloride
solution, where the Cl− solution is reduced by two orders of magnitude. This is perfused for
five minutes, after which again the new stable Vt level is noted and the change in Vt due to the
low Cl− solution can be determined (labelled 3 in example). Finally a low chloride HEPES +
amiloride + isoprenaline solution is perfused for a final five minutes, from which ∆Vt+iso. and
∆Vt+(0[Cl
−]l + iso.) can be determined. These last two metrics are not highlighted here as I
do not model the +isoprenaline stage, but this information is present in the Royal Brompton
data set.
From the cohort of CF nasal PD traces, I only retained for further analysis those traces
where the three nasal PD metrics of interest to me (basal Vt, ∆Vt+amiloride and ∆Vt+0[Cl−])
could be unambiguously measured, as in the example just discussed. The criteria I used for
selection was to retain traces where Vt relaxed to a new equilibrium level before the second
solution exchange occurred. Those traces where Vt had not relaxed to a new steady state level
five minutes after amiloride addition were not retained for further analysis. An example of such
an ambiguous trace is shown in Figure 6.2. Here it is not clear that Vt has stabilised before the
low Cl− solution is introduced, as the PD appears to be still depolarising. In cases like this, the
assumptions I make to model the nasal PD test may not be accurate. For example, I assume that
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Figure 6.1: Nasal transepithelial potential recording from a CF patient (blue trace). The red
dashed lines highlight the values of Vt that are used to measure baseline PD (1), amiloride
sensitive PD (2) and (3) ∆Vt+0[Cl−]l. The PD is relatively stable before each of the three
solution exchanges.
when amiloride is added P ap
Na+
will then be zero, however in this trace it may be more realistic
that P ap
Na+
transitions to zero over a period of 10-15 minutes.
6.2.1.1 Summary statistics for nasal PD data
After selecting from the clinical data set only those traces with unambiguous PD metrics, I was
left with a group of 42 separate traces (32 patients with one trace, 5 with two traces - a full
list of the nasal PD measurements is in the appendix, see Section A.10). The distributions of
baseline Vt, amiloride-sensitive Vt, and ∆Vt+0[Cl−]l in this remaining population of traces are
plotted in Figure 6.3.
There are a number of interesting features of this data set that are worth pointing out here.
• There is a statistically significant correlation between baseline Vt and amiloride sensitive
Vt, the Spearman correlation coefficient ρ = −0.8352, with p << 0.001. The more
hyperpolarised basal Vt is the greater the corresponding ∆Vt+amiloride.
• Some traces display a large amiloride insensitive Vt. For example, traces that have a basal
Vt of approximately −45 mV showed values of ∆Vt+amiloride ranging from around
17 − 37 mV. Patients with the same baseline Vt can exhibit amiloride insensitive Vt
values that that differ by tens of millivolts.
• There are four traces that exhibit values of ∆Vt+0[Cl−]l which are much greater than
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Figure 6.2: An example of a nasal PD trace where it is difficult to separate the amiloride sensi-
tive Vt component, from the change induced due to the low Cl− solution exchange. At the time
of this solution exchange Vt is still depolarising, and it appears that the amiloride continues to
have a depolarising effect beyond this point, when its effect is usually assumed to be complete.
Hence, due to this ambiguity, I did not include any of the nasal PD traces which did not have a
clear, stable Vt value before the start of each solution exchange.
expected in CF patients (i.e. ∆Vt+0[Cl−]l <−10 mV). This was noted by Simmonds
et al. and suggests that the three patients from which these recordings were made have
levels of apical Cl− conductance similar to non-CF patients.
• There are no traces where ∆Vt+0[Cl−]l > 0. That is, in the traces I have analysed,
introducing a Cl− free solution in the lumen induces a hyperpolarisation of Vt and never
a depolarisation.
Table 6.1 gives a breakdown by patient group of the median and interquartile range (IQR)
for each of these three nasal PD metrics. The table also lists the p-values found when the
Kruskal Wallis statistical test was used to assess whether or not there is a statistically signifi-
cant difference between the NPD metrics observed in each patient group. This information is
displayed graphically in Figure 6.4(a)-(c). The boxplots display the group median (red line),
first (q1) and third (q3) quartiles (upper/lower bounds of blue box), and any points larger than q3
+ 1.5(IQR) or smaller than q1 −1.5(IQR) are marked as outliers (note the interquartile range
IQR is given by q3 − q1).
In panel (a), baseline Vt across the Old, Young/Severe and Young/Mild groups are com-
pared. The subset of traces I have analysed retain the qualitative features found by Simmonds et
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Figure 6.3: Overview of the Vt measurements in the subset of 42 nasal PD traces I retained
for further analysis. Median values for each of the nasal PD metrics are: basal Vt, −46.3 mV;
∆Vt+amiloride, 32.1 mV; ∆Vt+0[Cl−]l, −2.8 mV. Note the strong correlation between
baseline PD and amiloride sensitive PD, and a number of anomalous ∆Vt+0[Cl−]l values which
are more typical of non-CF traces.
Patient group
All Old Young/Severe Young/Mild p-value
NPD metric n=42 n=16 n=15 n=11
Baseline Vt median -46.3 -46.8 -50.6 -40.5 0.13
IQR 16.5 17.5 14.1 17.3
∆Vt+amil. median 32.1 35.6 32.2 29.0 0.25
IQR 17.2 16.4 12.4 18.0
∆Vt+0[Cl
−]l median -2.8 -4.1 -2.7 -2.7 0.10
IQR 2.7 4.0 2.3 1.4
Table 6.1: Summary of the nasal potential differences measurements made from a cohort of
patients with CF. The median and interquartile ranges (IQR) are listed for the entire group, as
well as for the subsets of Old, Young/Severe and Young/Mild groups. All PD values displayed
are in units of mV. The differences in each nasal PD metric observed in the Old, Young/Mild
and Young/Severe groups were tested for significance using the Kruskal-Wallis test, however
none of the differences were signficant at the p < 0.05 level.
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Figure 6.4: Panel (a),(b) and (c) plot the measurements of baseline Vt, amiloride sensitive Vt
and ∆Vt+0[Cl−]l respectively, made from CF patients that have been categorised into groups
as either Old, Young/Severe or Young/Mild. Each boxplot highlights the median (central line),
lower quartile q1 and upper quartile q3 (lower / upper bounds of box). Whiskers on the box-
plot highlight the range [q1 − 1.5 IQR, q3 + 1.5 IQR] and red crosses indicate outliers which
lie outside this range. The difference between the nasal PD metrics between any two of these
groups is not statistically significant. Panels (d), (e) and (f) plots FEV1 from all 42 traces,
against the same three nasal PD measures. Data from patients exhibiting unusually large values
for ∆Vt+0[Cl−]l have been marked as outliers and highlighted in red. The correlation coeffi-
cients between the respective quantities are given in each plot, first including outliers, and also
excluding outliers (value given in brackets). I find there is a statistically significant correlation
(p < 0.05) between baseline Vt and FEV1 values, regardless of whether the outlier traces are
included.
6.2. Methods 123
al., in order of the most hyperpolarised median baseline Vt, the groups are ranked Young/Severe,
Old and Young/Mild. The difference in median values between Young/Mild and Young/Severe
groups is around 10 mV but it is not statistically significant given the large variation in basal Vt
within groups. Panel (b) shows how ∆Vt+amiloride varies between the three groups, the me-
dian is greatest in the Old group followed by Young/Severe then Young/Mild groups, although
again as there is significant overlap in the observed values and because of the low sample size
in this subset of traces, the difference between any two of the group medians is not statistically
significant. Finally, panel (c) plots ∆Vt+0[Cl−]l in the three severity categories. Here we can
clearly see the outliers in the Old and Young/Severe categories with ∆Vt+0[Cl−]l < −10 mV
which were highlighted in the preceding section. Apart from the outliers the distributions of
the three groups are similar, and again I find no statistically significant difference in median
∆Vt+0[Cl
−]l between any two of the three groups.
Panels (d)-(f) in Figure 6.4 plot the relationships between FEV1 and each Vt metric. The
correlation between each pair is quantified by the Spearman correlation coefficient ρ, and the
statistical significance of this correlation is specified by a corresponding p-value. Note I have
also computed the correlation coefficients that are found if I do not include the 4 traces that have
∆Vt+0[Cl
−]l < −10 mV - the new correlation coefficients are given in brackets, and these data
points are highlighted in red in the scatter plots. Panel (d) shows that baseline PD is correlated
with FEV1, the more hyperpolarised your baseline Vt the lower your predicted lung function,
and this relationship is statistically significant regardless of whether or not the patients with
residual Cl− channel function are included. Panel (e) shows a scatter plot of ∆Vt+amiloride
against FEV1. There is a trend for an increased amiloride sensitive Vt to lower the FEV1,
but it is not statistically significant. Panel (f) shows that there is only a significant correlation
between FEV1 and ∆Vt+0[Cl−]l if I include the traces with abnormally large levels of Cl−
conductance.
Table 6.1 summarises the median values for each quantity of interest, in each patient group.
How does the data set compare with that of Simmonds et al. once I have chosen the subset of
nasal PD traces for further analysis? Simmonds et al. found (a) that the Young/Severe group had
a greater amiloride sensitive Vt than the Young/Mild group, and (b) that FEV1 was correlated to
baseline Vt as well as ∆Vt+amiloride. The trend seen in (a) remains in this subset but it is not
statistically significant, possibly due to the reduced sample size. The same can be said for the
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relationship between amiloride sensitive Vt and FEV1. However, baseline Vt and FEV1, are
significantly correlated in the remaining sample. The subset of traces I analysed hence retain
several of the characteristics of the general data set.
6.2.2 Estimating transport parameters from nasal PD data
6.2.2.1 Estimating P apCl− and P
ap
Na+ from a single nasal PD trace
Following on from my initial analysis of the raw data in the Royal Brompton data set, I wanted
to see if I could reproduce the nasal PD metrics present in the patient group (Figure 6.3) by
only varying the values of P ap
Na+
and P ap
Cl− . To address this question, I performed parameter
estimation on the 42 different nasal PD traces, in order to estimate individual values of P ap
Cl− and
P ap
Na+
from each trace. The parameter estimation as before was implemented by minimising an
appropriate objective function, which in this case was
minimize
Pap
Na+
,Pap
Cl−
3∑
k=1
(
Vˆt(tk)− Vt(tk)
)2
(6.1)
Here tk are the time points at which Vt was measured just before a solution exchange. A pair
of parameter values {P ap
Na+
, P ap
Cl−} was estimated from the set of Vt values obtained from an
individual nasal PD trace, and it was assumed that all other transport parameters were at the
CF values estimated previously (see Table 3.4). It was also assumed that amiloride completely
blocked all ENaC channels in each patient (i.e. η = 1) and hence did not contribute to patient
to patient variability. Each parameter estimation was implemented as an optimisation problem,
using the lsqnonlin function.
6.2.2.2 Estimating three transport parameters
The next stage of the analysis I carried out was to determine whether allowing the model have
three free parameters would improve its ability to reproduce the full range of nasal potential
difference measurements in the clinical data set. From the sensitivity analyses performed I had
observed that Ppa, P baK+ and η could significantly influence the simulated CF nasal PD traces.
Therefore I separately investigated estimating one of Ppa, P baK+ , or η, at the same time as both
P ap
Na+
and P ap
Cl− .
Paracellular permeability or basolateral K+ permeability were estimated by minimising
the objective function 6.1 as a function of either
(
P ap
Na+
, P ap
Cl− , Ppa
)
or
(
P ap
Na+
, P ap
Cl− , P
ba
K+
)
respectively. Both could be carried out with the lsqnonlin function. The only difference here is
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that now one of Ppa or P baK+ is a free parameter to be estimated, rather than fixed at its CF value
(estimated in Chapter 3) as it had been while the previous objective function 6.1 was being
optimised.
When estimating η as well as P ap
Na+
and P ap
Cl− , the objective function was again the same
as that in 6.1 apart from the third degree of freedom. However, as η represents the proportion of
ENaC channels that are blocked by amiloride, it can only take a value between 0 and 1. Hence,
if the unconstrained minimisation using lsqnonlin estimated a value of η greater than 1, I did
not keep that set of parameter estimates. Instead I carried out a constrained minimisation with
the function fmincon in MATLAB Optimisation Toolbox, with the constraint 0 ≤ η ≤ 1.
6.2.2.3 Estimating four transport parameters
If I naively assume I can estimate 4 model parameters from three Vt data points, this leads
to problems with the ability to identify unique values for model parameters. To highlight this
point, I attempted to estimate 4 model parameters, P ap
Na+
, P ap
Cl− , Ppa and η, from a single
CF patient nasal PD trace. P ap
Na+
and P ap
Cl− were chosen again since the aim of the exercise
has always been to infer CFTR and ENaC activity from these CF patients recordings, while
Ppa and η were chosen as they had the most significant influence on basal Vt and Vt after
amiloride addition in CF nasal PD simulations (see Chapter 5, Section 5.3.3). The parameter
estimation was implemented in the same manner as described in the previous section, except
four parameters were now estimated instead of three. On finding the parameter values that were
found to minimise the objective function value, I then went on to assess the uniqueness of these
estimates, by computing the profile likelihood for each of the four parameters I was attempting
to estimate.
6.3 Results
6.3.1 Estimates of P apCl− and P
ap
Na+ in cohort of CF nasal PD data
I estimated individual values for P ap
Cl− and P
ap
Na+
from each of the 42 separate nasal PD traces
I had selected for analysis from the Royal Brompton data set (the full set of nasal potential
difference measurements used in this analysis can be inspected in the appendix, Section A.10).
Figure 6.5(a) shows the resulting squared residual values found by the minimisation algorithm,
plotted against the sum of squared residuals. It is clear in each case that the residual error due to
fitting the value of Vt after amiloride addition is the largest contributor to the total error, much
greater than the errors due to fitting basal Vt or Vt after Cl− free solution perfusion. Figure
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Figure 6.5: (a) Individual residual errors plotted against the minimum value of the objective
function 6.1 found for each of the 42 individual nasal PD traces, allowing only P ap
Na+
and P ap
Cl−
to vary. In all cases, the error due to not fitting the value of Vt after amiloride addition correctly
(green), is greater than the error between predicted and observed baseline Vt (blue) and between
predicted observed value of Vt after external Cl− is reduced (red). (b) The total error found is
proportional to the level of this amiloride insensitive Vt.
6.5(b) then plots the minimum value found for the sum of squared residuals in each case, as a
function of the value of Vt after amiloride itself. This highlights that the total error is correlated
with the magnitude of amiloride insensitive Vt.
To highlight this two examples are shown in Figures 6.6 and 6.7. In the first example, Fig-
ure 6.6, the blue dotted line is the nasal PD trace recorded from a CF patient, and the three values
of Vt from this recording that are used to determine basal Vt, ∆Vt+amiloride and ∆Vt+0[Cl−]l
are highlighted in red. The grey dashed line shows the nasal PD trace predicted by the model,
found as a result of varying P ap
Na+
and P ap
Cl− in order to minimise error between the three mea-
sured Vt data points and the predicted Vt points. In this case, the simulated nasal PD trace does
a good job of reproducing the necessary Vt values, even if it is obviously a very idealised trace
in comparison to the noisy recording.
In the second example however, Figure 6.7, the fit to the observed data is quite poor. While
the model can accurately fit the baseline transepithelial potential, the value it predicts once
P ap
Na+
→ 0 is approximately 10 mV out from the actual observed value. Similarly, the model
then does not accurately reproduce the value of Vt after the low Cl− solution is introduced.
Given how sensitive we have seen our estimates of P ap
Na+
and P ap
Cl− are to ∆Vt+amiloride and
∆Vt+0[Cl
−] respectively, in this case it is probable that I am overestimating the ENaC and
CFTR activity.
The insight I gained here is that it is not possible to explain the range of values of nasal po-
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Figure 6.6: Nasal PD recording taken from a CF patient (blue dotted line). The three values
of Vt used to determine basal Vt, ∆Vt+amiloride and ∆Vt+0[Cl−] are highlighted in red.
The grey dashed line shows the nasal PD simulation predicted by the model, which minimises
difference with the observed Vt data by varying P
ap
Na+
and P ap
Cl− .
Figure 6.7: Nasal PD recording from a CF patient that displays an apparently large amiloride
insensitive Vt. It is not possible to reproduce these Vt levels using the model system, by only
varying apical Na+ and Cl− permeability. The solution which minimises the objective function
in this case (gray dashed line) overestimates the amiloride sensitive Vt, and also overestimates
∆Vt+0[Cl
−]l.
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tential difference measurements in the Royal Brompton data set (Table 6.1) by simply assuming
patient to patient variability in apical Na+ and Cl− permeability. This is primarily as varying
these parameters cannot alter the value of Vt after amiloride addition significantly, relative to
the level of variation seen in the patient cohort, if we assume P ap
Na+
→ 0 on amiloride addition.
However, this should not be entirely surprising given what I observed in the sensitivity analyses
of the previous chapter. There I found (see Table 5.2 and 5.3) that membrane permeabilities and
paracellular permeabilities could only cause changes in the level of amiloride insensitive Vt on
the order of 5− 10 mV, if I allowed incomplete block of ENaC channels.
There is a clear conclusion to be made from this, and that is that variability in raw nasal
PD traces collected from CF patients in this data set, cannot be explained simply by different
CFTR and ENaC activities - if we assume our model system and nasal PD protocol is a realistic
picture of the physiological processes generating these traces. It is particularly clear that if I
assume all apical Na+ current is blocked by amiloride, I cannot explain the traces where there
is a significant amiloride insensitive Vt remaining. Another factor must be responsible for this
observed variation, and I will now assess a number of possible explanations. In particular I
will look at allowing a third transport parameter to be adjustable, and determine if this will
significantly improve the ability of the ion transport model to reproduce these large amiloride
insensitive Vt values in the CF patient group.
6.3.2 Estimates of three model parameters in cohort of CF nasal PD data
6.3.2.1 Estimates of P apNa+ , P
ap
Cl− and Ppa
Figure 6.8(a) shows the individual squared residuals plotted against the minimum objective
function value found in each of the 42 separate optimisation exercises, when P ap
Na+
, P ap
Cl− and
Ppa are allowed to vary. As in Figure 6.5(a), the largest error arises from the inability to repro-
duce the value of Vt after amiloride addition. Similarly, in Figure 6.8(b) I see that the larger the
amiloride insensitive Vt, the greater the error in the best fit solution that I found via optimisation
- this is the same trend I saw when only estimating P ap
Na+
and P ap
Cl− (see Figure 6.5(b)).
Estimating a third parameter value, that of Ppa, does allow me to increase the range of
nasal potential difference measurements reproduced - that is there is a quantitative improve-
ment in the ability to fit the traces. Over the 42 traces analysed, the median reduction in the
minimum objective values found is 0.98%. However, the systematic inability to account for
large amiloride insensitive Vt values remains, and hence allowing for patient to patient vari-
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Figure 6.8: (a) Minimum objective function values found when varying P ap
Na+
, P ap
Cl− and Ppa
in order to fit the model prediction to observed Vt values. The largest component of the total
error is coming from the second residual (fit to Vt value after amiloride addition). (b) The
minimum objective value found is correlated to the amiloride sensitive Vt value, suggesting that
variability in paracellular permeability cannot explain the large amiloride insensitive Vt seen in
some patients.
ability in paracellular permeability cannot fully explain this feature of the CF patient nasal PD
traces. This is consistent with the sensitivity analysis where I note that amiloride insensitive Vt
was significantly more sensitive to Ppa, if amiloride block of P
ap
Na+
was incomplete.
6.3.2.2 Estimates of P apNa+ , P
ap
Cl− and P
ba
K+
Looking at the magnitude of the objective function values arrived at when P ap
Na+
, P ap
Cl− and
P baK+ are allowed to vary (Figure 6.9), there is a noticeable improvement in the ability to fit these
traces, relative to the minimum errors achieved when only apical Na+ and Cl− permeabilities
were estimated, or when estimating P ap
Na+
, P ap
Cl− and Ppa. However, there is a still a trend for
those traces that are not adequately fit to have a large error if the amiloride insensitive Vt value
is significantly hyperpolarised (see Figure 6.9(b)).
Another important observation from this exercise, is that the estimated parameter val-
ues may not be physiologically realistic, given only these three degrees of freedom. Figure
6.10 plots, (a), estimated P ap
Na+
against measured basal Vt values, (b), estimated P
ap
Cl− ver-
sus measured ∆Vt+0[Cl−]l and (c), estimated P baK+ versus amiloride insensitive Vt values.
While the estimates of apical Na+ and Cl− permeability are not unreasonable (median val-
ues of 0.082 µm/s and 0.054 µm/s respectively), several of the P baK+ estimates made here are
3-4 orders of magnitude greater than the estimates made from in vitro data in Chapter 3 and
4. The median estimated basolateral K+ permeability in this group of nasal PD recordings is
73.0 µm/s, where as in Chapter 3 the median CF estimate was 1.540 µm/s, and the median es-
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Figure 6.9: (a) Minimum objective function values found when varying P ap
Na+
, P ap
Cl− and P
ba
K+
in order to fit model predictions to observed Vt values. Although many traces can be fit with
little error, the largest component of the total error is still due to an inability to fit the level of Vt
remaining after amiloride addition. (b) There is a trend for the minimum objective value found
to correlate with to the amiloride sensitive Vt value.
Figure 6.10: Summary of estimated values of (a) P ap
Na+
, (b) P ap
Cl− and (c) P
ba
K+ made from nasal
PD recordings made in CF patients. Estimated parameter values are plotted with Vt metrics
baseline Vt, ∆Vt+0[Cl−] and Vt after amiloride addition respectively. Note large values of
estimated P baK+ are made from traces with large amiloride insensitive Vt values.
timate in Chapter 4 was 0.632 µm/s. Hence, although the model fits the Vt trace with this level
of basolateral potassium permeability, and the corresponding concentration and membrane po-
tential kinetics are physiologically realistic in these nasal PD simulations, it remains to be seen
if it would still be realistic in other scenarios where potassium transport is perturbed directly.
6.3.2.3 Estimates of P apNa+ , P
ap
Cl− and fraction of P
ap
Na+ blocked by amiloride
On minimising 6.1 as a function of
(
P ap
Na+
, P ap
Cl− , η
)
for each of the patient traces, I found
contrary to the previous parameter estimation exercises, I could now fit the majority of the 42
traces very well - the median objective value in this case is 7 × 10−19. Figure 6.11 shows this,
plotting the minimum objective function found in each case. This suggests that allowing for
partial block rather than complete block of ENaC channels on amiloride addition, can account
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Figure 6.11: Minimum objective value function found when reproducing 42 individual nasal
PD traces by varying P ap
Na+
, P ap
Cl− and η. Traces with ∆Vt+0[Cl
−]l < −10 mV are highlighted
in red.
Figure 6.12: Parameter estimates found when fitting cohort of CF NPD traces by varying P ap
Na+
,
P ap
Cl− and η only. (a) Estimated P
ap
Na+
plotted as a function of measured basal Vt. (b) Estimated
P ap
Cl− plotted as a function of measured ∆Vt+0[Cl
−]l values. (c) Estimated partial block pa-
rameter η plotted against measured amiloride sensitive Vt values observed. Note data from the
four traces exhibiting ∆Vt+0[Cl−]l < −10 mV have been highlighted in red.
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for the wide range of nasal PD values measured in the clinical data set. The only traces that
were not satisfactorily reproduced were those that exhibited unusual ∆Vt+0[Cl−]l values (<
−10 mV), and they have been highlighted in red in Figure 6.11.
Figure 6.12 shows the relationships between the estimated values of the three transport
parameters in question, P ap
Na+
, P ap
Cl− and η, and the measured nasal PD values, basal Vt,
∆Vt+0[Cl
−]l and ∆Vt+amiloride. In panel (a) P
ap
Na+
estimates are plotted against basal Vt
values. Traces with a very hyperpolarised basal Vt (less than −70 mV), give rise to large
estimates for apical Na+ permeability here, on the order of 0.8 µm/s, which is an order of
magnitude greater than the estimate made using the in vitro data set in Chapter 3 (0.07 µm/s).
Estimates of P ap
Cl− are plotted against measurements of ∆Vt+0[Cl
−]l in panel (b). There
is a clear linear correlation between the two. This suggests that the change in Vt observed is
primarily a result of the underlying CFTR activity, even if there is a significant non-zero ENaC
current after amiloride addition. It also suggests if ENaC and CFTR are indeed the only two
channels whose expression level varies significantly in the nasal epithelium of CF patients, then
this low Cl− solution exchange is a good indicator of that patient’s underlying CFTR activity
and could be used as a reliable indicator of changes in its residual function. It is worth noting
as well, that the “outlier” traces (those with ∆Vt+0[Cl−]l < −10 mV) are estimated to have
much greater apical Cl− permeability than the rest of the cohort, as one might intuitively have
expected. Panel (c) of Figure 6.12 plots estimated values of η against amiloride sensitive Vt
measurements, and there is a strong correlation between the two.
Although I have satisfactorily reproduced the range of measured nasal PD values in the
majority of cases, by varying the apical permeability and fractional block parameters, it is
not clear that the resulting parameter estimates I have found are physiologically realistic. In
particular as just discussed, several values of ENaC permeability are estimated to be an order
of magnitude greater than the values estimated to be present in CF HNE cells from in vitro
Ussing Chamber experiments. It may be that as basal Vt is strongly influenced by P
ap
Na+
, that
the extremely hyperpolarised traces can only be fit in this scenario with excessively large Na+
permeabilities. If the model had further degrees of freedom, perhaps other parameters (say Ppa)
could also account for some of the range of Vt values measured, and more reasonable levels of
P ap
Na+
would be estimated. In the next section, I will go on to investigate this scenario, by
estimating 4 transport parameters from individual patient nasal PD traces.
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Figure 6.13: Estimates of 4 model parameters were made, given only the set of nasal PD metrics
baseline Vt (−25.7 mV), ∆Vt+amiloride (+10.8 mV) and ∆Vt+0[Cl−]l (−3.5 mV). The
profile likelihoods for the following parameters were computed: (a) P ap
Na+
, (b) P ap
Cl− , (c) Ppa
and (d) η. Regions of parameter space where χ2PL (line with circles) is flat with no well defined
minimum signify issues with parameter identifiability. The dashed line on each plot defines
the threshold ∆α in the profile likelihood required to give a 70% confidence limit for a given
parameter.
6.3.3 Issues with parameter identifiability
The next question that arises is whether allowing the model system four degrees of freedom (i.e.
estimating four parameters) - would allow me to reproduce the range of nasal PD measurements
observed in the clinical data set, while also resulting in physiologically reasonable parameter
estimates.
The trace I used for this illustrative example, consists of basal Vt = −25.71 mV, Vt after
amiloride addition = −14.88 mV and Vt after perfusion of a Cl− free solution, = −18.36 mV.
The global minimum objective function I find is χ2 = 1.6 × 10−20, given by the parameter
vector, θˆ = {P ap
Na+
, P ap
Cl− , Ppa, η} = 0.0793 µm/s, 0.0348 µm/s, 0.0489 µm/s, 0.5803.
Figure 6.13(a) plots the resulting profile likelihood I found for P ap
Na+
, calculated around
its initial estimated value. The threshold ∆α that the profile likelihood needs to breach in
order to determine confidence intervals for a 70% probability of finding the true value of
P ap
Na+
is given by ∆α =
(
χ2(0.7, 1)− χ2(θˆ)
)
= 1.0742 (since minimum of χ2PL is 0 in
this case). However, the profile likelihood for P ap
Na+
is flat over the range of values searched
here, 0.05 µm/s < P ap
Na+
< 0.1 µm/s, suggesting the value of this parameter is not identifiable
within this region of parameter space. Figure (b) and (c) similarly show the χ2PL trajectorys de-
termined for P ap
Cl− and Ppa respectively, and in both cases the parameters are unidentifiable in
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Figure 6.14: Panel (a) plots several particular values of P ap
Na+
(taken from 6.13(a)) that lie in
the region of parameter space where the computed profile likelihood for this parameter is flat.
Panel (b) then plots the parameters P ap
Cl− , Ppa, η as a function of P
ap
Na+
, along the manifold that
keeps χ2PL = 0. This is a picture of a discrete family of distinct parameter sets, that will give
degenerate nasal PD traces.
the regions of parameter space searched. Figure (d) shows the profile likelihood determined for
η in this case. χ2PL is flat for η ≥ 0.58 again highlighting an issue with identifiability in this
region of parameter space, however it increases for η < 0.58 and breaches the threshold for a
70% confidence interval at η = 0.49.
The next step I followed, was to take the parameter sets which gave rise to the flat profile
likelihood for P ap
Na+
, and then plotted the model solutions predicted by these sets of parameter
values. Figure 6.14(a) shows the values of P ap
Na+
for which χ2PL = 0, and panel (b) shows the
corresponding values that P ap
Cl− , Ppa and η must take in order for χ
2
PL to remain 0 while the
value of P ap
Na+
increases.
Figure 6.15 then shows the traces of cellular variable values produced along this particular
manifold of parameter space. Here the solutions are colour coded from white to black, as P ap
Na+
increases in value in the range 0.05→ 0.1 µm/s. The first thing to notice is in panel (d), which
displays the predicted Vt traces, as well as the measured values of Vt used in the parameter
estimation and profile likelihood calculations (highlighted in red). Here we see visually the
effect of the degeneracy, despite the different parameter sets used for each simulation, they all
predict the same Vt values, at the time points measurements are made at. Hence if we only
use these Vt measurements these solutions become indistinguishable and we cannot uniquely
identify values for the parameters of interest.
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In the other panels (a), (b), (c), (e) and (f), the predicted membrane potential traces and
internal concentrations do differ significantly. It hence may be possible to uniquely identify
values for P ap
Na+
, P ap
Cl− , Ppa and η if measurements of the other cellular variables were available.
However, in the absence of additional measurements, we can make the assumption that the
internal ion concentrations in vivo are similar to those measured in vitro, and investigate what
parameter estimates this leads to.
6.3.3.1 Knowledge of internal [Na+] and [Cl−] alters identifiability of parameters
In order to investigate how knowing the internal concentrations would change the ability to
estimate parameter values, I repeated the preceding parameter estimation exercise. However, I
now included the intracellular Na+ and Cl− concentrations in the objective function as follows
minimize
Pap
Na+
,Pap
Cl− ,Ppa,η
3∑
k=1
(
Vˆt(tk)− Vt(tk)
)2
+
(
ˆ[Na+]i(t0)− [Na+]i(t0)
σˆ[Na+]i(t0)
)2
+ . . .
(
ˆ[Cl−]i(t0)− [Cl−]i(t0)
σˆ[Cl−]i(t0)
)2
subject to 0 ≤ η ≤ 1
(6.2)
Only the initial, steady state values of [Na+]i and [Cl−]i were included in the objective function.
The values used were those measured in CF HNE cells in vitro; ˆ[Na+]i(t0) = 25.9 ± 3.5 mM
and ˆ[Cl−]i(t0) = 67.7±5.6 mM, which had previously been introduced in Chapter 3 (see Table
3.3).
The global minimum objective function value found (again using the lsqnonlin func-
tion) is now χ2(θˆ) = 1.852, given by the parameter vector θˆ = {P ap
Na+
, P ap
Cl− , Ppa, η} =
{0.0910 µm/s, 0.0398 µm/s, 0.0556 µm/s, 0.582}. The combination of the three Vt measure-
ments and initial Na+ and Cl− concentrations can no longer be reproduced perfectly by the
model system. To assess if the issue with identifiability was also resolved, I again computed
the profile likelihood for each of the four parameters being estimated, starting at the point in
parameter space which minimised the objective function in 6.2.
The new profile likelihood trajectories are shown in Figure 6.16 for (a) P ap
Na+
, (b) P ap
Cl− ,
(c) Ppa and (d) η, and these can be compared with those which were calculated previously in
Figure 6.13. In each case χ2PL is now convex, and we can determine unique estimates for these
four parameters. The threshold for a 70% probability of finding the true value of one of these
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Figure 6.15: The parameter sets shown in Figure 6.14(b) were used to simulate several CF nasal
PD traces (+amiloride and +0[Cl−]l stages). Panels (a)-(c) show internal ion concentrations
[Na+]i, [Cl−]i and [K+]i respectively, and (d)-(f) plot the electrical state of the cell, Vt, V
ap
m and
V bam . Vt data used for parameter estimation is shown in red in panel (d), and the traces coloured
from white to black (in order of increasing P ap
Na+
) highlight the degenerate solutions which all
produce the same Vt metrics. The dashed blue traces show the unique “best-fit” solution found,
if initial Na+ and Cl− concentrations are used in the objective function (values used are plotted
in red in panels (a) and (b) respectively).
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Figure 6.16: Estimates of P ap
Na+
, P ap
Cl− , Ppa, and η were made given nasal PD metrics baseline
Vt (−25.7 mV), ∆Vt+amiloride (+10.8 mV) and ∆Vt+0[Cl−]l (−3.5 mV), and assuming
known initial conditions [Na+]i = 25.9 ± 3.5 mM and [Cl−]i = 67.7 ± 5.6 mM. The profile
likelihood was then computed for each of the four parameters around the respective values
that minimised χ2(θ). Compared with those seen in Figure 6.13, the χ2PL trajectories are now
convex and I can make a unique estimate for each parameter of interest.
parameters is now χ2PL = 1.85 + 1.07 = 2.92 (since χ
2(0.7, 1) = 1.0742), for example we
would conclude that there is a 70% chance of finding the true value of P ap
Na+
within the range
of values [0.009, 0.216] µm/s (a range of −90% → +137% of the estimated true value). This
highlights the fact that having additional information on the intracellular concentrations during
nasal PD recordings, even just the initial steady state conditions, can greatly improve our ability
to constrain membrane transport parameters.
6.3.4 Estimates of P apNa+ , P
ap
Cl− , Ppa and η in CF nasal PD traces
For the final stage of my analysis of the nasal PD records from the Royal Brompton data set,
I estimated values for P ap
Na+
, P ap
Cl− , Ppa, and η from each patient’s nasal PD trace, using the
method outlined in the previous section. Each patient has a set of three Vt metrics, and I assume
the initial intracellular [Na+] and [Cl−] are also known, and are the same for each patient.
This then allows me to determine a cohort of estimated parameter values, representing each
patient’s airway epithelial transport physiology. I also had the FEV1 values for each patient,
which is a measure of their disease severity. By investigating the relationship between estimated
permeability parameters and FEV1 values I intended to see if there would be any suggestion
of an association between the disease severity and the apparent underlying ion channel activity.
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Figure 6.17: Estimates of P ap
Na+
, P ap
Cl− , Ppa and η were made from 42 individual nasal PD
traces (assuming initial [Na+]i and [Cl−]i are the same in each patient). The minimum value
of χ2(θ) found in each case is plotted here. The median value is 1.85, but several traces have
values of χ2(θ) significantly greater than this, indicating they have not been fit satisfactorily.
These outliers correspond to those traces with ∆Vt+0[Cl−]l < −10mV (highlighted in red)
.
Figure 6.17 shows the minimum objective function values found across the cohort of nasal PD
traces. Again, the majority of traces are fit reasonably well, apart from a number of traces with
∆Vt+0[Cl
−]l < −10 mV which are highlighted in red.
Figure 6.18 shows the estimated parameter values found from the group of 42 nasal PD
traces. Panel (a) plots the relationship between basal Vt measurements and estimated P
ap
Na+
values. As before there is a strong non-linear correlation between the two quantities, however
now the range of values estimated is more reasonable. Very hyperpolarised traces of around
−70 mV give rise to P ap
Na+
≈ 0.4 µm/s. Noticeably, the two traces with ∆Vt+0[Cl−]l ≈
−20 mV are poorly reproduced, and the corresponding estimates of P ap
Na+
do not follow the
general trend.
Panel (b) highlights the relationship between estimated P ap
Cl− and measured ∆Vt+0[Cl
−]l,
and, as seen in previous exercises there is an approximately linear relationship between the two.
Panel (c) plots estimated Ppa against basal Vt and there is a non-linear relationship between
these two quantities. Traces which have been poorly fit give rise to estimates of Ppa that do
not follow the trend observed with the rest of the population, as was the case with estimates
of P ap
Na+
from these particular traces. Finally, panel (d) shows estimated fraction of ENaC
channels blocked on addition of amiloride, η, plotted against measured ∆Vt+amil.. There is a
positive correlation seen in this plot - those traces with a large amiloride sensitive Vt tend to be
best fit with values of η near to 1 (close to complete block of P ap
Na+
).
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Figure 6.18: Estimates of P ap
Na+
, P ap
Cl− , Ppa and η were made from each nasal PD trace in the CF
patient cohort (assuming initial [Na+]i and [Cl−]i are the same in each patient). The resulting
distributions of parameter values are shown. (a) P ap
Na+
and (c)Ppa have non-linear relationships
with baseline Vt. (c)P
ap
Cl− is linearly correlated with ∆Vt+0[Cl
−]l. (d) The estimated value of
η is largely determined by its relationship with ∆Vt+amiloride. Note data from the four traces
exhibiting ∆Vt+0[Cl−]l < −10 mV have been highlighted in red.
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Figure 6.19: Parameters (a) P ap
Na+
, (b) P ap
Cl− , (c) Ppa, and (d) η were estimated using nasal
PD measurements taken from a cohort of CF patients. Patients were categorised as Old,
Young/Severe or Young/Mild based on their age and lung function, and parameter estimates
in each category are compared here. Each boxplot highlights the median (central line), lower
quartile q1 and upper quartile q3 (lower / upper bounds of box). Whiskers on the boxplot high-
light the range [q1−1.5 IQR, q3 +1.5 IQR] and red crosses indicate outliers which lie outside
this range.
However, despite the difficulty in reproducing a couple of outliers, the majority of the
42 traces can be explained relatively well by variations in these 4 model parameters, and the
corresponding estimated values of these parameters are physiologically realistic.
6.3.5 Correlations between FEV1 data and nasal PD metrics
Given that I felt that these parameter estimates were physiologically realistic, I wanted to see
if there were any clear relationships between them and the measured FEV1 values associated
with each trace. As when comparing measured Vt values to FEV1 values earlier in this chapter,
I performed the analysis in two separate parts. First, I divided parameter estimates into groups
based on patient severity (itself determined by FEV1 value), and compared the median esti-
mated value in the Old, Young/Severe, and Young/Mild groups. Secondly, treating FEV1 as
a continuous variable this time, I determined if there were any statistically significant correla-
tions between the FEV1 values and estimated parameter values, across the cohort of 42 nasal
PD traces.
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Patient group
All Old Young/Severe Young/Mild p-value
Metric n=42 n=16 n=15 n=11
P ap
Na+
median 0.153 0.171 0.165 0.126 0.060
IQR 0.066 0.107 0.058 0.048
P ap
Cl− median 0.018 0.023 0.014 0.018 0.147
IQR 0.022 0.016 0.023 0.021
Ppa median 0.030 0.029 0.028 0.036 0.186
IQR 0.015 0.019 0.010 0.020
η median 0.879 0.895 0.835 0.819 0.294
IQR 0.179 0.173 0.143 0.154
Table 6.2: Transport parameter values in a cohort of CF patients, estimated from individual
nasal PD traces. Note permeablity values are given in units of µm/s. The median and in-
terquartile range (IQR) are given for the distribution of parameter values in each patient group.
A breakdown of statistics by patient category is also given. The differences in transport pa-
rameter values estimated in the Old, Young/Mild and Young/Severe groups were tested for
significance using the Kruskal-Wallis test, however none of the differences were signficant at
the p < 0.05 level.
Figure 6.19 shows boxplots of the distributions of estimated parameter values, classified
by patient type as Old, Young/Severe or Young/Mild. Panel (a) shows estimated P ap
Na+
distribu-
tions, panel (b) shows the equivalent P ap
Cl− boxplots, (c) gives the same for Ppa and finally (d)
shows the estimated η distributions. Table 6.2 summarises the median and interquartile ranges
of each distribution, for each category as well as the for the entire group. The Kruskal-Wallis
test was used to assess the significance of differences in median NPD metric values between
the three patient groups, and the p-values found are also listed in this table. There were no sig-
nificant (p < 0.05) differences in estimated transport parameter values across patient groups.
Finally, Figure 6.20 plots the FEV1 values versus the estimated parameter values. Each
panel also gives the Spearman correlation coefficient between the two quantities along with
the statistical significance of that correlation. From panel (a) we can see that there is strong
correlation between apical Na+ permeability and FEV1 values, which has a significance level
p = 0.001. Here the higher the value of P ap
Na+
the poorer the level of lung function. None of
the other transport parameter - FEV1 correlations are statistically significant at the p = 0.05
level.
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Figure 6.20: Parameters (a) P ap
Na+
, (b) P ap
Cl− , (c) Ppa, and (d) η were estimated using nasal
PD measurements taken from a cohort of CF patients. These estimates are plotted relative
to their expected lung function here, given by the FEV1(%predicted) scores. Correlations
between parameter estimates and FEV1 scores are plotted on each panel (ρ) along with the
associated statistical significance (p). The correlation between P ap
Na+
estimates and FEV1 val-
ues is deemed to be statistically significant, suggesting an association between increased apical
Na+ permeability and reduced lung function. Note estimates made from outlier traces with
∆Vt+0[Cl
−]l < −10 mV are highlighted in red.
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6.4 Discussion
6.4.1 Insights from analysis of raw nasal PD data
Before beginning modelling and parameter estimation work, I analysed a set of nasal PD traces
from CF patients. The cohort displays the expected characteristics of CF nasal PD metrics;
hyperpolarised baseline Vt, large amiloride sensitive Vt, and little evidence of Cl− secretion
(i.e. low ∆Vt+0[Cl−]l values). Simmonds et al. also commented on a number of patients with
unusually large values of ∆Vt+0[Cl−]l < −10 mV, values more in line with those expected in
non-CF patients.
As well as these general insights, I made a number of specific observations regarding the
subset of 42 nasal PD traces that I selected for further analysis;
• Baseline Vt and amiloride sensitive Vt exhibit a strong linear relationship, with a Spear-
man correlation coefficient ρ = −0.8352.
• Several traces exhibit large amiloride insensitive Vt, 28% having Vt after amiloride addi-
tion ≤ −20 mV.
• No trace exhibited depolarisation on removal of lumen Cl−, i.e. ∆Vt+0[Cl−]l < 0 mV
in all instances.
The forced expiratory volume in one second (FEV1) was measured for each CF patient
whose nasal PD was recorded. This metric could then be used as a measure of lung function
for the patient, and was compared with the measured Vt metrics. Patients were also categorised
into three different groups, Old, Young/Mild and Young/Severe, based on their age, and their
relative FEV1 score. The observations I made at this point were as follows:
• The differences in median basal Vt, ∆Vt+amiloride and ∆Vt+0[Cl−]l, between any
two of the three patient groups, were not statistically significant as determined by the
Kruskal-Wallis test.
• Basal Vt and FEV1 are correlated (Spearman correlation coefficient of ρ = 0.37), but
there is no significant correlation between FEV1 and ∆Vt+amiloride or ∆Vt+0[Cl−]l
(assuming outlier traces are excluded).
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6.4.2 CFTR and ENaC activity cannot explain all variability in nasal PD data
After performing the various sensitivity analysis exercises in Chapter 5, I went on to estimate
values of P ap
Na+
and P ap
Cl− , from each of the 42 patient nasal PD traces. Here I assumed all
other parameters were fixed at previously estimated CF values. Following on from this initial
parameter estimation exercise, I made several further analyses estimating the value of three
transport parameters at a time. I made the following observations:
• Nasal PD traces with large amiloride insensitive Vt are poorly fit when only P apNa+ and
P ap
Cl− vary from patient to patient. Hence changes in ENaC and CFTR activity alone
could not adequately explain the full variation of nasal PD measurements observed in
this cohort of CF patients.
• The “goodness-of-fit” is inversely related to the magnitude of this amiloride insensitive
Vt. This follows intuitively from one of my earlier observations, where I saw that as-
suming 100% block of ENaC current would prevent large variation in the new resting Vt
value after amiloride addition, with only slightly hyperpolarized (> −10 mV) amiloride-
insensitive Vt values possible.
• Allowing for variation in one of P baK+ or Ppa, can account for part, but not all of large vari-
ation in amiloride insensitive Vt. However, there are questions over how physiologically
realistic the resulting estimates of these extra transport parameters are.
• Allowing variation in the fraction of P ap
Na+
that is blocked on amiloride addition, η, as
well as apical Na+ and Cl− permeability, I found that I could explain the observed range
of values of amiloride insensitive Vt. However, the resulting estimates of P
ap
Na+
are quite
large (an order of magnitude greater than in vivo estimates in some cases) and it is not
certain that they are physiologically realistic.
• A small number of nasal PD traces with ∆Vt+0[Cl−]l < −10 mV remain poorly fit even
when allowing P ap
Na+
, P ap
Cl− and η to vary. The estimates for apical Cl
− permeability
found from these traces are significantly larger than those of the rest of the patient group,
reinforcing the suggestion that these patients have normal levels of Cl− channel activity.
The poor fit found by my model in this case, may suggest these patients are closer to a
non-CF phenotype and would be better fit by assuming fixed parameters were set at the
non-CF levels rather than CF levels as they had been in this study.
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6.4.3 Number of transport parameters identifiable from nasal PD is limited
I had found evidence to suggest that variation in three transport parameters did not satisfactorily
explain the range of observed Vt values in the CF patient data set. I went on to investigate
whether allowing variation in 4 transport parameters could improve this situation, and in doing
so addressed the question of whether transport parameter values could be uniquely determined,
given the limited number of Vt observations I was using in each estimation. I came to the
following conclusions:
• Assuming only baseline Vt, ∆Vt+amiloride and ∆Vt+0[Cl−]l are used for estimation, it
is in general not possible to uniquely identify four transport parameter values. In the case
of estimating P ap
Na+
, P ap
Cl− , Ppa, and η, I saw that there was a family of solutions which
would all produce the same values for these three nasal PD measures.
• Sets of parameter values that produced degenerate nasal PD traces made different predic-
tions for internal ion concentrations, and also different predictions for apical and basolat-
eral membrane potentials, during these simulations.
• It is possible to distinguish between degenerate solutions, if we assume knowledge about
the internal state of the cell to begin with. I found that by assuming internal [Na+] and
[Cl−] were known at steady state, and these values are included in the objective function
used for parameter estimation, then I could uniquely identify values for P ap
Na+
, P ap
Cl− , Ppa
and η from an individual nasal PD trace.
6.4.4 Are estimated permeabilities more informative than Vt metrics?
The final analysis I performed, was to estimate P ap
Na+
, P ap
Cl− , Ppa and η for each of the 42
CF patient nasal PD traces (assuming initial [Na+]i and [Cl−]i were known). I then looked
at the relationships between the resulting distribution of parameter estimates, the measured Vt
metrics, and the measures of lung function (individual FEV1 values). I made the following
observations:
• P ap
Na+
and Ppa are largely determined by the baseline Vt value, P
ap
Cl− is correlated to
∆Vt+0[Cl
−]l, despite variations in three other transport parameters, and estimated η is
correlated with the measured ∆Vt+amiloride.
• There is no statistically significant difference between the estimated median value of
either P ap
Na+
, P ap
Cl− , Ppa or η across the Old, Young/Severe and Young/Mild groups.
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• There is a statistically significant correlation between FEV1 values and estimated P apNa+
values (Spearman correlation coefficient ρ = −0.49). Increased apical Na+ permeability
is correlated with reduced lung function.
The observations here regarding relationships between FEV1 values and apical Na+ per-
meability are perhaps not too surprising. Simmonds et al. noted (as we did, see 6.4(d)) that
baseline Vt was correlated to FEV1 values, and I have seen that the estimated values of P
ap
Na+
are determined largely by the baseline Vt value. Hence one would intuitively expect there would
be a similar correlation between the FEV1 values and these P
ap
Na+
estimates.
This should not detract from the potential utility of this combined biophysical modelling
and parameter estimation approach. I have shown that it is possible to make quantitative esti-
mates of apical Na+ and Cl− permeabilities for an individual patient, as well as other important
transport parameters, given only their nasal PD trace. In clinical trials assessing the effect of
drug or gene therapy on epithelial ion transport in cystic fibrosis in vivo, this could be used as
an analysis technique to complement existing methods, potentially giving a deeper insight into
the biophysicsal mechanisms underlying any apparent improvements in disease severity.
Chapter 7
Conclusion
At the beginning of this thesis I set out a list of objectives that I hoped to achieve through my
research activity. In this chapter I will summarise my work towards meeting these objectives,
with particular emphasis on the material outlined in Chapters 3 - 6 which constitutes original
research contributions. I will end by discussing some potential avenues for future research work
of this nature.
7.1 Contributions
7.1.1 Physiologically realistic model of ion transport in human nasal epithelia
My initial research goal was to develop a mathematical model of electrolyte transport in human
airway epithelial cells. This model would need to be capable of relating the biophysical state of
the cell, in terms of membrane potentials and intracellular ion concentrations, to the transport
physiology underlying these properties, characterised by the expression levels and activity of
different membrane proteins.
In Chapter 2 I outlined the development of the mathematical model, and validated its basic
behaviours. Given a set of initial estimates for the major ion transport parameters (Table 2.2),
my model reproduced several of the electrophysiological features of a human airway epithelial
cell under open circuit conditions. This included amongst others: low intracellular [Na+] and
high intracellular [K+], a lumen negative transepithelial potential difference, and a large driving
force for Na+ absorption across the apical membrane (see Table 2.3).
This aspect of my work was not in itself novel. My mathematical model is motivated by the
general framework of Latta et al. (1984), and shares similarities with several previous models
of epithelial transport published by Hartmann and Verkman (1990), Duszyk and French (1991),
Horisberger (2003), and Garcia et al. (2013).
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7.1.2 Ability to simulate common Ussing chamber experiments
In Section 3.2.1, I described how one could use this mathematical modelling framework to
simulate Ussing chamber experiments. I outlined how one could model the effect of introduc-
ing a transport inhibitor to the bath solution, or how an ion replacement experiment could be
performed, by making appropriate changes to the model parameter values.
In particular, I simulated the effect of amiloride being added to the lumen solution, by set-
ting the apical Na+ permeability parameter, P ap
Na+
, to zero (Section 3.2.2). I saw that given the
initial reference parameters, my model produced the expected depolarisation of Vt on block-
ing ENaC channels, as well as a decrease in the internal Na+ concentration. I also simulated
replacing Cl− ions in the lumen compartment with gluconate− ions (Section 3.2.3). On per-
forming this ion replacement simulation, with the same reference parameter values, my model
produced a hyperpolarisation of Vt as would be expected for a human airway epithelial cell with
a significant apical Cl− permeability.
These simulations demonstrated that, one, the modelling framework could be used to
successfully implement simulations of Ussing chamber experiments common in the study of
epithelial transport, such as amiloride addition or removal of lumen Cl−, and two, that my
mathematical model made physiologically realistic predictions for the transient behaviour of
transepithelial potential difference in these scenarios.
7.1.3 Ability to estimate transport parameters from electrophysiological data
In Chapter 3 I showed that it was possible to estimate transport parameter values from in vitro
electrophysiological measurements made on HNE cells. I simulated +amiloride and +0[Cl−]l
interventions with my mathematical model, and by varying the parameters P ap
Na+
, P ap
Cl− , P
ba
K+ ,
P baCl− , ρNaK and ρNKCC , I could accurately reproduce the time evolution of cellular variables
[Na+]i, [Cl−]i, V
ap
m and Vt during these experiments. Employing an algorithm in order to sys-
tematically minimise the discrepancy between model predictions and observed cellular proper-
ties, I was able to estimate values for each of the 6 parameters listed, as well as determining
confidence intervals for these estimates.
A similar approach was recently taken by Garcia et al. (2013), and although there are
differences in the details of how they implement the parameter estimation, the general premise is
the same. They showed that by simulating a number of different Ussing Chamber experiments it
was possible to constrain significant numbers of major ion transport parameters. The values they
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estimate for P ap
Na+
and P ap
Cl− in non-CF HNE cells (0.017 µm/s and 0.043 µm/s respectively),
are remarkably similar to the values I arrived at, P ap
Na+
= 0.024 ± 0.004 µm/s and P ap
Cl− =
0.066 ± 0.017 µm/s. The fact that this approach to parameter estimation has been carried out
independently in a similar study, gives us further confidence in its validity.
7.1.4 Quantified activity of transport proteins in CF and non-CF HNE cells
The most significant original contribution I made in the course of my PhD research, was to de-
termine quantitatively the value of key transport parameters, apical Na+ and Cl− permeability,
not only in non-CF but also in CF HNE cells. This allowed me to ascertain if in cystic fibrosis
disease there were significant differences in the activity of CFTR and ENaC channels, relative
to the their basal activity in non-CF epithelia.
In Chapter 3 I showed that the estimates of P ap
Na+
in CF HNE cells were higher than in
non-CF HNE cells, that the estimates of P ap
Cl− were lower in CF cells, and that these differences
were statistically significant. In Chapter 4 I found that my estimate of the relative non-CF / CF
differences in these parameter values remained unchanged, even when allowing for large cell to
cell variation in biophysical properties used to estimate their values. In other words the results
of my analysis did not depend on the assumption of mean behaviour of HNE cells.
To my knowledge no other study has performed this analysis and given this insight. In
determining that apical Na+ permeability must be increased in the CF HNE cells, in order to
explain the hyperpolarised basal Vt and increased amiloride sensitive Vt, I had ruled out the
possibility these phenomena, of the observed magnitude, could arise as a result of electrical
coupling of CFTR and ENaC currents. That is, there is no evidence that loss of apical Cl−
conductance alone could explain these bioelectric properties, suggesting this line of reasoning
should not be pursued any further.
7.1.5 Quantified influence of transport parameters on epithelial properties
In Chapter 4, I investigated the relationships between parameters of ion transport, such as
membrane permeabilities, and electrophysiological properties, basal Vt, ∆Vt+amiloride and
∆Vt+0[Cl
−]l. In order to quantify these relationships, I performed a variance based param-
eter sensitivity analysis, relating model parameters to model outputs via a multiple regression
model. The major insights I found from this analysis, with regard to non-CF HNE cells, are
summarised as follows:
• Basal Vt in HNE cells is most sensitive to changes in apical Na+ permeability and ba-
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solateral K+ permeability. Increasing both P ap
Na+
and P baK+ tends to hyperpolarise the
value Vt takes at a steady state. Apical Cl− permeability has little or no influence on the
resting transepithelial PD, explaining why loss of CFTR permeability cannot account for
the significant hyperpolarisation observed in CF epithelia. The different sensitivities can
be understood in terms of the different magnitude of driving forces for movement of the
ions along these respective pathways.
• Amiloride sensitive Vt is most sensitive to P apNa+ . ∆Vt+amiloride can also be influenced
to a lesser extent by P ap
Cl− , with increasing apical Cl
− permeability decreasing its magni-
tude. The change in driving force for movement of Cl− across the apical membrane after
amiloride addition, can explain why P ap
Cl− influences Vt in these simulations, but cannot
change Vt under normal resting conditions.
• ∆Vt+0[Cl−]l is most sensitive to changes in P apCl− , as one would expect. Interestingly,
the other apical permeability parameter, P ap
Na+
, has very little influence on this metric,
suggesting it is a reasonable means of inferring the underlying levels of Cl− transport in
HNE cells.
To my knowledge, this is the first rigorous elucidation of quantitative membrane perme-
ability - transepithelial PD relationships in human airway epithelia. While in Chapter 3, I
showed it was possible to quantify individual membrane permeabilities, this was not the only
aim of my research, as it is in recent similar studies (see Garcia et al. (2013)). Here, I have not
only asked what values ion permeabilities take in CF relative to non-CF epithelia (quantifica-
tion), which is in itself informative, but I also addressed the question of why the permeabilities
differ. Via this sensitivity analysis I have gained the insights provided above, and these gave
answers relevant to several controversial questions regarding the relationship between CFTR
and ENaC activities in cystic fibrosis disease.
7.1.6 Ability to simulate clinical nasal PD recordings
In Chapter 5 I showed how one could simulate several stages of a clinical nasal PD test, using
the same approach as I had outlined for simulating Ussing chamber experiments in Chapter 3.
This highlighted how one could relate the parameters of airway ion transport that are commonly
recorded in the clinic, for example baseline Vt, ∆Vt+amiloride and ∆Vt+0[Cl−]l, to param-
eters that characterise the actual physiological state of the patient in question, such as apical
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Na+ and Cl− permeability.
Using the estimated values of transport parameters in non-CF and CF HNE cells (that I had
found in Chapter 3) as a starting point, I investigated how the commonly measured Vt metrics
responded to changes in these underlying parameters. As in Chapter 4, this took the form of a
parameter sensitivity analysis, however here I also took into account variations in paracellular
permeability, Ppa, and assessed how the results of the sensitivity analysis differed, depending
on whether the reference state was a CF or non-CF HNE cell.
The outcome of the non-CF sensitivity analysis largely reproduced the insights gained
in the earlier, similar analysis of Chapter 4. One new point of note was that changes in Ppa
had a large influence on all three Vt metrics, and the greater the paracellular permeability,
the lower the magnitudes of these measurements. Repeating the analysis with CF reference
parameter values, showed that Ppa, P baK+ and P
ap
Na+
again had large influences on basal Vt and
∆Vt+amiloride. Interestingly however, after amiloride addition (assuming all ENaC channels
are blocked), no parameter could significantly influence the transepithelial PD (either amiloride
insensitive Vt or ∆Vt+0[Cl−]l), save for a ≈ 1 − 2 mV change for a ±50% movement in
parameter value.
Following up from this insight, I investigated how these nasal PD measurements would
vary if only a certain fraction of ENaC channels were blocked on amiloride addition, rather than
assuming a 100% block. In both the CF and non-CF simulations, incomplete block of P ap
Na+
significantly affected the predicted ∆Vt+amiloride and had little or no effect on predicted
∆Vt+0[Cl
−]l (the effect was most pronounced in the CF case). Finally, I repeated the CF
sensitivity analysis, assuming now that P ap
Na+
would be reduced to 10% of its initial value on
amiloride addition, rather than reduced completely such that P ap
Na+
= 0. This changed the
sensitivity of Vt post amiloride addition to certain transport parameters, most notably apical
Na+ permeability and paracellular permeability.
These analyses constitute an original contribution, as previously the theoretical underpin-
nings of the standard nasal PD test carried out in clinical studies of cystic fibrosis have not, to my
knowledge, been investigated in a computational modelling study of this nature. Another novel
contribution is the insight that in theory the transepithelial PD is insensitive to large changes in
transport parameters, post amiloride addition, if all ENaC channels are blocked and no further
apical Na+ transport is possible. As there is often significant patient to patient variability in
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the value of Vt measured after amiloride addition, this provides further evidence that perhaps
not all Na+ transport is being abolished during these tests, either due to technical difficulties
with the application of amiloride, or due to the presence of a pool of amiloride insensitive Na+
channels in the apical membrane of HNE cells.
7.1.7 Investigate viability of parameter estimation from clinical nasal PD traces
The final contribution of my thesis was a feasibility or “proof-of-principle” study, where I in-
vestigated the viability of quantifying transport parameters directly from clinical nasal PD mea-
surements. Previously I had seen that it was possible to quantify membrane permeabilities given
in vitro Ussing chamber recordings, and now I wanted to ascertain if using the same approach
with in vivo nasal transepithelial PD recordings would prove to be informative. Ideally, given a
set of nasal PD recordings from a cohort of patients, I would like to determine the distribution
of transport parameters in that group, and use this information to gain some insight into what
aspect of transport physiology is liable to be causing patient to patient variations in nasal Vt
metrics.
I determined in this chapter, that differences in P ap
Na+
and P ap
Cl− alone cannot account for
the distribution of nasal PD metrics in a cohort of CF patients (for which I had data). This related
specifically to the level of Vt remaining post amiloride addition, which varied significantly in
this clinical group. I found that the data could only be fitted satisfactorily if I assumed not all
ENaC channels were being blocked, and estimated the actual block fraction η individually from
each trace.
I also highlighted in this chapter, the limitations placed on estimating transport parameter
values, given only nasal PD metrics. I showed that given basal Vt, Vt after amiloride addition
and Vt after luminal Cl− removal, three parameters could be uniquely estimated, but not four.
I found that estimating four parameters from Vt data alone would lead to degeneracies, and
therefore we could not assign specific physiological parameter values to a given nasal PD trace.
It was necessary to assume some information regarding intracellular ion concentrations was
known, in order to resolve the issue of degenerate parameter estimates.
Finally, given the assumption that initial intracellular Na+ and Cl− concentration were
the same in each patient, I estimated the values of P ap
Na+
, P ap
Cl− , Ppa and η from a group of CF
patients. I then compared how the distributions of parameter estimates differed by patient group,
Old, Young/Severe or Young/Mild, and looked for correlations between these parameter values,
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and metrics of lung function, such as the forced expiratory volume in one second (FEV1).
Although there was no statistically significant difference between estimated parameter values
across the three patient groups, one interesting finding that was that estimated P ap
Na+
values
were strongly correlated to FEV1 values, suggesting a link between increased ENaC activity
and reduced lung function in CF.
This chapter highlighted some of the problems related to using Vt metrics alone to infer the
membrane ion permeability of an individual. Although these issues may be well known, it is the
first time to my knowledge, that an actual demonstration of the possible degenerate nasal PD
traces has been given. I showed that the exact same values for basal Vt, ∆Vt+amiloride, and
∆Vt+0[Cl
−]l, can be produced by any number of different values of P
ap
Na+
, P ap
Cl− , Ppa and η,
provided we are not worried about what the intracellular conditions or individual membrane po-
tential values are. This has important implications for how nasal PD recordings are interpreted,
and particularly how one would interpret changes in a given metric over time. It has been
assumed for example, that changes in ∆Vt+0[Cl−]l in a given patient over time, correspond
directly to changes in CFTR permeability in that patient. However I have shown that it would
be possible to reproduce such Vt metrics with any value of P
ap
Cl− , provided the other transport
parameters take appropriate values, hence placing the reasoning behind using ∆Vt+0[Cl−]l
metrics in clinical trials into doubt.
7.2 Further model development and future applications
7.2.1 Incorporating bicarbonate transport and cell pH
As discussed briefly in Chapter 1, there is evidence that disruption to bicarbonate transport in
the human airways plays a pivotal role in the progression of CF lung disease. One hypoth-
esis proposes that loss of bicarbonate transport onto the airway surfaces, reduces the pH of
the surface fluids, thereby reducing the ability of bacteria to kill inhaled pathogens (Pezzulo
et al., 2012). A second hypothesis gives evidence that reduced bicarbonate concentrations on
the airway surface (caused by reduced secretion) leads to increased mucus viscosity, and that
resulting thick mucus is the cause of lung disease in CF (Quinton, 2008, 2010). At the root
of both hypotheses is abnormal bicarbonate transport in airway epithelial cells, due to mutated
CFTR ion channels through which HCO−3 ions can permeate.
In order to incorporate bicarbonate transport and a description of the cell’s pH, into the
current model framework, several adjustments would need to be made to the current frame-
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work. This would include the inclusion of two new ionic species, H+ and HCO−3 , and also the
inclusion of further transport proteins, responsible for moving bicarbonate and protons in and
out of epithelial cells in the airways. From a modelling perspective, this means having two new
variables (thus two new ODEs), plus several new parameters to describe the relative expression
level of different proton and bicarbonate exchangers and transporters.
Another difference to keep in mind when modelling H+ and HCO−3 transport, is that unlike
Na+,Cl− and K+ ions, we cannot reasonably assume that they do not take part in chemical
reactions in the intracellular compartment. For example, one would have to model H+ ions
binding to impermeant buffer ions in the cell, B−, and the effect of H+ ions combining with
HCO−3 to form H2CO3. The number of free protons or bicarbonate ions in the cell would then
be less than the total numbers of these ions entering the cell
d[H+]f
dt
=
1
fH+([H
+]f , [HCO
−
3 ]f )
(
J inH+ − JoutH+
)
(7.1)
d[HCO−3 ]f
dt
=
1
fHCO−3
([H+]f )
(
J in
HCO−3
− Jout
HCO−3
)
(7.2)
The buffering functions fH+ and fHCO−3 in equations 7.1 and 7.2 respectively, account for
the proton and bicarbonate ions that participate in binding reactions. They are given by the
following expressions, and their derivation can be found in the appendix, Section A.8
fH+
(
[H+]f , [HCO
−
3 ]f
)
= 1 +
KHB[B
−]t
(KHB + [H+]f )
2 +
[HCO−3 ]f
KH2CO3
(7.3)
fHCO−3
(
[H+]f
)
= 1 +
[H+]f
KH2CO3
(7.4)
In order to be able to integrate the new set of model ODEs numerically, one would require
values for KHB , KH2CO3 , and an estimate of the total impermeant buffer in HNE cells, [B
−]t.
It would be necessary as well to decide which proton and anion exchanger and transporter
proteins should be included in the expanded model system. As a useful starting point, one
could incorporate those described by Falkenberg and Jacobsson in their model epithelial system
(Falkenberg and Jakobsson, 2010). These authors developed a physiologically realistic model
of ion transport in human bronchial epithelial cells, which included an accurate description
of how cell pH changed during Ussing chamber experiments. In their model they included a
sodium bicarbonate cotransporter, an anion exchanger and a sodium hydrogen exchanger in the
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basolateral membrane (see Section 1.1.3.4).
While a generic Michaelis-Menten type function can be used to model the cycle rate of
each of these additional transport proteins, this introduces further model parameters. For each
exchanger or transporter, there would be at least an additional two half-saturation constants to
consider, plus another parameter to represent the expression level of that protein in the mem-
brane. Therefore including only those proteins considered by Falkenberg and Jacobsson would
add on the order of 10-15 new model parameters, when one considers the saturation constants,
expression levels, the details of H+ and HCO−3 buffering, and values of the external proton
and bicarbonate concentrations. Considering there is already a large number of parameters in
the model I have outlined in Chapter 2, this would make the prospect of carrying out parame-
ter estimation in this expanded model quite daunting, given the general paucity of intracellular
recordings during Ussing chamber experiments that one could use for constraining model out-
put. On the other hand, it does seem probable that one could gain useful qualitative insights
into the bicarbonate and pH kinetics in HNE cells during Ussing chamber experiments, by im-
plementing some of the ideas outlined here. For example one could ask, how does the apical
bicarbonate flux change as a function of CFTR and ENaC activity?
7.2.2 Model with variable Airway Surface Liquid compartment
The current mathematical model could be extended in order to investigate the delicate balance
of ion and water transport between epithelial cells in the airways and the airway surface liquid
(ASL). This would entail modifying the description of the lumen compartment, which in the
research outlined in this thesis, has a constant ionic composition (and no variation in volume).
The unchanging luminal compartment would be replaced by a compartment with variable vol-
ume, and variable ionic composition, like the intracellular compartment in the current model
framework.
One implication of making this change, would be to increase the number of state variables
from from six to ten, incorporating the four new variables that describe the ASL compart-
ment: ASL volume (WASL), moles of Na+ (Na+ASL), moles of Cl
− (Cl−ASL) and moles of K
+
(K+ASL). Consequently, the number of ODEs required to describe the kinetics of the cell plus
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ASL system would also increase to ten, the new ODEs being as follows:
dWASL
dt
= Japw (7.5)
dNa+ASL
dt
=
(
Iap
Na+
+ Ipa
Na+
)
/FzNa+ (7.6)
dCl−ASL
dt
=
(
Iap
Cl− + I
pa
Cl−
)
/FzCl− (7.7)
dK+ASL
dt
= Ipa
K+
/FzK+ (7.8)
Given the increased dimensionality of the ODE system, it may be more difficult to solve
f(x, θ) = 0 in order to find satisfactory steady state solutions. However, the number of model
parameters will not increase significantly in this new framework, if one considers a model with
the same transport pathways as described in this thesis. In that case the current CF and non-CF
parameter estimates could be used as an initial starting point, from which to investigate the
properties of this expanded system.
7.2.2.1 Investigation of relationship between Vt and ASL depth
Changes in transepithelial PD are used to quantify the CF disease state (see 1.2.4), and ASL
dehydration has been causally related to this disease state (Boucher, 2007a,b). However it is not
known if there is a well defined relationship between basal Vt and ASL depth. Using a similar
approach to that outlined in this report, I can hope to begin to answer questions such as, is there
a linear monotonic relationship between Vt and ASL depth? Or can homeostatic conditions be
maintained without any correlation between these two properties?
7.2.2.2 Investigate potential strategies for airway re-hydration
This extended ASL plus cell model could also be used to determine strategies for increasing the
volume of the ASL layer by pharmacologically modulating different transport proteins. With a
quantitative description of electrolyte transport between HNE cell and ASL, it may be possible
to determine how much water can be drawn onto the mucosal surface for a certain increase in
membrane permeability to a given ion for example. Therefore it may be useful in comparing
the relative efficacy of different strategies for hydrating the airway surfaces.
7.2.3 Use of model and identifiability analysis in experimental design
In Chapter 6 I investigated the potential utility of this mathematical modelling framework to
estimate physiological parameters from nasal PD traces. There are difficulties with the current
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approach, as only using data for Vt, ∆Vt+amiloride and ∆Vt+0[Cl−]l limits the number of
parameter values that we can estimate, without resorting to making assumptions regarding the
cell’s intracellular state, or with regard to the values other transport parameters remain fixed at,
if they are not being estimated.
There are two potential ways forward that I see, that may help overcome this problem.
One potential solution is to model the next stage of the nasal PD test. In the standard nasal PD
test, after the removal of Cl− from the lumen perfusate, the solution to be added contains a β-
agonist which will raise intracellular cAMP concentration and increase CFTR activity, leading
to a consequent change in Vt. The benefit of including this stage is that we could include the
next commonly used nasal PD measurement, ∆Vt+isoproterenol, in our objective function
for parameter estimation, giving us more power to constrain parameter values. The downside
is that we would need to include further parameters to determine how much CFTR activity
increases once isoproterenol is added, and over what time period the increase takes place. The
simplest assumption to make is that apical Cl− permeability increases by a fixed amount ξ
immediately as isoproterenol is added, in the same manner as apical Na+ permeability goes to
zero instantaneously on addition of amiloride in my Ussing chamber simulations. That is
P ap
Cl− → ξ
(
P ap
Cl−
)
; {ξ > 1} (7.9)
One could assume that all patients experience the same relative increase in CFTR activity, or
one could try and estimate ξ individually from each nasal PD trace, as I had done with the block
fraction η in Chapter 6. In the case of estimating the increase ξ each time, it is likely that the
ability to constrain further transport parameters would be limited.
A different approach to take, would be to try and determine in advance, a set of solution
exchanges which would be most informative in determining parameter values, particularly in
satisfactorily estimating values of P ap
Na+
, P ap
Cl− , P
ba
K+ and Ppa from a Vt trace alone. To begin
with, one could experiment on an ad hoc basis with different solution exchanges that could
reasonably be carried out in a clinical situation. For example, instead of reducing lumen Cl−
from 140 mM to 5 mM in one go, it could be performed in stages, say 40 mM at a time. The
lumen Cl− could be removed before amiloride is added, or a solution exchange introducing a
large K+ concentration could be incorporated. The general idea in each case would be to make
an initial assumption regarding transport parameter values, run one of these devised sets of
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solution exchanges, then try and reverse engineer the original parameter values given only the
values of Vt that the system relaxes to after each perturbation. In each case one could determine
whether parameter values of interest were practically identifiable given the resulting set of Vt
values, and determine how tightly constrained parameter values were in cases where they were
identifiable.
Appendices
159
Appendix A
Supplementary material
A.1 Constants and fixed model parameter values
Table A.1: Fixed parameter values used in mathematical model. Subscripts i, l & s refer to
intracellular, luminal and serosal quantities respectively
Property Parameter Value Units Reference
Paracellular permeability Ppa 0.035 µm/s (Willumsen and Boucher, 1989)
Activity coefficient γ 0.77 − (Hille, 2001)
Membrane H2O conductance Lw 220 µm/s (Falkenberg and Jakobsson, 2010)
Partial molar volume H2O vw 1.805× 10−5 m3/mol (Warren et al., 2009)
Moles impermeable anions ψi 2.375× 10−15 mol −
External osmolarity [S]l,s 290 mOsm −
External Na+ [Na+]l,s 140 mM (Willumsen et al., 1989b)
External Cl− [Cl−]l,s 120 mM (Willumsen et al., 1989b)
External K+ [K+]l,s 5 mM (Willumsen et al., 1989b)
External impermeable anions ψl,s 25 mM −
Membrane capacitance Cm 1 µF/cm2 (Hille, 2001)
Faraday constant F 96485 C/mol (Hille, 2001)
Universal gas constant R 8.314 J/molK (Hille, 2001)
Temperature T 310 K (Hille, 2001)
A.2. Derivation of Goldman-Hodgkin-Katz flux equation 161
A.2 Derivation of Goldman-Hodgkin-Katz flux equation
Fick’s law relates the diffusive flux Jdiff (x, t) of a particle to it’s concentration profile c(x, t)
via the diffusion co-efficient D.
Jdiff (x, t) = −D ∂
∂x
c (x, t) (A.1)
The flux of ions Jdrift due to the presence of an electric potential ψ (x, t) is given by
Jdrift(x, t) = −c(x, t)uzF ∂
∂x
ψ (x, t) (A.2)
where u is the molar mechanical mobility of the ion, z is the valence, and F is the Faraday
constant.
The molar mechanical mobility un of a specific ion n is related to it’s diffusion co-efficient
Dn by the Einstein relation, Dn = unRT where R is the universal gas constant, and T is the
absolute temperature. Therefore the net flux of an ion n due to both diffusion and drift is given
by
Jn (x, t) = −Dn∂cn (x, t)
∂x
− unznFcn (x, t) ∂ψ (x, t)
∂x
(A.3)
Current density is related to flux via In(x, t) = znFJn(x, t), and from this we arrive at
the following expression, known as the Nernst-Planck equation (Weiss, 1996)
In (x, t) = −unznFcn (x, t)
(
RT
cn (x, t)
∂cn (x, t)
∂x
+ znF
∂ψ (x, t)
∂x
)
(A.4)
An analytical solution to the Nernst-Planck equation can be found for the steady state
flux Jn across a membrane separating two well mixed solutions under certain assumptions. A
schematic of this particular scenario is shown in Figure A.1.
Under the constant field assumption, electric field  = −∂ψ/∂x is constant, therefore
∂ψ
∂x
=
∆ψ
∆x
= −Vm
L
(A.5)
where the membrane potential Vm is defined as V im − V om, and L is the width of the membrane.
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Figure A.1: Steady state electro-diffusion in one dimension across a membrane (grey area).
The concentration inside, cin, and outside, c
i
n, are constant, and vary with position x within the
membrane. In the constant field approximation there is a constant electric potential gradient
within the membrane, ∂ψ(x)/∂x = (V om − V im)/L, where V im − V om is the transmembrane
potential difference.
Replacing A.5 in A.3 one finds
Jn = −Dndcn(x)
dx
+ unznFcn(x)
Vm
L
(A.6)
remembering that since we are now considering a steady state, concentration is a function of x
only and flux becomes a constant Jn. Re-arranging in terms of concentration, and replacing un
with Dn/RT one finds
dcn(x)
dx
=
znFVm
RTL
cn(x)− Jn/Dn (A.7)
By separation of variables one can arrive at the following differential equation
dcn
− JnDn + znFVmRTL cn
= dx (A.8)
The ion concentration inside the cell is assumed to be known and constant, with value cin, and
similarly the concentration outside the cell is assumed to be a constant con. To determine the
ionic concentrations within the membrane, we utilise the fact that at the membrane boundaries,
the concentrations are a constant times the concentration on the opposite side of the interface.
This constant is called the partition coefficient kn, and the concentrations within the membrane
at the internal and external boundaries, are hence given by cmn (0) = knc
i
n and c
m
n (L) = knc
o
n
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respectively (Note I have used superscript m to denote concentration within the membrane).
Given this information we can now integrate A.8 within the membrane, using the limits
x = 0 to x = L and cn = cinkn to cn = c
o
nkn, to arrive at the expression
RTL
znFVm
ln
(
− JnDn + znFVmRTL kncon
− JnDn + znFVmRTL kncin
)
= L (A.9)
which, after taking the exponential of each side, becomes
− Jn
Dn
+
znFVm
RTL
knc
o
n =
(
− Jn
Dn
+
znFVm
RTL
knc
i
n
)
e
znFVm
RT (A.10)
Re-arranging in terms of the steady state flux Jn one arrives at the following expression
Jn =
znFVm
RT
(
knDn
L
)(
cin − cone−
znFVm
RT
1− e− znFVmRT
)
(A.11)
Defining the membrane permeability as Pn = (knDn)/L, and now computing the current
density per unit area (multiplying by znF ), we arrive at the constant field flux equation or the
Goldman-Hodgkin-Katz equation
In = Pn
z2nF
2Vm
RT
cin − cone−
znFVm
RT
1− e− znFVmRT
(A.12)
Note that in practice I will use ion activities in place of ion concentrations in equation
A.12. The two are related via an = γncn where γn is the activity co-efficient of ion n.
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A.3 Smith-Crampin Na+ −K+ − ATPase active transport model
A full description of the sodium potassium pump model is available in Smith and Crampin
(2004), I use their model description and parameter values in my work. A brief description of
the pump model is outlined here. Flux from the sodium potassium pump, JNaK(t), is given by
JNaK(t) = ρNaKνNaK(t) (A.13)
where νNaK(t) is the turnover rate of an individual pump protein, and ρNaK is the number of
pump proteins per unit area of the basolateral membrane (a free parameter in my model). The
turnover rate is given by
νNaK(t) =
α+1 α
+
2 α
+
3 α
+
4 − α−1 α−2 α−3 α−4
Σ
(A.14)
where α+/−1,2,3,4 are the forward and backward rate constants of the reduced 4 stage pump cycle:
α+1 =
k+1 N˜a
+
i
3(
1 + N˜a+i
)3
+
(
1 + K˜+i
)2
− 1
(A.15)
α+2 = k
+
2 (A.16)
α+3 =
k+3 K˜
+
s
2(
1 + N˜a+s
)3
+
(
1 + K˜+s
)2
− 1
(A.17)
α+4 =
k+4 M˜gATP
1 + M˜gATP
(A.18)
α−1 = k
−
1 [MgADP] (A.19)
α−2 =
k−2 N˜a
+
s
3(
1 + N˜a+s
)3
+
(
1 + K˜+s
)2
− 1
(A.20)
α−3 =
k−3 [Pi][H
+]
1 + M˜gATP
(A.21)
α−4 =
k−4 K˜
+
i
2(
1 + N˜a+i
)3
+
(
1 + K˜+i
)2
− 1
(A.22)
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Normalised concentrations:
N˜a+i = [Na
+]i/kd,Na+i
(A.23)
K˜+i = [K
+]i/kd,K+i
(A.24)
N˜a+s = [Na
+]s/kd,Na+s (A.25)
K˜+s = [K
+]s/kd,K+s (A.26)
M˜gATP = [MgATP]/kd,MgATP (A.27)
Voltage dependent dissociation constants:
kd,Na+s = k
0
d,Na+s
exp
{
(1 + ∆)FV bam
3RT
}
(A.28)
kd,Na+i
= k0
d,Na+i
exp
{
∆FV bam
3RT
}
(A.29)
Free inorganic phosphate is given by
[Pi] =
[ΣPi]i
1 + [K+]i/kd,H+Pi + [H
+]/kd,H+Pi + [Na
+]i/kk,Na+Pi
(A.30)
The term Σ in the denominator of A.14 is given by a sum of permutations of the rate constants
Σ = α−1 α
−
2 α
−
3 + α
−
1 α
−
2 α
+
4 + α
−
1 α
+
3 α
+
4 + α
+
2 α
+
3 α
+
4 +
α−2 α
−
3 α
−
4 + α
+
1 α
−
2 α
−
3 + α
+
1 α
−
2 α
+
4 + α
+
1 α
+
3 α
+
4 +
α−1 α
−
3 α
−
4 + α
+
2 α
−
3 α
−
4 + α
+
1 α
+
2 α
−
3 + α
+
1 α
+
2 α
+
4 +
α−1 α
−
2 α
−
4 + α
−
1 α
+
3 α
−
4 + α
+
2 α
+
3 α
−
4 + α
+
1 α
+
2 α
+
3 (A.31)
Rate constants used in the pump model are k+1 = 1050 s
−1, k−1 = 172.1 s
−1mM−1, k+2 =
481 s−1, k−2 = 40.1 s
−1, k+3 = 2000 s
−1, k−3 = 79, 287.1 s
−1mM−2, k+4 = 320 s
−1, k−14 =
40.1 s−1. Dissociation constants used are k0
d,Na+s
= 15.5 mM, k0
d,Na+i
= 2.49 mM, kd,K+s =
0.213 mM, k0
d,K+i
= 0.5 mM, kd,MgATP = 2.51 mM, kd,K+Pi = 292 mM, kd,H+Pi =
1.69×10−4 mM, and kd,Na+Pi = 224 mM. Other parameters fixed in this model are [ΣPi]i =
4.2 mM, [H+]i = 8 × 10−5 mM, [MgATP] = 9.8 mM, [MgADP] = 0.01 mM, and ∆ =
−0.031.
Note that in practice, I convert ion concentrations to ion activities (an = γcn) before
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computing equations A.23 - A.26, since under physiological conditions the intra- and extra-
cellular solutions considered will not behave as ideal electrolytes.
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A.4 Benjamin-Johnson NKCC cotransporter model
A full description of kinetic model and parameter values used in this model of the NKCC co-
transporter is given in Benjamin and Johnson (1997). I describe it briefly here. The basolateral
flux due to cotransport is given by JNKCC(t) = ρNKCCνNKCC(t) where νNKCC (a free pa-
rameter in my model) is the number of cotransporters per unit area of the basolateral membrane,
and νNKCC(t) is the turnover rate of a single cotransport protein, given by
νNKCC (t) =
kfullf k
empty
f [Na
+]s[K
+]s[Cl
−]2s − kfullb kemptyb [Na+]i[K+]i[Cl−]2i∑16
n=1 Z
n
nkcc
(A.32)
The terms Znnkcc are determined as follows
Z1nkcc = Z1
[
Cl−
]
i
(A.33)
Z2nkcc = Z2
[
Na+
]
s
(A.34)
Z3nkcc = Z3
[
Cl−
]
i
[
K+
]
i
(A.35)
Z4nkcc = Z4
[
Cl−
]
s
[
K+
]
s
(A.36)
Z5nkcc = Z5
[
Cl−
]2
i
[
K+
]
i
(A.37)
Z6nkcc = Z6
[
Cl−
]
s
[
K+
]
s
[
Na+
]
s
(A.38)
Z7nkcc = Z7
[
Cl−
]2
i
[
K+
]
i
[
Na+
]
i
(A.39)
Z8nkcc = Z8
[
Cl−
]2
s
[
K+
]
s
[
Na+
]
s
(A.40)
Z9nkcc = Z9
[
Cl−
]2
i
[
K+
]
i
[
Na+
]
i
[
Na+
]
s
(A.41)
Z10nkcc = Z10
[
Cl−
]
i
[
Cl−
]2
s
[
K+
]
s
[
Na+
]
s
(A.42)
Z11nkcc = Z11
[
Cl−
]2
i
[
K+
]
i
[
Na+
]
i
[
Cl−
]
s
[
Na+
]
s
(A.43)
Z12nkcc = Z12
[
Cl−
]
i
[
K+
]
i
[
Cl−
]2
s
[
K+
]
s
[
Na+
]
s
(A.44)
Z13nkcc = Z13
[
Cl−
]2
i
[
K+
]
i
[
Cl−
]2
i
[
K+
]
s
[
Na+
]
s
(A.45)
Z14nkcc = Z14
[
Cl−
]2
i
[
K+
]
i
[
Na+
]
i
[
Cl−
]
s
[
K+
]
s
[
Na+
]
s
(A.46)
Z15nkcc = Z15
[
Cl−
]2
i
[
K+
]
i
[
Na+
]
i
[
Cl−
]2
s
[
K+
]
s
[
Na+
]
s
(A.47)
Z16nkcc = K
2
ClKKKNa(k
empty
b + k
empty
f ) (A.48)
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where the coefficients Zn are given by
Z1 = KClKKKNak
empty
b (A.49)
Z2 = K
2
ClKkk
empty
f (A.50)
Z3 = KClKNak
empty
b (A.51)
Z4 = KClKKk
empty
f (A.52)
Z5 = KNak
empty
b (A.53)
Z6 = KClk
empty
f (A.54)
Z7 = k
empty
b + k
full
b (A.55)
Z8 = k
full
f + k
empty
f (A.56)
Z9 = K
−1
Nak
full
b (A.57)
Z10 = K
−1
Cl k
full
f (A.58)
Z11 = K
−1
Cl K
−1
Nak
full
b (A.59)
Z12 = K
−1
Cl K
−1
K k
full
f (A.60)
Z13 = K
−2
Cl K
−1
K k
full
b (A.61)
Z14 = K
−1
Cl K
−1
K K
−1
Nak
full
b (A.62)
Z15 = K
−2
Cl K
−1
K K
−1
Na
(
kfullb + k
full
f
)
(A.63)
kemptyb =
K2Cl KK KNa k
full
f k
empty
f
K2ClKKKNak
full
b
(A.64)
Rate constants and dissociation constants used in this model are KCl = 2.42 mM, KNa =
22.38 mM, KK = 234.74 mM, k
empty
f = 37, 767 s
−1, kfullf = 1406 s
−1, kemptyb =
13, 196 s−1, kfullb = 4025 s
−1 and they are also taken from Benjamin and Johnson (1997).
Note that in practice, I convert ion concentrations to ion activities (an = γcn) before
computing equations A.32 - A.48, since under physiological conditions the intra- and extra-
cellular solutions considered will not behave as ideal electrolytes.
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A.5 Determining paracellular permeability from shunt resistance
In my model I assume that under resting conditions the paracellular pathway is only permeable
to Na+,K+ and Cl− ions, therefore the total paracellular or shunt current will be given by
Is = I
pa
Na+
+ Ipa
Cl− + I
pa
K+
(A.65)
Assuming the paracellular currents are accurately described by the GHK formalism A.2, and
that the cation/anion permeability ratio is 1/λ, then in the limit of identical bathing solutions
this expression reduces to
Is = Ppa
(
VtγF
2
)
/RT
(
[Na+] + [K+] + λ[Cl−]
)
(A.66)
where Ppa ≡ P paNa+ ≡ P paK+ is the permeability of the pathway to cations. Shunt resistance Rs
is related to shunt current via Is = Vt/Rs therefore
Ppa =
1/Rs
(F 2γ/RT ) ([Na+] + [K+] + λ[Cl−])
(A.67)
Mean shunt resistance was measured to be 412 Ω cm2 and 623 Ω cm2 for non-CF and CF
HNE cells respectively (Willumsen and Boucher, 1989), with solution composition [Na+] =
140 mM, [Cl−] = 120 mM, and [K+] = 5.2 mM. For a non-selective pathway λ = 1, we find
that
Pnon−CFpa = 3.29074× 10−8 m/s = 0.0329 µm/s (A.68)
PCFpa = 2.17616× 10−8 m/s = 0.0218 µm/s (A.69)
If we assume a cation selective paracellular pathway with λ = 1/1.3 (Levin et al., 2006; Flynn
et al., 2009) the values we find are
Pnon−CFpa = 3.67442× 10−8 m/s = 0.0367 µm/s (A.70)
PCFpa = 2.42989× 10−8 m/s = 0.0243 µm/s (A.71)
All parameter estimation and Monte Carlo filtering analyses were carried out with the following
paracellular transport configurations: (A) Ppa unchanged in CF and non-selective, (B) Ppa
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unchanged in CF and cation-selective , (C) Ppa reduced in CF relative to non-CF and non-
selective, (D) Ppa reduced in CF relative to non-CF and cation selective.
For simulations where I assumed a cation selective Ppa, I also assumed that P
pa
Cl− =
1.4 P pa
gluc− . I estimated the ratio of 1.4 based on recreating the experiments of Coakley et al.
(2003) who found a permeability ratio P pa
Cl− > P
pa
gluc− .
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A.6 Effect of including [Na+]i kinetics on CF parameter estimates
Parameter (A) Including [Na+]i (B) Excluding [Na+]i
Median IQR Median IQR
P ap
Na− 0.070 0.011 0.070 0.014
P ap
Cl− 0.004 0.005 0.005 0.004
P baK+ 0.886 4.716 1.540 6.835
P baCl− 0.370 1.837 0.568 2.414
ρNaK 0.942 3.405 1.250 4.239
ρNKCC 3632 14243 1990 16267
Table A.2: Transport parameter values estimated using experimental data from CF HNE cells.
The experimental data used for constraining model behaviour was the same in both cases, apart
from the value of [Na+]i after amiloride addition, which was included in the objective func-
tion in case A, but was not included in case B. Estimates of P ap
Cl− and P
ap
Na+
are not altered
significantly by the inclusion or exclusion of this extra observation. The median values of the
basolateral transport parameters are different in both cases, but the differences are small relative
to the uncertainty in each estimate.
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Figure A.2: Including post amiloride addition [Na+]i in the objective function when estimat-
ing transport parameter values in CF HNE cells leads to different “optimum” solutions. Here
the best fit solution when the additional Na+ observation is included, is in green, and the blue
trace is the best fit solution when the additional observation is not included in the fitting pro-
cess. Experimental observations and associated uncertainties are plotted in red in each panel. In
these simulations the model system cannot qualitatively reproduce an increase in [Na+]i after
amiloride is added (at t = 150 s), hence if this observation is included in the fitting process,
parameter values move such that ∆[Na+]i + amiloride tends towards zero. This is not neces-
sarily a physiologically realistic situation, as I am forcing the system to fit a behaviour it cannot
predict.
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A.7 Influence of paracellular permeability and selectivity on pa-
rameter estimates
Parameter estimation described in Section 3.4.3 was carried out in four different scenarios, to
assess the influence that the magnitude of paracellular permeability and selectivity ratios had
on estimated transport parameter values, particularly those of P ap
Na+
and P ap
Cl− . The results of
this work are shown in Tables A.3 and A.4.
Parameter (A) Baseline P paNa+ , no selectivity (B) Baseline P
pa
Na+ , cation selective
Non-CF CF Non-CF CF
Median IQR Median IQR Median IQR Median IQR
P apNa− 0.0241 0.0039 0.0701 0.0140 0.0202 0.0031 0.0589 0.0121
P apCl− 0.0655 0.0166 0.0049 0.0043 0.0462 0.0113 0.0041 0.0041
P baK+ 0.1014 0.0733 1.5398 6.8347 0.0781 0.0395 1.1377 5.9989
P baCl− 0.0955 0.1146 0.5679 2.4145 0.0586 0.0560 0.3902 2.1851
ρNaK 0.1325 0.0906 1.2501 4.2394 0.1008 0.0544 0.9035 3.7991
ρNKCC 0.1991 0.4076 1990 16266 0.1543 0.2811 3159 11639
P paNa+ 0.035 - 0.035 - 0.035 - 0.035 -
P paNa+/P
pa
Cl− 1.0 - 1.0 - 1.3 - 1.3 -
P paCl−/P
pa
gluc− 1.0 - 1.0 - 1.4 - 1.4 -
Table A.3: Results of parameter estimation via minimisation of residual error between model
predictions and CF and non-CF HNE cell data. (A) Estimates of transport parameters found
when paracellular permeability is assumed to be fixed at the baseline estimate in both CF and
non-CF simulations, and is assumed to be the same for all ions. (B) Estimates of transport pa-
rameter values found when assuming baseline P pa
Na+
with a cation selective paracellular path-
way, and a Cl−/gluconate− paracellular selectivity ratio greater than 1.
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Parameter (C) P paNa+ reduced in CF, no selectivity (D) P
pa
Na+ reduced in CF, cation selective
Non-CF CF Non-CF CF
Median IQR Median IQR Median IQR Median IQR
P apNa− 0.0227 0.0036 0.0429 0.0087 0.0212 0.0033 0.0409 0.0083
P apCl− 0.0616 0.0155 0.0030 0.0028 0.0484 0.0118 0.0028 0.0029
P baK+ 0.0947 0.0688 0.9047 4.2966 0.0819 0.0402 0.7824 4.8400
P baCl− 0.0898 0.1077 0.2974 1.5111 0.0614 0.0592 0.2715 1.7954
ρNaK 0.1246 0.0836 0.6753 3.2724 0.1056 0.0584 0.6263 3.2322
ρNKCC 0.1871 0.3827 1538 14355 0.1612 0.2938 1441 13628
P paNa+ 0.0329 - 0.0218 - 0.0367 - 0.0243 -
P paNa+/P
pa
Cl− 1.0 - 1.0 - 1.3 - 1.3 -
P paCl−/P
pa
gluc− 1.0 - 1.0 - 1.4 - 1.4 -
Table A.4: Results of parameter estimation via minimisation of residual error between model
predictions and CF and non-CF HNE cell data. (C) Estimates of transport parameters found
when the magnitude of paracellular permeability is reduced in CF relative to non-CF simu-
lations, and paracellular selectivity is assumed to be the same for all ions. (D) Estimates of
transport parameter values found when assuming P pa
Na+
is reduced in CF simulations, and both
the Na+/Cl− and Cl−/gluconate− paracellular selectivity ratios are greater than 1.
A.8 Modelling H+ and HCO−3 transport
In this section I will give a brief outline of how transport of bicarbonate and protons could be
incorporated into the existing model of ion transport in HNE cells.
To begin with, I assume that H+ is present in three forms in the intracellular compart-
ment; free protons, [H+]f , protons bound to impermeant buffer, [HB], and protons bound to
bicarbonate ions in the form [H2CO3]. This gives for the total proton concentration in the cell
[H+]t = [H
+]f + [HB] + [H2CO3] (A.72)
Free H+ and impermeant buffer ions B− combine according to the following reaction
[H+]f + [B
−]f 
 [HB] (A.73)
If we assume this reaction is at rapid equilibrium such that
[H+]f [B
−]f
[HB]
= KHB (A.74)
and the total impermeant buffer [B−]t = [B−]f + [HB] is constant, then we can determine the
A.8. Modelling H+ and HCO−3 transport 175
free buffer in terms of the total buffer and the free protons, via
[B−]f = [B−t ]
(
1 +
[H+]f
KHB
)−1
(A.75)
The amount of protons bound to buffer at any time is given, via equation A.74, by
[HB] =
[H+]f [B
−]f
KHB
(A.76)
If we now replace [B−]f in this expression with the right hand side of A.75, we find
[HB] = [H+]f
[B−]t
KHB + [H+]f
(A.77)
When we replace A.77 in the equation for total protons in the cell we find
[H+]t = [H
+]f
(
1 +
[B−]t
KHB + [H+]f
)
+ [H2CO3] (A.78)
Next we consider the total amount of HCO−3 in the cell, which is either free or bound to
protons, such that
[HCO−3 ]t = [HCO
−
3 ]f + [H2CO3] (A.79)
Again, assuming rapid equilibrium free protons, [H+]f , and free bicarbonate, [HCO−3 ]f , we
can write for the total amount of free bicarbonate (analogous to equation A.75)
[HCO−3 ]f = [HCO
−
3 ]t
(
1 +
[H+]f
KH2CO3
)−1
(A.80)
And in the same manner as equation A.77, we can determine the number of bicarbonate ions
bound to protons, in terms of free protons, and total bicarbonate
[H2CO3] = [H
+]f
(
[HCO−3 ]t
KH2CO3 + [H
+]f
)
(A.81)
Finally, adding this into the expression for the total H+ in the cell, we get
[H+]t = [H
+]f
(
1 +
[B−]t
KHB + [H+]f
+
[HCO−3 ]t
KH2CO3 + [H
+]f
)
(A.82)
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The total amount of H+ in the cell can only change if H+ ions flow into or out of the cell
d[H+]t
dt
= J inH+ − JoutH+ (A.83)
Using the chain rule we can relate changes in free H+ to the total H+ in the cell
d[H+]t
dt
=
d[H+]t
d[H+]f
d[H+]f
dt
(A.84)
We can determine d[H+]t/d[H+]f from the expression we have previously determined for total
[H+]t, equation A.82
d[H+]t
d[H+]f
=
d
d[H+]f
(
[H+]f
(
1 +
[B−]t
KHB + [H+]f
+
[HCO−3 ]t
KH2CO3 + [H
+]f
))
(A.85)
= 1 +
KHB[B
−]t
(KHB + [H+]f )
2 +
[HCO−3 ]f
KH2CO3
(A.86)
Replacing A.86 in A.84 we have
d[H+]t
dt
=
(
1 +
KHB[B
−]t
(KHB + [H+]f )
2 +
[HCO−3 ]f
KH2CO3
)
d[H+]f
dt
(A.87)
If I now define a buffering function
fH+
(
[H+]f , [HCO
−
3 ]f
)
= 1 +
KHB[B
−]t
(KHB + [H+]f )
2 +
[HCO−3 ]f
KH2CO3
(A.88)
Then I can define the rate of change of free H+ in the cell as
d[H+]f
dt
=
1
fH+
d[H+]t
dt
(A.89)
=
1
fH+
(
J inH+ − JoutH+
)
(A.90)
The expression we arrive at states that free H+ in the cell changes due to net influx / efflux of
protons into the cell, but there is a buffering effect present (taken into account by the function
fH+) which dampens the rate at which changes in [H+]f take place, as some protons which
enter the cell will bind to impermeant buffer B− or to free bicarbonate to form [H2CO3].
Similarly, for free bicarbonate concentration in the cell, we can define a buffering function
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(from A.80)
fHCO−3
(
[H+]f
)
=
d[HCO−3 ]t
d[HCO−3 ]f
(A.91)
= 1 +
[H+]f
KH2CO3
(A.92)
Then the rate of change of free bicarbonate, as a function of influx and efflux of this ion, is
given by
d[HCO−3 ]f
dt
=
1
fHCO−3
([H+]f )
(
J in
HCO−3
− Jout
HCO−3
)
(A.93)
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A.9 MATLAB source code
All simulations and data analysis were performed using MATLAB Release R2010b, along with
MATLAB Optimisation Toolbox and Statistics Toolbox from the same release.
The MATLAB source code used to perform the simulations and data analysis described in
this thesis is available as an electronic supplement. In the case of physical copies of this thesis
they are stored on a CD/DVD attached inside the back cover. These files will also be made
available online to accompany the final electronic version of this thesis, which will be available
at the UCL Discovery website (discovery.ucl.ac.uk) once approved.
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A.10 Clinical Nasal Potential Difference data set
Trace Category Nasal PD measurements (mV) FEV1
Basal After amil. ∆Vt+amil. After 0[Cl−]l ∆Vt+0[Cl−]l
CF5a Young/Mild -25.7 -14.9 10.8 -18.4 -3.5 0.97
CF29a Young/Mild -20.2 -6.6 13.6 -7.1 -0.5 1.03
CF45 Young/Mild -39.6 -14.8 24.8 -17.3 -2.5 0.92
CF51 Young/Mild -47.1 -17.4 29.7 -19.3 -1.9 0.82
CF52 Young/Mild -40.5 -4.9 35.7 -6.7 -1.9 0.93
CF59 Young/Mild -44.3 -14.6 29.7 -20.4 -5.8 0.77
CF60 Young/Mild -43.4 -24.4 19.0 -27.1 -2.7 0.70
CF70 Young/Mild -19.4 -7.3 12.2 -10.0 -2.7 0.72
CF72 Young/Mild -39.0 -10.1 29.0 -12.8 -2.7 0.67
CF73 Young/Mild -55.4 -11.4 44.0 -14.9 -3.5 0.85
CF77 Young/Mild -47.0 -13.0 34.0 -14.8 -1.8 0.79
CF7b Old -54.2 -16.3 37.9 -20.1 -3.8 0.48
CF9a Old -52.2 -13.8 38.4 -20.2 -6.4 0.81
CF10a Old -58.2 -21.8 36.4 -23.1 -1.3 0.81
CF11a Old -36.3 -9.3 27.0 -29.3 -20.0 0.21
CF11b Old -43.2 -6.2 36.9 -25.6 -19.4 0.21
CF12a Old -41.0 -8.0 32.9 -8.8 -0.8 0.91
CF12b Old -48.2 -7.2 41.0 -12.8 -5.6 0.91
CF13a Old -28.1 -21.8 6.3 -23.8 -2.0 0.89
CF13b Old -36.5 -9.7 26.8 -11.8 -2.1 0.89
CF14a Old -50.1 -15.4 34.7 -19.7 -4.4 0.79
CF15a Old -62.8 -13.2 49.6 -18.1 -5.0 0.76
CF17a Old -34.9 -15.2 19.8 -18.6 -3.4 0.64
CF17b Old -30.3 -14.0 16.3 -15.9 -2.0 0.64
CF19a Old -53.6 -9.3 44.3 -21.7 -12.4 0.22
CF20b Old -45.5 -28.2 17.3 -32.9 -4.7 0.47
CF25a Old -72.1 -21.1 51.0 -25.0 -3.9 0.26
CF1 Young/Severe -50.9 -24.1 26.8 -35.2 -11.1 0.52
CF2b Young/Severe -50.6 -22.7 27.9 -25.7 -3.0 0.37
CF3a Young/Severe -55.9 -7.5 48.4 -9.7 -2.2 0.38
CF26a Young/Severe -20.0 -8.1 11.9 -11.0 -2.9 0.41
CF30a Young/Severe -55.0 -13.2 41.8 -15.1 -1.9 0.42
CF30b Young/Severe -35.8 -15.1 20.8 -15.4 -0.4 0.42
CF67 Young/Severe -33.5 -20.2 13.3 -25.1 -4.9 0.58
CF39 Young/Severe -38.8 -3.8 35.0 -6.6 -2.8 0.42
CF47 Young/Severe -55.7 -15.3 40.4 -17.6 -2.2 0.46
CF48 Young/Severe -71.5 -14.1 57.4 -17.8 -3.7 0.36
CF49 Young/Severe -49.8 -14.6 35.2 -20.5 -5.9 0.29
CF61 Young/Severe -52.4 -20.2 32.2 -22.9 -2.7 0.24
CF65 Young/Severe -53.0 -21.0 32.0 -21.9 -0.9 0.38
CF69 Young/Severe -50.5 -22.5 28.0 -23.1 -0.6 0.54
CF76 Young/Severe -45.5 -8.4 37.1 -9.4 -1.0 0.53
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